The molecular and genetic evolution of foot-and-mouth disease virus by Logan, Grace
  
 
 
 
 
 
 
 
 
Logan, Grace (2017) The molecular and genetic evolution of foot-and-
mouth disease virus. PhD thesis. 
 
 
http://theses.gla.ac.uk/7877/  
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, without prior 
permission or charge 
This work cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
UNIVERSITY OF GLASGOW
The Molecular and Genetic Evolution of
Foot-and-Mouth Disease Virus
by
Grace Logan
A thesis submitted in partial fulfillment for the
degree of Doctor of Philosophy
in the
College of Medical, Veterinary and Life Sciences
Institute of Biodiversity, Animal Health and Comparative Medicine
January 2017
Abstract
Foot-and-mouth disease virus (FMDV) (Family: Picornaviridae, Genus: Aphthovirus) is
a significant global pathogen with extensive economic impact. FMDV has a low fidelity
RNA-dependent RNA polymerase and lacks proof reading capability. This coupled
with its relatively short generation time and large population sizes means it exists in
a swarm of genetically closely related variants. The reservoir of diversity contained
within this mutant spectrum allows the virus to adapt rapidly to new environments.
Much of the previous work looking at virus evolution has focused on the consensus level
genetic sequence. The advent of next generation sequencing (NGS) technologies enables
evolutionary studies of the entire viral swarm. This PhD project uses NGS technologies
to interrogate the swarm structure by investigating factors affecting the viral swarm and
the dynamics of variants within it. Furthermore, this work shows how analysis of the
swarm can reveal fundamental information about virus biology.
A PCR-free NGS methodology was developed to create deep sequencing data sets of all
genomes present within an FMDV viral swarm. The elimination of the PCR step results
in less errors being introduced in the sequencing process thereby improving the resolution
and reliability of the identification of low level variants. This optimised method was then
used to define and compare the FMDV swarms of several wildtype isolates. This revealed
differences in swarm structure from isolate to isolate and produced evidence of within
swarm selection. Not all proteins known to be under selection at the consensus level
were also under selection within the swarm. The diversity of viruses within the swarm
was found to be dependent upon the host from which a virus was sampled, with African
buffalo potentially able to maintain multiple infections. Subconsensus variants in these
mixed samples had mutations at positions previously associated with immune escape.
Investigation of the evolution of swarm structure when adapting to new cell type in
vitro indicated that two distinct population structures can exist relative to the existence
of adaptive pressure. These two population structures have different distributions of
variable nucleotides but comparative total levels of variation (as measured by Shannon’s
entropy). Deep sequencing of the virus swarm enabled the discovery of conserved novel
stem loop structures, which were hypothesized to be required for packaging of the virus
genome. Mutating these sites produced a virus with decreased packaging efficiency.
This thesis includes novel analysis techniques for considering the viral swarm. It demon-
strates how investigating the diversity in the swarm can help us to understand virus
molecular biology, its evolution and the limits upon this. Understanding viral evolution
at this scale has the capacity to improve our fundamental understanding of the biology
and evolution of FMDV which can in turn inform vaccine design and disease control
strategies.
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Chapter 1
Introduction
This thesis investigates the genetic and molecular evolution of foot-and-mouth disease
virus (FMDV). This introductory chapter describes what is known about FMDV and
the disease it causes; foot-and-mouth disease (FMD). A summary of the current global
distribution and predicted financial burden is included followed by a description of the
virus, its life cycle and the clinical signs it causes. A description of transmission, cur-
rent diagnostic techniques and vaccine design is also made. The latter section of this
chapter discusses viral evolution. This describes how viruses exists in a diverse swarm
of genetically related variants. The creation of this diversity is discussed along with the
concepts of the sequence space the swarm exists within and effect of the mutant spec-
trum on fitness. The current molecular techniques available to consider these concepts
are summarised. Finally the objectives of this thesis are outlined.
1.1 Foot-and-mouth disease
Foot-and-mouth disease virus is a global pathogen with an extensive economic impact.
The virus is a member of the family Picornaviridae within the genus Aphthovirus. There
are seven serotypes of FMDV. Serotype O and A were the first to be assigned in 1922 by
Valle´e and Carre´. They were named after their country of origin. Valle´e O was named
after the northern French region of Oise and is now known as type O. Valle´e A was
named after Allemagne (Germany) and is now referred to as type A [1]. Simultaneously
Waldman and Trautwein identified three serotypes; Waldman A, B and C. Waldman
A and B were then found to be the same serotypes as Valle´e O and Valle´e A and the
French nomenclature was retained. Waldman type C was novel and is now known as
type C [2]. In the 1950s, subsequent to the classification of the European serotypes, Asia
1
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1 was isolated in Pakistan and India [3, 4] and three distinct serotypes were isolated in
southern Africa (southern African territories 1-3)(SAT1-3) [5].
1.1.0.1 Global distribution
FMDV is not evenly distributed throughout the globe. This is affected by a number of
factors including (but not limited to);
 livestock density and the presence of reservoir hosts
 animal husbandry, movement and trade
 investment in disease control
The global FMDV population can be roughly divided into seven regional pools. Pool
1 covers south-east Asia with spillover into eastern Asia. Pool 2 represents southern
Asia. Pool 3 covers EurAsia (including the Middle East). In these three regions type O,
type A and Asia 1 are circulating. Pools 4, 5 and 6 cover eastern, western and southern
Africa respectively. In pool 4 type O, type A and SAT 1, 2 and 3 are circulating. In
pool 5 type O and A circulate with SAT 1 and 2 and in pool 6, southern Africa, only
the SATs tend to circulate. Pool seven covers South America and has only type A and
type O circulating.
Figure 1.1: Conjectured FMD country status Countries marked in dark green
are OIE member countries and zones recognised as free from FMD without vaccination.
Countries marked in light green are OIE member countries or zones recognised as free
from FMD with vaccination. All other countries are without an OIE official status for
FMD (accurate in Aug 2016)[6]. The conjectured status of FMD in countries without
an OIE official status (as compiled by the WRLFMD, Pirbright) is shown in yellow for
countries with sporadic outbreaks and in red for those countries/regions predicted to
have endemic infection.
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A, O and C are the most globally distributed [7] although C has not been isolated since
2004 and may no longer be circulating [8]. As can be seen from the pools, the southern
African serotypes mostly circulate in sub-saharan Africa [9] and Asia 1 outbreaks are
usually restricted to Asia [10] although both SATs and Asia 1 have made incursions
outside these limits.
1.1.0.2 Economic cost
FMDV outbreaks can have an extensive economic impact in both FMD free countries
and those endemically infected. Conjectured FMD country status is outlined in Figure
1.1.
Outbreaks in FMD free countries An outbreak in an FMD-free country causes
the loss of stock and the loss of many trade rights. Restoration of trade rights requires
regaining FMD free status from the World Organisation for Animal Health (OIE). Rec-
ommendations set by OIE policy currently suggest quarantine and slaughter in response
to an FMD outbreak in an FMD free country. This involves ’stamping out’ of all an-
imals infected and those in contact or at risk of infection (i.e. herds at neighbouring
premises). This results in a large loss of life amongst susceptible livestock. In the 2001
outbreak in the United Kingdom 2030 infected premises were identified across the coun-
try which resulted in the culling of 6 million animals. Only 1.3 million of these were on
infected premisses [11]. There is increasing public pressure to adopt policies less costly
to livestock lives than ’stamping out’. For bovine tuberculosis (TB) the Department for
Environment Food and Rural Affairs (DEFRA) employs a policy of removal of animals
only if they have tested positive for the disease [12]. This reduces the impact of loss
of life improving animal welfare and decreasing the financial burden of outbreaks but
would struggle to be effective with FMDV due to its highly contagious nature. Others
have suggested the use of emergency vaccination and the Council of the European Union
(EU) has issued a directive which includes the provision and use of vaccination [13, 14].
The loss of stock and the inability to trade has an extensive economic impact. The
direct impact of the UK 2001 FMDV outbreak was estimated at 8 billion pounds [15].
Endemic Countries The economic impact of an outbreak in FMD free countries can
be clearly documented as described above. However, the continued burden of infection
in endemic countries is more challenging to quantify. Rushton et al have proposed a
framework for assessing the impact of FMD outlined in Fig. 1.2 [16]. Although the
mortality of FMD is limited the disease has numerous more constant affects. Knight
and Rushton highlight that as well as the immediate loss of production, the long term
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productivity can be affected by changes in the structure of the herd due to lower fertility.
The cost of managing disease through diagnostics, vaccination and movement control is
high but without those controls access to the international markets cannot be achieved.
Vaccination and production losses caused by FMD are estimated to cost 5 billion USD
per annum globally [17].
Figure 1.2: Impact of FMD The Impact of FMD in endemic countries can be
broadly split into direct losses (both visible and invisible) and indirect loses such as the
cost associated with disease control and revenue that cannot be achieved due to trade
restrictions. Figure taken from Knight-Jones et al [17]
1.1.1 The disease
Hosts FMD is a disease of cloven hooved animals. It has an extensive host range with
the majority of even-toed ungulates (order Artiodactyla) able to contract the disease [18].
Species that have been identified with FMD are outlined in Table 1.1.
Order Family Number
Artiodactyla Bovidae 24
Camelidae 4
Cervidae 10
Giraffidae 1
Suidae 4
Tayasuidae 1
Hydracoidea Procaviidae 1
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Insectivora Erinaceidae 2
Talpidae 1
Lagomorpha Leporidae 1
Probiscidae Elephantidae 2
Rodentia Bathyergidae 2
Capromyidae 1
Chinchillidae 1
Dasyproctidae 1
Hydrochaeridae 1
Hystricidae 1
Muridae 4
Sciuridae 2
Table 1.1: Species susceptible to FMDV A list of families within orders able to
contract FMDV. Number represents the number of species within that family identified
as susceptible [19].
Carrier Animals An animal is considered a persistent carrier if live virus is present
in an asymptomatic animal over 28 days post recovery from acute infection [20]. Some
animals do not suffer acute infection but are still able to carry the disease. FMD carrier
animals have been identified in sheep, buffalo, goats and cattle. Virus recovered from
these animals is generally low titre [21] and has been found to persist for up to three
years [22].
Site of infection In cattle the tissue that serves as the primary site of replication
is contested. Some studies have found it to be the pharynx [23] while other studies
have identified bronchiolar epithelium [24]. These differences may be due to the specific
infecting virus. Different cell types have a different range and number of receptors on the
cell surface which is the distinguishing factor in tropism. Virus particles disseminate from
the primary site of replication to oral and podal epithelium potentially via monocytes
or macrophages [25]. In pigs, virus is predicted to replicate in the pharynx [26]. From
here it passes through local lymph nodes and enters the blood stream to disseminate to
mostly podal epithelial tissues. This is where lesions in pigs most commonly occur [27].
Clinical Signs FMD generally causes low mortality although this can be elevated in
older, younger or immunocomprimised animals [28]. As well as age and immune status,
severity of disease can be affected by the host species or breed. For example, FMD
infection in African buffalo produces no clinical signs [29].
Chapter 1. Introduction 6
Clinical signs of FMD (if apparent), appear from 7-10 days post infection and include
fever and vesicular lesions on tongue, snout, teats and feet leading to lameness [30].
These symptoms can result in refusal to feed causing loss of body condition and drop in
milk production.
Transmission The most common form of transmission is through direct contact
between infected and susceptible animals. Transmission can also occur through indirect
contact such as contact between a susceptible animal and infected feed products or
equipment [31]. This is due to the presence of virus in saliva, expelled air, milk, urine
and faeces of acutely infected animals [32]. In cattle the respiratory tract is generally
considered to be the infection route although infection has also been recorded through
skin abrasions and mucous membranes [33]. Pigs are much less suceptible to infection
via aerosolized virus [34]. In pigs infection is mostly caused by direct contact or ingestion
of infected feed.
Diagnostics The clinical signs of FMDV bare some similarity to other animal disease
(such as vesicular stomatitis in cattle and pigs). Therefore, clinical diagnosis by veteri-
narians in the field is supplemented by laboratory diagnosis. Samples from the field can
be sent to country reference laboratories or the World Reference Laboratory for FMD
(WRLFMD) based at The Pirbright Institute.
The OIE gold standard for diagnosis of FMD is isolation of the virus from primary
bovine cell culture (Bovine Thyroid Cells (BTys)) [35]. This is supplemented with viral
antigen enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain
reaction (RT-PCR) detection [35] which allow for virus serotyping. Sanger sequencing
of a section of the capsid coding region of the genome is also performed to provide data
for molecular epedemiological studies and allow for more informed vaccine selection
[36]. Vaccine selection is further supplemented by vaccine matching, a process that
involves virus neutralisation tests of animal serum with a panel of vaccine candidates
[37]. Some pen-side tests are also available including field PCR machines (and isothermal
amplification processes) and lateral flow devices [38, 39]
Vaccine Currently almost all available vaccines are inactivated virus preparations
[40] although some peptide based vaccines are in use in China. There are vaccines de-
signed against single strains and multivalent vaccines designed to protect against mul-
tiple strains but no single vaccine exists that protects against all seven serotypes of
FMDV. The majority of FMDV vaccines are prepared by growth in cell culture, clari-
fication, inactivation and blending with appropriate adjuvants [41]. Extensive research
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continues into the manufacture of a multivalent vaccine appropriate for all serotypes
and strains of FMDV. Recently published work has focused on the stabilisation of an
empty FMDV capsid [42, 43]. This technique involves the recombinant expression of
FMDV capsids. This would negate the need to grown up large quantities of virus for
subsequent binary ethyleneimine inactivation [44] and allow the production of vaccine
outside of high containment facilities.
1.1.2 Foot-and-mouth disease virus
1.1.2.1 Classification
As previously described FMDV is a Aphthovirus within the family Picornaviridae. This
is a diverse virus family with thirty one different genera further divided into 54 species
[45] (Fig. 1.3). There are also currently over 40 unclassified viruses within this family.
Figure 1.3: Phylogenetic tree of the Picornaviridae family An unrooted neigh-
bour joining tree of 31 genera of the family Picornaviridae completed using the se-
quences of 3D polymerase by Nick Knowles [45]. FMDV is highlighted in red
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The genome organisation of the genera of Picornaviridae is similar. Further details of
each of the proteins within the genome is described in the subsequent section. These
similarities have allowed for work completed in some model organisms to be consider
potentially indicative of viral function in other viruses within the family (Fig. 1.4).
The most studied virus in this family is poliovirus (PV). Poliovirus is a human en-
terovirus and is the causative agent of poliomyelitis. There are three serotypes of PV;
poliovirus type 1 (PV1), poliovirus type 2 (PV2) and poliovirus type 3 (PV3). Offi-
cial global eradication of poliovirus type 2 was declared in September 2015. PV3 was
last identified in 2012 in Nigeria and it is hoped this serotype has also been eradicated.
Poliovirus type 1 is therefore the most highly circulating virus although this strain is
currently thought to be restricted to Pakistan and Afghanistan [46]. Due to the exten-
sive cost on human life (or quality of life) a large amount of funding has been provided
to research effective vaccines and study this virus. Much of what is known about po-
liovirus’ life cycle is predicted to be similar in other Picornaviridae and it is sometimes
used as a proxy for FMDV when comparable experiments have not been completed.
Figure 1.4: Picornaviridae genome organisation Each genome contains a 5 prime
untranslated region followed by a Leader protease which can be produced in two iso-
forms in some family members (Grey/Yellow). The structural capsid proteins follow
(shades of blue) with some virus members (Kobuvirus and Parechovirus) lacking a
cleavage event completed by the other viruses and thus having only three capsid pro-
teins one of which is a precursor in other viruses (VP0-purple) non structural proteins
coded by P2 (green) and P3 (red) are similar although FMDV codes for three copies
of 3B compared to 1 in each of the other virses. Figure taken from Lewis-Rogers et al
[47]
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1.1.2.2 Virion
The FMDV virion is approximately 30nm in diameter. The virus produces four capsid
proteins (VP4, VP2, VP3 and VP1) coded for by the P1 section of the polyprotein.
Proteolytic processing of P1 produces VP1, VP3 and the precursor VP0. A single
copy of each of these assembles to form a protomer structure. Five protomeric subunits
assemble to form a pentamer and 12 pentamers assemble to form a capsid. A maturation
event occurs in which VP0 undergoes RNA dependant autocleavage to form VP2 and
VP4 stabilising the capsid [48]. FMDV forms an icosahedral capsid that exhibits 2-, 3-
and 5- fold axes of symmetry [49]. The capsid demonstrates pseudo T=3 architecture
[50](Fig. 1.5).
Figure 1.5: FMDV capsid Surface representation of atomic models of an FMDV
capsid protomer. Five of these produce a pentamer, twelve pentamers form an intact
virion. Capsid subunits are colour coded; VP1 is blue, VP2 is green, VP3 is red and
VP4 is yellow. Negative-stain EM images are shown of dissociated pentamers and
intact inactivated FMDV O1Manisa (O1M) capsids. Figure adapted from Kotecha et
al [43, 51]
VP4 is internal to the capsid and has been predicted to interact with the RNA [28].
The other three capsid proteins (VP1, 2 and 3) are external. VP2, VP3 and VP1 are
involved in antigenicity and cell entry [52–54]. VP1 has an extended loop that protrudes
from the capsid surface. This loop, termed the G-H loop, contains an Arg-Gly-Asp motif
(RGD motif) that mediates the binding of virus to integrin receptors on the cell surface
[55]. Recombination and mutation within this region can allow access to cells with
different cell surface receptors. This often involves the appearance of positively charged
amino acids allowing the utilisation of negatively charged proteoglycan receptors such
as heparin sulphate [56, 57]. The FMDV pentamer is acid labile and dissociates when
exposed to a pH below 6.5 [58].
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1.1.2.3 Genome organisation
FMDV is a single stranded RNA virus. The genome is approximately 8500 nucleotides in
length [59]. The genome consists of a 5 prime un-translated region (5’UTR) a single open
reading frame (ORF) and a 3 prime un-transalted region (3’UTR). Covalently bound to
the 5’ end of the genome is a viral encoded protein (VPg or 3B)[60]. Within the 5’UTR
there are a number secondary structure elements: the short fragment (S-fragment),
poly-c tract, RNA pseudoknots, the cis-acting replication element (cre) and internal
ribosome entry site (IRES). The cre and IRES have been found to be important for
translation and replication as described later. Although studies have been completed to
consider their function, the exact role of the S-fragment [61, 62], poly-c tract [63, 64] and
RNA pseudoknots [65] remain unknown. The 3’UTR also contains secondary structure
elements. There are two stem loops directly following the ORF called stem loop 1 (SL1)
and stem loop 2 (SL2) which are involved in viral replication. The 3’ end of the genome
consists of a poly-A tail (Fig. 1.6).
Figure 1.6: FMDV genome Schematic of the FMDV genome showing the secondary
structure elements of the 5’UTR, the proteins coded for by the single ORF and the
components of the 3’UTR.
1.1.2.4 Open reading frame
The FMDV genome encodes for a single open reading frame that is translated into a
single polyprotein.
The N-terminus of polyprotein codes for a papain-like proteinase called leader protease
(LPro). This protein has two start codons 84 nucleotides apart leaving it able to create
two separate forms of this protein: Lab and Lb. Both proteins facilitate autocatalytic
cleavage from the polyprotein (LPro/P1 cleavage site)[66]. Both forms of LPro also
function to cleave host factors. For example, LPro acts as a viral deubiquitinase that
negatively regulates the Type 1 interferon pathway [67] and cleaves a number of other
host factors [68].
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P1/2A, the section of the polyprotein downstream from LPro, contains the structural
proteins VP1-4 (termed in some literature 1A-1D) and non-structural protein 2A. The
structural elements undergo proteolytic processing to form the viral capsid as described
previously.
Figure 1.7: FMDV Polyprotein The leader protease separates itself from the
polyprotein via autocatalytic cleavage. P3 is separated from the polyprotein via 3C
protease cleavage. P1/2A is separated from P2 via ribosomal slippage. Subsequent
processing is completed by 3C protease cleavage (purple diamond). The cleavage mech-
anism of VP0 into VP4 and VP2 is predicted to be RNA dependant autocleavage.
The subsequent section of the polyprotein, P2, contains non-structural proteins 2B and
2C. P2 is separated from P1 via ribosomal skipping. This is caused by the hydrolysis of
a peptidyl-tRNA ester linkage formed during translation promoted by a sequence con-
tained in the C-terminus of 2A [69]. The function of 2B in FMDV in not well classified.
Work has found that it may function as a viroporin localised to the endoplasmic reticu-
lum and acting to disrupt cell membranes. It has also been implicated in the formation
of autophagosomes [70]. FMDV non-structural protein 2C has been associated with nu-
merous functions. It has a predicted amphipathic helix at the N-terminus that may be
associated with membrane binding [71]. It has ATPase activity [72] and has also been
found to bind beclin, a key component of the cellular autophagy pathway [73]. It also
has helicase domains [74].
The P3 coding region includes 3A, 3C and 3D. 3A is a membrane-associated protein
that has been implicated in influencing host range [75–78]. There are three copies of 3B
(or VPg), a feature unique to FMDV among the picornaviruses. VPg acts as a primer
for initiation of RNA replication. 3C is a virally encoded protease. 3C processes P1-2A
to produces the structural proteins (VP0, VP3 and VP4) as well as processing of P2
and P3 to produce the non-structural proteins [79] as shown in Fig. 1.7. 3D is an RNA
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dependent RNA polymerase (RdRP). It has limited copying fidelity and determination
of its crystal structure has shown no evidence of a proofreading domain [80, 81].
1.1.2.5 Life cycle
FMDV viral particles bind to cell surface receptors to trigger cell entry. In the case
of the majority of wildtype FMDV strains the RDG motif on the GH loop of VP1
interacts directly with integrin receptors on the cell surface. Virions are then trafficked
to endosomal compartments. In the case of integrin binding this is mediated by clathrin
coated vesicles. These early endosomes have low internal pH [82]. The lower pH causes
protonation of residues at the 2-fold axis of the virion, resulting in electrostatic repulsion
of the capsid subunits from one another [83]. This exposes the hydrophobic internal
capsid protein VP4 which interacts with the membrane of the early endosome to create
a pore that allows for the release of viral RNA into the cytosol [84].
Translation can begin immediately via use of cellular machinery [85]. The majority of
cellular mRNA translation is dependant on a 5’ terminal cap. The 5’ terminal of the
mRNA is scanned by the ribosome until the 5’ terminal cap is identified, this initial
interaction then prompts recruitment of the rest of the cellular translational machin-
ery. FMDV lacks this terminal cap structure. Instead, translation initiation relies upon
the internal ribosomal entry site. A number of cellular proteins are essential for viral
translation. These cellular proteins interact with the IRES [86, 87]. One such protein
is translation initiation factor 4G (eIF4G). LPro cleaves eIF4G halting cellular transla-
tion. The C-terminal cleavage product binds with the IRES and 40S ribosomal subunit
prompting ribosome assembly and viral RNA translation [88]. The virus shuts off host
translation and transcription by cleavage of cellular proteins (for example eIF4G as
described above) [89].
The mechanism that produces the switch from translation to replication is unknown.
Some work has suggested that the accumulation of the precursor to the RdRP (3CD)
triggers reduced host factor binding to the IRES [90]. Replication occurs in replication
complexes formed from cellular membranes. These membranes are thought to be derived
from the endoplasmic reticulum or golgi apparatus [91, 92]. The cre may act as a
template for binding protein-linked dinucleotides to VPg creating VPGpUpU at the
5’end of the genome [93]. VPgpUpU acts as a primer for replication. Some work
suggests the genome circularises bringing the VPgpUpU and poly-A tail together [94].
The generation of the VPgpUpU may also be cre independent at the 3’end of the genome
[95]. FMDV RdRP 3D catalyses the elongation of the negative strand to generate double
stranded RNA. This double strand is then unwound.
Chapter 1. Introduction 13
Figure 1.8: FMDV Lifecycle A cartoon of known elements of the FMDV life cycle
[96]. FMDV virions bind to receptors on the cell surface facilitating cell entry. Acidic
early endosomes cause capsid dissociation and VP4 forms a pore in the endosomal mem-
brane allowing RNA to exit. CAP-independant translation utilising cellular machinery
begins immediately and subsequent replication. RNA is packaged and the virions leave
the cell via cellular lysis of prelytic release via cytoplasmic blebs.
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The exact process of this is unknown although 2C has been implicated due to its helicase
motifs [97]. Priming and elongation of a positive sense strand can then occur. A study
in poliovirus has shown that a single negative sense RNA strand can act as a template
for multiple positive strands although this work has not been replicated in FMDV [98].
RNA encapsidation is not well characterised. Studies in poliovirus have suggested that
only newly formed RNA strands linked to a VPg are encapsidated leading to the sugges-
tion that replication and encapsidation could in some way be linked [98, 99]. Whether
RNA is inserted into a preformed capsid, as seen in other enteroviruses, or the capsid
forms around the RNA utilising RNA packaging signals has yet to be discovered.
FMDV egress from the cell is generally accepted as being a results of cell lysis [100]
although some evidence suggests there is some prelytic release of FMDV virions via
cytoplasmic blebs [101, 102].
FMDV has a relatively short replication cycle in vitro with formed virions appear 4-5
hours post infection (hpi) [103].
1.2 Viral Evolution
A large number of RNA viruses are of global importance in both human and animal
biology. Recent epidemics such as the 2014 Ebola epidemic has highlighted the impor-
tance of fully understanding these viruses and how they evolve [104]. Rapid rate of
evolution complicates control of RNA viruses as it can allow them to become resistant
to treatments [105].
Most RNA viruses are believed to exist as a swarm of genetically related variants. Due to
their high mutation rates and short generation times they have extreme evolutionary dy-
namics with large population sizes exhibiting extensive antigenic variation and genetic
diversity making traditional population genetics challenging [106, 107]. A viral pop-
ulation’s ability to adapt to new environments and survive evolutionary bottlenecks is
partially a consequence of the genetic diversity that is present in a viral swarm [108–110].
This has been clearly shown in field studies and experimental analysis. For example,
deformed wing virus (DWV), originally a diverse viral population with relatively low
pathogenicity amongst honey bees (Apis mellifera), overcame an evolutionary bottle
neck to survive in Varroa destructor. This new vector improved transmission to A.
mellifera and prevalence. Although resulting in an immediate decrease in diversity, the
original diversity allowed its successful evolution and subsequent increased pathogenesis
and proliferation [111]. Similarly, decreased diversity in Polioviridae has been shown to
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decrease pathogenicity and decrease ability to survive in different tissue environments
[112].
Viral evolution is largely attributed to genetic drift and recombination within these
populations or swarms [113, 114]. Synonymous point mutations are suggested to occur
across the genome and be fixed through positive selection [115]. Understanding how
diversity allows viruses to adapt is critical to studying the spread of virus and controlling
disease. For example for disease control, virus transmission tracing of FMDV in the 2001
epidemic [115], and the use of entropy to study viral evolutionary bottlenecks [116] and
in the design of more multivalent vaccines, seen in the use of ancestral strains of HIV
for vaccine design to increase cross-reactivity to more modern genetic variants [117].
1.2.1 How diversity is created
Genetic diversity within viral swarms can be attributed to a myriad of factors such as
mutations rate, recombination, selective pressure, population size and speed of replica-
tion [118–121].
1.2.1.1 Viral mutation rate
RNA dependant RNA polymerases High mutation rates within viral species
are considered to be due to their error prone polymerases and lack of proofreading
[122]. Viral polymerases tend to exhibit low fidelity and a high rate of misincorperation.
This can be affected by a number of things including RNA structure [123]. Secondary
structure can affect the polymerases progression and some regions of code have been
shown to cause a higher rate of polymerase slippage [124]. Viral RNA polymerase
mutation rates are be predicted to be 10−4 mutations per nucleotide copied, much greater
than the majority of DNA viruses [107, 125–128].
Measuring mutation rate There are numerous difficulties associated with accurate
measurement of mutation rate. Haydon et al [129] succinctly summarised common issues
in the prediction of mutation rates as;
 not all virus particles being equally infectious
 not all viral particles leaving a host at the same rate
 a limited number of hosts spreading the infection (not all host being infectious,
even if they are infected)
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 and biased selection in purification processes
Apparent mutation rates can also appear higher due to sequencing errors and may
vary dependent on current selective pressures or periods of replication versus periods of
dormancy [130]. It may therefore be inaccurate to assume a constant mutation rate for
a virus. Further to the potential for varying mutation rates dependent on environment,
it has been suggested that there is variation in mutation rate across the genome with
less than 40% of sites within the capsids being conserved compared to highly conserved
regions within 3B and D [131].
Error Threshold RNA viruses are predicted to live at the maximum error rate they
can achieve and survive [119, 132]. The point at which the number of mutations that
occur becomes lethal is referred to as the error threshold or error catastrophe [133].
Experiments have been completed to increase mutation rates in RNA viruses through
mutagen introduction resulting in viral extinction due to reaching this error threshold
[134–136]. Even minor increases in the mutation frequency in poliovirus (using ribavirin)
reduce the percentage of infectious genome sufficiently to cause viral extinction [137].
1.2.1.2 Recombination
Recombination is an important factor in the creation of genetic diversity. Evidence of
recombination has been found in FMDV [138, 139] although it’s direct impact on the
diversity of a viral swarm has not been investigated. Recombination has the capacity
to have an extensive effect on viral evolution. For example, HIV has a higher rate of
recombination than mutation [140].
1.2.1.3 Selective pressure
The RdRP introduces mutations; selective pressures determine which mutations out-
compete others and thus remain in the population in higher number. Selective pressure
has an effect on genetic diversity from an environmental to cellular level. Viral success
is dependent upon a viruses ability to leave a host, its transmission capability, environ-
mental stability, entry into a host, evasion of host immune system, entry into a cell and
within cell replication efficiency. All of these selective pressures contribute towards the
genetic diversity that persists within a viral population.
Mutation does not always result in a beneficial or adaptive outcome, viral evolution is
often associated with fitness trade-offs and epistatic interactions as reviewed by Wargo
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and Kurath [141]. It has, however, been repeatedly demonstrated that viral population
diversity can provide a selective advantage by allowing virus to adjust to changes in
environment. It should be considered that an adaptive advantage in one environment
could have a negative effect in another. This non-constant nature of selective pressures
on viruses has a great effect on genetic diversity.
1.2.1.4 Population size
Population size and replication speed also affect genetic diversity. A greater population
size and higher replication rate results in the potential for a higher mutation rate and
greater overall genetic diversity. Large population size allows for large numbers of vari-
ants to be present however a bottleneck transmission event can result in the fixation of a
mutation and its propagation in the virus population regardless of its prevalence in the
original large population. A negative correlation has been shown between the rate of
nucleotide substitution and the size of genome regardless of population size [142]. This
correlation promotes the view that a high level of mutation imposes limits on genome
size unless error-correction mechanisms are in place such as seen in Coronavirus.
1.2.1.5 Replication strategy
Genetic diversity can be affected by viral replication strategy. For example, the number
of positive and negative RNA strands present and being replicated has an overall effect
on the level of genetic diversity [143].
1.2.2 How diversity is compared
1.2.2.1 Sequence space
A viral swarm’s sequence space contains all possible sequences and can be represented
geometrically where genetic similarity is represented by distance on the diagram. An
example of this is seen in Fig. 1.9 [144]. Each round of replication a virus undergoes
produces progeny that differ from the starting virus. Each round produces a more com-
plex mutant spectrum with variants more genetically diverse (represented at a further
distance from) the starting virus.
The space a sequence can cover is not infinite. The mutant genomes that arise will only
continue to exist if they are able to replicate and persist. Detrimental or non-functional
mutants will be removed from the population by purifying selection. The selective
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pressure on this virus swarm is however complicated. A mutation on the genome that
causes a minor fitness cost may be within a genome that is otherwise fit. This can cause
low fitness mutants to appear in a swarm at a higher proportion than might otherwise
be predicted [145].
Figure 1.9: Sequence space expands through replication A geometric represen-
tation of a viral swarm’s sequence space. Each round of replication produces a larger
mutant spectrum in the progeny that is genetically diverse from the originally infecting
virus. Figure taken from Lauring et al [144].
1.2.2.2 Fitness
The term fitness has been used to mean a variety of things within population dynamics
and genetics [146]. Barker defines five different forms of fitness; phenotypic, genotypic,
adaptedness, adaptability and durability [147]. In short this can be summarised as an
organisms ability to survive and reproduce in their environment [146]. RNA replication
rate can be used as an indicator of this but fails to consider numerous elements in viral
persistence such as:
 the ability of the virus to transmit to a new host
 host range
 antigentic variation/immune escape
This becomes even more complicated when considering the virus population as a whole.
The replicative efficiency or antigenicity/tropism/transmissibility of viruses within the
swarm may be variable. Different viruses will be more or less fit than the progeny virus
depending on the genomic mutations between them.
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1.2.2.3 Survival of the flattest
Figure 1.10: A graphical representation of survival of the flattest Population
one is high fitness but any mutation will lead to a dramatic drop in fitness. In population
two a mutation will have a lesser effect on fitness making it more mutationally robust.
Figure taken from Lauring et al [144].
In Darwinian evolution there is a concept of survival of the fittest. In simplest terms,
with replication as an indicator of fitness, the fastest replicator would be the most likely
to survive. However, in RNA viruses this concept does not hold. Due to high mutation
rate viruses that are most able to overcome deleterious mutations are the most likely to
survive. Therefore it is potentially the slower replicators that are the more fit. With a
high replication rate and low fidelity polymerase a virus swarm would be very diverse
but many of viruses are less fit than the progenitor. In comparison low replication rate
and a low fidelity polymerase produces a less diverse population with less low fitness
variants. On average, the population replicating more slowly is more fit, it takes up a
flat fitness landscape Fig. 1.10 [144]. This concept has been shown to be accurate via
computer modelling [148] and in lab experiments [149]
1.2.2.4 Eigen’s quasi-species
The concept of a quasi-species was first described in Eigen, McCaskill and Schuster’s
1988 paper ’Molecular Quasi-species’ [150]. In this paper they offered an alternative to
Darwin’s survival of the fittest;
’...not a single fittest type but an optimal ensemble - a master sequence together with
its frequent mutants - will survive. Such stationary mutant distributions, usually distin-
guished by a unique consensus sequence, were named quasi-species...’
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In a quasi-species natural selection acts on the the swarm of mutants in which a virus
exists. This means the population evolves as a single unit. Research has considered if
an RNA viral swarm conforms to this population structure. This would require exper-
imentation to shown that selection acts on the population as a whole. To date it has
been demonstrated that RNA viruses exists as a swarm of genetically related variants
and changing the swarm structure (through high fidelity polymerases or the introduc-
tion of mutagens) does affect the pathogenicity and fitness of the infection. This does
not categorically provide evidence of natural selection acting on the virus population as
a unit. It merely shows the extensive effect populations size, polymerase fidelity and
genetic bottlenecks can have on the successful progression of infection.
Until work has been completed that indicates natural selection acts on the swarm as a
unit rather than individual viruses within it the term quasi-species may not be appro-
priate.
1.2.2.5 Bottlenecks
A population bottleneck is any event that causes a decrease in the size of a population.
For example, in FMDV, transmission from one host to another has been found to be
a population bottleneck or transmission from one site of replication to another [116].
The smaller population that overcomes a population bottleneck can be less diverse.
Furthermore, smaller populations face a higher level of genetic drift which can result in
lower level variants being lost, decreasing the diversity further [151].
1.2.3 Tools to create data sets
The advent of high throughput sequencing has allowed the more efficient and precise
exploration of genetic diversity both within and between samples. The majority of
past work has focussed on VP1 due to technological and financial limitations but new
sequencing platforms allow for full genome sequencing and subsequent analysis.
1.2.4 High throughput sequencing
Research and investment in high through put sequence has been extensive in the last
twenty years. The associated decrease in costs has made high through put sequencing
a cost effective process in a research laboratory setting. Illumina estimate that the cost
per gigabase has decreased from approximately one hundred million dollars in the year
2000 to 1-10 dollars on the HiSeqX in 2014. High throughput sequencing technologies
can be broadly split into two categories; short read sequencing and long read sequencing.
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1.2.4.1 Short read sequencing
Short read sequencing technologies fall into two categories; sequencing by synthesis
(SBS) and sequencing by ligation (SBL). Both of these technologies involve the clonal
amplification of the DNA fragment of interest. DNA amplification can be bead based
(and beads are subsequently attached to a solid surface) and solid state. Amplification
involves fragmentation of the DNA of interest and addition of an adaptor sequence
that allows the fragmented DNA to bind to either a bead or solid surface (such as the
Illumina flow cell). These bound fragments are then amplified on the bead or flow cell.
The complete genomics technology (designed by the Beijing Genomics Institute) has a
slightly different amplification involving the creation of what they term DNA nanoballs.
This involves the iterative ligation, circularisation and cleavage of DNA fragments to
create circular templates with adaptors. Rolling circle amplification of these fragments
creates billions of nanoballs. These nanoballs are then distributed on a solid surface in
a manner similar to bead base amplification technologies.
SBS technologies include The Roche 454 platform, Ion Torrent and Illumina HiSEQ,
MiSEQ and NextSeq platforms. Illumina SBS is explained in detail below. SBL is the
technology used by SOLiD and Complete Genomics. In this process the DNA fragments
hybridises to a fluorescent probe. This is then ligated to an oligo and imaged. The
fluorescence of the probe identifies the base to which it is complementary bound.
1.2.4.2 Long read sequencing
The development of long read sequencing technologies has allowed for the establishment
of linkage information, identification of repetitive elements within genomes and also in-
vestigation of copy number alterations or variations in DNA structure. There are two
main techniques for long read sequencing; single molecule real time (SMRT) sequenc-
ing and synthetic approaches. Synthetic approaches rely upon the existing short read
technologies outlined above to synthetically construct long reads in silico. Examples of
this include the Illumina long-read sequencing platform and 10x genomic instruments
such as GemCode and Chromium. Synthetic read technologies do not actually generate
long reads but build large fragments using computational assembly from DNA barcodes.
SMRT sequencing technologies do create long reads. Two main technologies have been
established in this area. The PacBio SMRT sequencer has a flow cell with millions of
picolitre wells. Each of these wells has a transparent bottom with a polymerase molecule
attached to it. The circularised DNA strand of interest passes through the polymerase
through zero mode waveguides (ZMW). The dNTP that is incorporate is visualised with
a laser and camera system focused on the polymerase. The laser excites and the camera
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records the colour and duration of the light emitted as a tagged nucleotide is incorpo-
rated. The flurophore is subsequently cleaved to allow it do diffuse away from the censor.
The circular nature of the DNA strand used allows the same template to be sequenced
several time. This is information is then used to create a circular consensus sequence
(CCS). The Oxford Nanopore works differently that all other technologies listed pre-
viously. Rather than monitoring the incorporation of hybridisation of a nucleotide it
directly detects the compositions of a single stranded DNA molecule. Motor proteins
pass the strand through a protein pore which has a current passed through it. The
temporal trace of signals produced represents a shift in the voltage which is specific to
each potential kmer.
These long read sequencing technologies offer a lot of interesting information for WGS
experiments such as those included in this thesis. The ability to determine linkage and
successfully determine repetitive regions have many potential uses. However, they are
still in their relative infancy and have high error rates. Further development will allow
for high speed sequencing of whole genome allowing for the identification of genotypes
with in the viral swarm. Until then a mix of both long and short read sequencing may
offer the best option [152].
1.2.4.3 Illumina sequencing by synthesis
Illumina have a number of sequencing platforms, including the MiSeq, HiSeq and MiniSeq,
all of which use the same sequencing technology: sequencing by synthesis (SBS).
Library preparation Creation of a library of DNA fragments ready for sequencing is
an important step of the sequencing process. Illumina sell several kits that can be used
for library preparation one of which is the Nextera XT Libary preparation kit. The first
step of Nextera XT library preparation is the simultaneous fragmentation of DNA and
addition of adapters. This is achieved with the use of transposons that insert themselves
into the double stranded DNA approximately 200bp apart (Fig. 1.11A). Primers are
then added that are complementary to the adapters and 12 cycles of high fidelity PCR
are completed to add sequencer binding sites, indexes and regions complementary to the
flow cell (Fig. 1.11B).
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Figure 1.11: Illumina NexteraXT library preparation A) Transposons are added
to double stranded DNA facilitating the fragmentation of the DNA and addition of
adaptor sequences. B Primers are added, complementary to the adaptors, and re-
duced cycle amplification is preformed producing a double stranded DNA fragment
with primer binding sites, indexes and regions complementary to the flow cell. Figure
adapted from Illumina literature [153].
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Figure 1.12: Illumina cluster formation A) The Illumina flow cell is a glass slide
with several lanes coated with two types of oligo. B) The oligos are complementary to
regions on the end of the DNA fragments C) Fragments undergo bridge amplification D)
This process forms multiple clusters of DNA all representing the same original fragment.
Figure adapted from Illumina literature [153]
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Clustering The flow cell is a glass slide with multiple lanes coated with two different
oligos (Fig. 1.12A). These oligos are complementary to regions on the DNA fragments
(Fig. 1.12B). The end of the fragments hybridises with the flow cell. Polymerase is
added and a reverse strand is created. This double stranded region is the denatured and
the original strand is washed away. Bridge amplification is then completed, where stands
are clonaly amplified. The strand folds and hybridises to the other oligo, polymerase
generates a complementary strand, the bridge is denatured and two copies of the strand
are left tethered to the flow cell (Fig. 1.12C). This is repeated until a cluster of fragments
exists, each cluster representing only one original fragment of input DNA (Fig. 1.12D).
This process occurs simultaneously for each fragment. The reverse strand is cleaved and
washed off and the 3’ end of the forward strand is protected to ensure it does not bind
to the flow cell again.
Sequencing The process of SBS starts with the addition of a sequencing primer (Fig.
1.13A). A mix of all four fluorescently labelled nucleotide with reversible terminators
are added (Fig. 1.13B).
Figure 1.13: Illumina sequencing by synthesis A) Addition of a sequencing
primer complementary to the strand. B) Addition of all four florescently tagged bases
simultaneously. C) The complementary base is incorporated and identified by fluores-
cent excitation. D) This process is repeated until the length of DNA has been read.
Figure adapted from Illumina literature [153]
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The complementary base binds and the terminator prevents any further bases binding.
This means only one nucleotide is added to each strand per cycle. The flow cell is then
excited by a light source and the unique signal from each base allows the base that
has been incorporated for that cycle for each cluster to be identified (Fig. 1.13C). The
reversible terminator is then cleaved and the process repeated to read the rest of the
DNA strand (Fig. 1.13D). The number of cycles represents the length of the read. The
read product is then washed away and the associated index is read. This allows for each
read to be pooled together with all other fragments originating from the same index.
Using different indexes during the library preparation step means up to 96 samples
can be multiplexed on to the flow cell and the data can bioinformatically sorted and
attributed to the contributing sample. The 3’ end of the sample is now de-protected
and a new bridge forms. Index two is read at this point and the read product of that
is washed away. Polymerase is added to produce a double stranded bridge, the strands
are unwound and the forward strand washed away. The termini of the reverse strand is
capped to ensure it does not re-bind to the flow cell. Read two sequencing primers are
added and the sequencing of the reverse strand of each cluster begins.
Bioinformatic analysis Each read produced by the sequencer is sorted by the index
associated to it, providing files with hundreds of thousands of reads attributed to each
sample muliplexed on a run. Each position in each read is associated with a quality
score which represents the probability the base has been correctly identified. Decisions
can be made to discard reads that are of a low quality. Otherwise, these reads are built
together to create a sequence by aligning over lapping region (de novo assembly) or
aligned to an already published relevant genome (Fig. 1.14).
Figure 1.14: NGS read coverage Forward (red) and reverse (blue) reads are ori-
entated and aligned to a reference genome. The coverage of each genome positions is
the number of reads that represent that region. Position A is represented in 19 reads
therefore its coverage is 19. Positions B is represented in 4 meaning its coverage is 4.
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If a large number of reads has been produced per sample then several reads will overlap
the same region of the genome, this increased coverage has seen more detailed informa-
tion gathered and lower frequency variants detected .
1.2.4.4 NGS Limitations
The limitations to the methodology associated with these high-throughput machines
include error accumulation. Errors accumulate throughout the sequencing process par-
ticularly in amplification and reverse transcription steps. If PCR is used to amplify a
sample artifacts can be incorporated through physical errors such as artificial recom-
bination or nucleotide misincorperation or via skewing of amplification and subsequent
obscuring of true sampling. While errors might not be important for the assembly of
consensus sequences, they have a significant impact in experiments where individual
reads are being interrogated. It is clearly necessary to overcome these issues and so far
efforts have been based on correcting for errors through mathematical models or tagging
samples with an ID that can be traced throughout the PCR process [143, 154]. The
ability to reach the required quantity of sample to begin library preparation (1ng of
cDNA for the Nextera XT Kit) without amplification steps would be greatly beneficial.
There are also some problems relating to variety of the samples multiplexed. Similar
sequences in close proximity on a flow cell can cause inaccurate reads by the machinery.
This is an issue that has been acknowledged by the manufactures and as such each
machine is able to provide a quality score. Sadly as yet there is no scale on which to
compare this between platforms as reviewed by Beerwinkel et al [155].
Figure 1.15: Summary of NGS platforms and their capabilities Different se-
quencing platforms vary on their adapter type, amplification method, sample separa-
tion and sequencing chemistry. This can affect the length of the read produced and the
amount of data collected from a sequencing run. Figure taken from Radford et al [156].
There are a number of variations between platforms (Table 1.15). Roche GS FLX 454
offers slightly longer reads but Illuminas MiSeq and HiSeq enable ultra-deep cover-
age. Considering the prediction of diversity is reliant on distribution of reads along the
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genome rather than length, the latter offers a greater service in this research area. It
should be noted that this platform is relatively new to the market and concrete protocols
have not yet been established. As such read coverage has been shown to differ by orders
of magnitude [155].
Error correction methods Due to the challenges associated with distinguishing
sample preparation introduced error from low level variants significant work in recent
years has been focused on producing methodologies that limit or identify errors so they
can be accounted for in downstream analysis pipelines.
CirSeq Circular-sequencing is a technique established by the Andio Lab [157, 158].
It focuses on the circularisation by ligation of small fragments of the genome or gene of
interest. These circular fragments are then used in subsequent sample preparation and
sequencing steps. The circular nature of the genomic fragment results in products of the
RT reaction that contain several repeats of the same sequence (Fig. 1.16).
Figure 1.16: Schematic of CirSeq methodology A schematic of CirSeq method-
ology taken from Acevedo and Andino’s paper ’Library preparation for highly accurate
population sequencing of RNA viruses’ [157]. Colour dots represent true genetic vari-
ants (green) and process introduced errors (all other colours).
For example, if the circularised fragment is 200nt long and the read length is 600nt
(assuming efficient reverse transcription) a read can include three tandem repeats of the
same region. These tandem repeats are then aligned and only mutations that appear
in all three repeats are accepted. This works to identify and remove RT, PCR and
sequencing introduced errors. This allows the method to have a greater resolution and
confidently identify low level variants. A direct comparison was made between CirSeq
and the sequencing methodolgy used in this thesis (Appendix A). Although CirSeq offers
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an excellent error correction methodology and thus improved resolution of minority vari-
ants the cost associated with the process both in time and financial reagents is extensive.
For this method to work each sample must be run individually on the sequencer without
multiplexing. This was not viable due to reagent costs. Consequently, this method was
not used in this work.
Barcoding Barcoding is the process of individually tagging RNA or DNA molecules
with a unique ID or barcode. This methodology has numerous uses in NGS. It has been
used to consider questions such as how diversity is transmitted from host to host. For
example, previous studies have used barcoding to understand how virus populations are
transmitted between individuals [159].
Barcoding not only allows for the tracking of variants but also for the correction of
errors and biases. As each sequence is individually identifiable, repeats can be grouped
together and a consensus sequence created as with CircSeq described above [157, 158].
This results in the irradiation of sample preparation induced errors and sequencing
errors. The distribution of each unique barcode can also be considered to address PCR
re-sampling errors [154, 160]. All of this combined allows for a better resolution of low
level variants. Therefore studies using this technique have been completed to consider
low level drug resistant variants [154, 160, 161].
The barcoding methodology relies upon the unique identifying sequencing to be suffi-
ciently different to be recognisable. This has its own challenges. PCR or sequencing
errors can result in false barcodes otherwise known as offspring primer IDs [162, 163].
Barcode design is therefore complex. Barcodes can be designed to account for the muta-
tion spectrum created by a sequencer. For example, the Illumina MiSeq most commonly
produces substitution errors, so barcodes must be designed that will not resemble one
another after one substitution [164]. Increasing the length of the barcode can aid in this
although this is clearly limited by read length. To ensure the barcodes include sufficient
redundancy to be distinguished from background noise error correction codes such as
Hamming codes are used in their design [162]. Although clever design can improve these
issues the number of unique barcodes that can be used is limited by their similarity to
each other and distinguishing them from background noise [163].
This limitation in barcode number and the complexity of its use meant using it in
this study was not viable although future work to consider the transmission of genetic
diversity would benefit from this methodology.
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1.3 Objectives of PhD
This introductory chapter describes how virus survival and evolution is greatly affected
by the viral swarm. The focus of this thesis is to investigate the swarm of viruses in
which foot-and-mouth disease virus exists.
All current sequencing methodologies for RNA viruses involved an RT step (to produce
cDNA from the RNA genome) and subsequent PCR to amplify the cDNA of interest.
The PCR has the capacity to introduce errors that can be misconstrued as variation
in deep sequencing giving an incorrect view of the viral swarm. Chapter 2 describes
the design of a method to sequence the swarm without PCR. This method focuses on
the production of data sets that represents the entire swarm rather than solely the
consensus/majority genome. This method does not use PCR during sample prepara-
tion reducing the errors produced and improving the resolution of low level variants.
This method is validated against multiple poly-adenylated viruses and has the capacity
to be used in both a high-throughput consensus sequencing environment and in deep
sequencing methodologies such as the experiments included within this thesis.
FMDV has previously been shown to exist as a swarm of genetically related variants
but there is no detailed understanding of the dynamics of this swarm. Chapter 4 makes
use of the newly designed sequencing method to define the parameters of the swarm
and consider how it can be compared from isolate to isolate. This work looks at how
diversity indices can be used to describe variation within a swarm similarly to how they
indicate variation in an ecological population. This work shows to what extent the viral
swarm varies between different isolates of FMDV.
Having defined the parameters of the swarm, work was completed to consider what
determines the swarm structure. Chapter 5 considers the effect the host can have on
the viral swarm. Previous work has suggest that the SAT viruses are highly variable
in comparison to their European counterparts. However, this work shows that this
variability may not be a product of the virus itself but the host from which it is isolated.
This indicates that evaluating the swarm can offer information about the environment
in which a viruses exists. This work is also important from a diagnostic perspective as
some subconsensus level variants identified were of antigenic importance.
Chapter 6 looks at how the swarm changes during adaptation to a new host. FMDV is
a highly adaptable virus with a broad host range. Consensus level changes and different
phenotypic features are investigated. Virus swarm structure was considered under the
adaptive pressure of a new host cell line. This work suggests in periods of adaptation
or no adaptation limitations on swarm variation may result in predictable dynamics
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of variable positions. This indicated how useful interrogating the swarm can be in
understanding the pressures a virus may or may not be under.
Chapter 7 shows how an understanding of the swarm can help to investigate fundamental
questions about the virus life cycle. Investigation of the swarm that is successfully
packaged is used to identify genome regions required for viral encapsidation. This work
starts to bring clarity to a long unanswered question of packaging in the Picornaviridae.
Furthermore, the methodology used for this experiment would be highly transferable to
other viruses with unknown packaging constrains.
Chapter 8 contains a summary of what was investigated in this thesis and a discussion
of what this new information tells us about FMDV evolution and adaptation. The novel
insight this work produces is commented upon as well as how these finding add to the
current body of knowledge. Future work that could be completed to add clarity to un
answered questions is also included.
Chapter 2
PCR-free sample preparation for
sequencing
2.1 Introduction
Next generation sequencing (NGS) protocols for RNA viruses usually involve a reverse
transcription (RT) reaction to produce a cDNA template from the RNA genome and
subsequent rounds of polymerase chain reaction (PCR) to amplify the cDNA. PCR al-
lows for the specific amplification of a genome or gene of interest. This results in a
higher percentage of the final sequencing data representing the region of interest [165].
In some samples the quantity of genetic material may be low and thus the ability to
specifically amplify it can be extremely beneficial. However, as next generation sequenc-
ing technologies improve the requirement for input material is decreasing and thus this
will become less of an issue.
Both RT and PCR enzymes are error prone. The extent of the error rate introduced by
RT, PCR and sequencing is thoroughly summarised by Orton et al [166]. Even with high
fidelity enzymes there is an inherent rate of misincorperation in both process meaning
the strand copied may not be identical to the template. This can be magnified when an
error is introduced in an early round of PCR and subsequently copied numerous times.
These so called ’jackpot mutations’ can then appear to be relatively high level variants
within a population. Due to the high level of error introduced in sample preparation
analysis of subsequent data requires error correction. This often relies upon an error
threshold cut-off. Variants below this cut-off will not be considered as they could be
a result of error introduced in sample preparation. Single nucleotide polymorphisms
(SNPs) represented at a high rate and overall distributions of variants can be tracked
32
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and PCR NGS sequencing techniques have been highly successful in numerous studies
[116, 167–169]. However, these methodologies often miss low level variants.
PCR methodologies are also limited by the fragment length they can produces. Multiple
PCR reactions may be needed to cover a genome. The placement of primers can result
in under represented regions where the primer sits.
In an effort to decrease errors incorporated and avoid jackpot mutations a sample prepa-
ration method was designed that did not include a PCR amplification step. The yield
from the method described was sufficient to allow sequencing on the Illumina Miseq and
was not limited by fragment length [170].
2.2 Published Method
The following work has been published (Fig. 2.1)[170] and is included in its entirety
below.
Figure 2.1: Methodology paper (BMC Genomics). The method outlined in this
chapter has been published in BMC genomics in 2014 [170].
2.2.1 Abstract
Background Next-Generation Sequencing is revolutionizing molecular epidemiology
by providing new approaches to undertake whole genome sequencing (WGS) in diag-
nostic settings for a variety of human and veterinary pathogens. Previous sequencing
protocols have been subject to biases such as those encountered during PCR amplifica-
tion and cell culture, or are restricted by the need for large quantities of starting material.
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We describe here a simple and robust methodology for the generation of whole genome
sequences on the Illumina MiSeq. This protocol is specific for foot-and-mouth disease
virus or other polyadenylated RNA viruses and circumvents both the use of PCR and
the requirement for large amounts of initial template.
Results The protocol was successfully validated using five FMDV positive clinical
samples from the 2001 epidemic in the United Kingdom, as well as a panel of represen-
tative viruses from all seven serotypes. In addition, this protocol was successfully used
to recover 94% of an FMDV genome that had previously been identified as cell culture
negative. Genome sequences from three other non-FMDV polyadenylated RNA viruses
(EMCV, ERAV, VESV) were also obtained with minor protocol amendments. We cal-
culated that a minimum coverage depth of 22 reads was required to produce an accurate
consensus sequence for FMDV O. This was achieved in 5 FMDV/O/UKG isolates and
the type O FMDV from the serotype panel with the exception of the 5’ genomic termini
and area immediately flanking the poly(C) region.
Conclusions We have developed a universal WGS method for FMDV and other
polyadenylated RNA viruses. This method works successfully from a limited quantity of
starting material and eliminates the requirement for genome-specific PCR amplification.
This protocol has the potential to generate consensus-level sequences within a routine
high-throughput diagnostic environment.
2.2.2 Background
Foot-and-mouth disease has been associated with severe productivity losses in cloven-
hoofed animals characterised by vesicular lesions of the feet, tongue, snout and teats as
well as fever and lameness [171]. The disease has a serious impact upon food security,
rural income and significant economic consequences for any country harbouring the virus
[172]. An integral part of any viral disease control strategy is the epidemiological tracing
of virus transmission together with conventional field investigations. For RNA viruses
with high evolutionary rates, this is routinely achieved with the application of molecular
and phylogenetic methods [167, 168, 173] one example being the global tracing of foot-
and-mouth disease virus (FMDV) [174]. Next-generation sequencing platforms offer
much promise as rapid, cost-effective, and high-throughput methods for the generation
of viral genome sequences. Recovering whole genome consensus level sequences of viruses
provides important information for outbreak epidemiology and pathogen identification
[175–178].
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The positive-sense single-stranded RNA genome of FMDV is comprised of a single long
open reading frame. This encodes a polyprotein which is flanked by 5’ and 3’ untrans-
lated regions of approximately 1200 nt and 95 nt, respectively, terminating in a poly
(A) tail. The 5’ UTR contains highly structured RNA which is involved in both repli-
cation and translation. Approximately 300-370 nt from the 5’ end of the genome lies a
homopolymeric cytidylic acid [poly(C)] tract of 100-170 nt [179]. The genome sequence
upstream of the poly(C) tract is known as the S fragment and that downstream as the
L fragment.
Previously, tracing and monitoring of the trans-boundary movements of FMDV has
been successfully achieved using consensus sequences of the VP1 region [9, 180, 181].
However, over shorter epidemic time scales, where viral populations have not substan-
tially diverged, VP1 sequencing cannot provide the required resolution to discriminate
between viruses in field samples collected from neighbouring farms within outbreak clus-
ters. At this scale, WGS at the consensus level has proven to be a powerful tool for the
reconstruction of transmission trees [182].
Previous strategies for viral WGS include PCR and Sanger sequencing methods or mi-
croarray approaches [182, 183]. Commonly, these processes have limited throughput
and are both resource and labour-intensive with biased outputs that may not reflect the
true diversity within samples [184, 185]. Furthermore, such methodologies have been
subject to errors incumbent within the nature of the protocol i.e. those protocols reliant
upon DNA amplification generate biased datasets from which it is difficult to make firm
conclusions [186]. Such strategies have also been dependent upon a priori knowledge of
virus sequences for primer design and are limited by potential inter and intra-sample
sequence variation [187].
This study describes the optimisation of a robust, high-throughput protocol for WGS of
all seven serotypes of FMDV excluding the 5’ genomic termini and poly(C) tract. It does
not use PCR amplification prior to the sequencing steps and overcomes the requirement
for large starting quantities of template nucleic acid, which has previously limited the
suitability of some NGS technologies for processing viral field isolates [188–190]. This
protocol, with minor changes, was also applied to other polyadenylated RNA viruses.
2.2.3 Methods
2.2.3.1 Virus specimens
The protocol was initially developed and validated using an FMDV field isolate (O/
UKG/35/2001) submitted to the FAO World Reference Laboratory for FMD (WRLFMD,
Chapter 2. PCR-free sample preparation for sequencing 36
F
a
m
il
y
G
en
u
s
S
p
ec
ie
s
S
er
ot
y
p
e
Is
ol
at
e
P
as
sa
ge
h
is
to
ry
P
ic
o
rn
a
vi
ri
d
a
e
A
p
h
th
o
vi
ru
s
F
o
o
t-
a
n
d
-m
ou
th
d
is
ea
se
v
ir
u
s
O
U
K
G
/1
73
4/
20
01
10
%
ep
it
h
.
su
sp
.
U
K
G
/1
45
0/
20
01
10
%
ep
it
h
.
su
sp
.
U
K
G
/1
45
97
/2
00
1
10
%
ep
it
h
.
su
sp
.
U
K
G
/1
55
8/
20
01
10
%
ep
it
h
.
su
sp
.
U
K
G
/4
99
8/
20
01
10
%
ep
it
h
.
su
sp
.
U
K
G
/1
48
5/
20
01
10
%
ep
it
h
.
su
sp
.
U
K
G
/3
5/
20
01
10
%
ep
it
h
.
su
sp
.
T
U
R
/1
1/
20
13
B
T
y
2
A
T
U
R
/1
2/
20
13
B
T
y
2
C
K
E
N
/1
/2
00
4
B
T
y
2
A
si
a
1
T
U
R
/1
3/
20
13
B
T
y
2
S
A
T
1
T
A
N
/2
2/
20
12
B
T
y
2
S
A
T
2
T
A
N
/5
/2
01
2
B
T
y
2
S
A
T
3
Z
IM
/6
/9
1
B
T
y
2
E
q
u
in
e
rh
in
it
is
A
v
ir
u
s
1
D
13
05
-0
3,
d
ro
m
ed
ar
y,
D
u
b
ai
,
20
03
V
er
o2
C
a
rd
io
v
ir
u
s
E
n
ce
p
h
al
om
yo
ca
rd
it
is
v
ir
u
s
1
V
R
-1
29
B
,
ch
im
p
an
ze
e,
F
lo
ri
d
a,
19
44
.
B
H
K
3
C
a
li
ci
v
ir
id
a
e
V
es
iv
ir
u
s
V
es
ic
u
la
r
ex
an
th
em
a
of
sw
in
e
v
ir
u
s
B
34
B
1-
34
,
p
ig
,
C
al
if
or
n
ia
,
19
34
.
P
K
5,
IB
-R
S
5
T
a
b
l
e
2
.1
:
V
ir
u
se
s
u
se
d
in
d
e
v
e
lo
p
m
e
n
t
a
n
d
v
a
li
d
a
ti
o
n
o
f
th
e
n
o
n
-a
m
p
li
fi
c
a
ti
o
n
p
ro
to
c
o
l
B
T
y
:
P
ri
m
a
ry
B
ov
in
e
T
h
y
ro
id
;
P
K
:
P
ig
k
id
n
ey
ep
it
h
el
ia
l
ce
ll
s;
B
H
K
:
B
ab
y
H
am
st
er
K
id
n
ey
;
IB
-R
S
:
in
st
it
u
to
B
ra
zi
li
a
R
en
a
l
S
w
in
e;
N
u
m
b
er
s
d
en
o
te
p
a
ss
a
g
e
n
u
m
b
er
.
Chapter 2. PCR-free sample preparation for sequencing 37
Pirbright, UK) during the 2001 FMD outbreak in the United Kingdom. It was further
validated with a panel of other samples originating from this outbreak as well as with
a panel of viruses representing all FMDV serotypes. The protocol was also validated
with other representative polyadenylated RNA viruses. The details of all viruses used in
the study are described in Table 2.1. Where appropriate, viruses were cultured for one
replication cycle in bovine thyroid cells (BTy) as described previously [191]. Dilutions
between 1x108 to 1x106 viral copies/µl of O/UKG/35/2001 were made with viral cell
culture supernatant in virus negative suspensions of bovine epithelium to mimic real
clinical samples with different viral loads.
2.2.3.2 RNA extraction and FMDV-specific RT-qPCR
Primer Name Primer Sequence
RT-qPCR Callahan 3DF [192] ACTGGGTTTTACAAACCTGTGA
Callahan 3DR [192] GCGAGTCCTGCCACGGAA
Callahan 3DP [192] TCCTTTGCACGCCGTGGGAC
First-strand UKFMD Rev6 [115] GGCGGCCGCTTTTTTTTTTTTTTT
synthesis NK72 [193] GAAGGGCCCAGGGTTGGACTC
UKFMD UKG 4926R AAGTCCTTCCCGTCGGGGT
EMC-2B65R [194] TCGGCAGTAGGGTTTGAG
ERAV-2A22R [195] GGGTTGCTCTCAACATCTCCAGCCAATTT
Vesi-3D1R CKNGTNGGYTTNARNCC
Vesi-3D2R TANCANCCRTCRTCNCCRTANGT
Table 2.2: Primers and probes used in quantitation and WGS of FMDV and
other RNA viruses International Union of Pure and Applied Chemistry (IUPAC)
nucleotide ambiguity codes: N: G or T or A or C; K: G or T; Y: T or C; R: G or A
Total RNA was extracted from 460 µl of cell culture virus isolate or original suspen-
sion [consisting of 10% tissue suspensions generated in M25 phosphate buffer (35 mM
Na2HPO4.2H2O; 5.7 mM KH2PO4; pH 7.6; made in-house)] using RNeasy MiniKit
(Qiagen) according to manufacturers instructions. Total RNA was eluted in 50 µl of
nuclease-free water and quantified using the Qubit RNA High Sensitivity (HS) Assay
Kit (Life Technologies). FMDV-specific RNA was detected using an FMDV-specific
real-time RT-qPCR as described previously (Table 2.2) [192] and quantified using an
RNA standard derived from O/UKG/35/2001.
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2.2.3.3 gDNA depletion
Genomic DNA (gDNA) was depleted from extracted total RNA samples through the
activity of rDNase1 using the DNA-free DNAse kit (Life Technologies). Briefly, 10 µg of
extracted nucleic acid in a 50 µl volume was combined with 5µl of DNase Buffer and 1
µl of rRDNase1 (2 U), and incubated at 37 C for 30 min. Inactivation agent was added
as per manufacturers protocol and the sample was incubated for a further 2 min at room
temperature with periodic mixing. The samples were then centrifuged at 17,000 xg for
2 min and the DNAse-treated supernatant was retained for subsequent processing.
2.2.3.4 cDNA synthesis
First-strand cDNA synthesis (reverse transcription) was performed using Superscript
III First-Strand Synthesis System (Life Technologies) according to the manufacturers
protocol. Briefly, 10 µl of DNase-treated total RNA was combined with oligonucleotide
primers (Rev6 (2 µM), NK72 (2 µM) or FMDV-4926R (2 µM)) depending on the appli-
cation of the protocol, random hexamers (50 ng/µl: Life technologies), dNTPS (10 mM:
Life Technologies) and nuclease-free water (Life Technologies) (Table 2.2). Reactions
were incubated at 65°C for 5 min and cooled on ice for 5 min. A second reagent mix was
added containing SuperScript III enzyme (200 U: Life Technologies), RNaseOUT (40 U:
Life Technologies), 0.1 M dTT (life Technologies) and 25 mM MgCl2, before incubating
at 50°C for 50 min. A final incubation with RNase H (2 U: Life Technologies) was then
performed at 37°C for 20 min.
Second-strand synthesis was performed using NEB Second Strand Synthesis kit (NEB)
as per manufacturers instructions using 20 µl of cDNA. The resulting dsDNA was pu-
rified using Illustra GFX DNA/gel clean-up kit (GE) as per manufacturers instructions
and samples eluted in 30µl of nuclease-free water. Double-stranded cDNA samples were
then quantified using the Qubit dsDNA High Sensitivity (HS) Qubit kit (Life Technolo-
gies) after which samples were adjusted to 0.2 ng/µl using nuclease-free water where
appropriate prior to library preparation.
2.2.3.5 Illumina library preparation
One nanogram of each dsDNA sample was used to prepare sequencing libraries using
the Nextera XT DNA Sample Preparation Kit (Illumina) according to manufacturers
instructions. Libraries were sequenced on a MiSeq using 300 cycle version 2 reagent
cartridges (Illumina) to produce paired end reads of approximately 150 bp each.
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Sequence data analysis Consensus sequences were attained using a complete pub-
lished sequence as a template or, where a closely related template was not available,
a de novo assembly. Sequence read quality was monitored with FastQC [196] prior to
Sickle [197] trimming all bases with a q score of <30. For de novo trimmed Fastq files
were processed using Velvet v1.2.10 [198] with an optimum Kmer length determined
by Velvet-Optimiser. A minimum contig length of 1000 was included in L fragment
analysis. A BLAST search with the contigs confirmed viral origin [199]. Final contig
assemblies were completed manually in BioEdit [200]. Alignments between MiSeq data
and appropriate reference genome (from publication or de novo assembly) were com-
pleted using Bowtie2.1.0 [201] and SAM/BAM processing carried out using Samtools
[202]. Alignments were visually checked using Tablet [203]. Coverage data and graphs
were generated using Bedtools [204] with final graphical output produced using Prism
v6 (GraphPad).
Read coverage required to obtain an accurate consensus sequence A sorted alignment file
(.sam) of FMDV O/UKG/35/2001was generated using Bowtie2.1.0 [205] and Samtools
[206]. A bespoke python script that truncated the samtools mpileup output format
(Appendix D) was used to simulate files with varying levels of coverage. A consensus
sequence was generated from each of these files using mpileup (Samtools). The consensus
sequences created were compared in BioEdit [200] and their sequence identities recorded.
This was completed for all FMDV type O isolates with a sufficient number of reads and
the mean was calculated.
2.2.4 Results
Protocol accuracy: calculations of minimum coverage required for accurate
consensus Next-generation sequencing analysis provided large numbers of short read
sequences that were assembled and aligned in order to determine a consensus sequence.
To define how much redundancy was required for accurate reconstruction of consensus
level sequences, we determined the minimum read coverage required to obtain a robust
consensus from the protocol described. Analysis was completed on all FMDV type O
samples with sufficient coverage (Fig. 2.2). From this a mean was calculated showing a
minimum coverage of 22 reads was required to obtain an accurate consensus sequence
in this instance.
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Figure 2.2: Read coverage required to obtain an accurate consensus sequence. The
consensus sequence resulting from varying levels of coverage was assessed for accuracy.
Isolates O/UKG/1450/2001 (blue), O/UKG/1558/2001 (green), O/UKG/1734/2001
(purple), O/UKG/4998/2001 (orange) and O/UKG/14597/2001 (red) alongside the
type O exemplar from the serotype panel (black) were analysed. Points on the graph
represent a comparison of the identities (scored on the y axis) of a consensus made
with total reads and a consensus made with limited read coverage (detailed on the x
axis). On average, an identity score of one was maintained up to (and including) a
coverage limit of 22 reads. Below this level of coverage, the accuracy of the identities
of the compared consensus sequences decreased i.e. consensus sequences made with a
depth of 22x reads were identical to the consensus. Sequences created with less than
22x coverage depth were not identical, and therefore considered less accurate.
Analytical sensitivity of WGS protocol: consensus sequence was obtained
to 1x107 virus genome copies The protocol workflow was optimised and tested
using a single FMDV O/UKG/35/2001 isolate. Initially, the sensitivity of the protocol
in the presence of gDNA (i.e. no rDNase1 treatment) was tested against viral dilu-
tions spanning 1x108, 1x107 and 1x106 RNA copies/µl. The total number of Illumina
reads in all five samples ranged between 2.5x106 and 1.2x106 (Table 2.3). Consensus
genome sequences (8176 nucleotides in length) were created from alignments of these
reads at each dilution. A decreasing percentage of viral reads correlated with decreasing
viral load (17.94%, 14.41%, 1.83%, 0.05% and 0.01% respectively). Consensus sequences
were found to be identical in all cases both between individual samples and the reference
sequence (data not shown). For this isolate, whole genome sequence was attained (ex-
cluding the 5’ termini) for 1x108 and 1x107 genomes copies/µl, however, below this level,
coverage was incomplete. Coverage was increased in regions adjacent to primer binding
sites and was lowest in the S-fragment (genome positions nt 1376), notably in regions
immediately adjacent to the poly(C) tract. The 3’ genomic termini were obtained in the
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cell culture neat virus sample (1x108 copies/µl) with only 2 bases missing at the 5’ ter-
mini. In order to gain accurate consensus our analysis shows that for type O we needed
a minimum viral read depth of 22. By this criterion accurate consensus sequences were
generated for >98.1% of the genome, down to 1x107 copies/µl. Below this threshold
(i.e. <1x107 copies/µl) we observed a rapid drop-off in the coverage depth of genome
sequences with average coverage across the genome dropping from 639 (1x107) to 18
(1x106) (Table 2.3). Furthermore both genomic termini, notably the 5’ end, were also
lost with decreasing viral load.
gDNA depletion increases proportion of reads attributed to virus genome
We investigated the impact of genomic DNA (gDNA) depletion by rDNase1 treatment
upon the final library complexity. Removal of gDNA was confirmed by Qubit measure-
ment before and after treatment (data not shown). Although the majority of DNA in
the sample was eliminated it should be noted that some residual DNA remained in the
sample. Samples that had not been subjected to rDNase1 treatment contained increased
total number of reads, compared to samples that had been treated with rDNase1 (av-
erage: 1.9x106 vs. 3.8x105 reads, respectively). However, a higher percentage of reads
aligned with the reference template for gDNA depleted samples compared to untreated
samples (Table 2.3).
Validation of protocol on field samples of FMDV and reproducibility Five
field samples submitted to the UK FMD National Reference Laboratory (Pirbright, UK)
during the UK 2001 outbreak were tested using the sequencing protocol for UKG spe-
cific viruses as described above. Virus load in all samples was quantified by real-time
RT-qPCR (Table 2.3). Four of five samples (O/UKG/1450/2001, O/UKG/1558/2001,
O/UKG/1734/2001 and O/UKG/14597/2001) contained between 1.8x108-5.0x108 copies
/µl. The remaining sample (O/UKG/4998/2001) was of lower viral loads with 1.01x107
copies/µl, respectively. The number of viral reads per sample varied between 1x106
(sample O/UKG/1450/2001) and 1x104 (O/UKG/4998/2001), potentially reflecting dif-
ferences in viral load. Reads were trimmed and aligned to a reference sequence FMDV
O/UKG/35/2001 (AJ539141). All samples exhibited increased coverage at primer spe-
cific sites (Fig. 2.3) and decreased coverage at the sites adjacent to the FMDV poly(C)
tract and at the 5 termini of the S fragment. Samples with viral load >1x108 copies/l
exhibited >69% of reads aligning to the reference template. The sample with the low-
est viral load, O/UKG/4998/2001, resulted in 67.5% of reads aligning to the template.
Complete genome sequences (excluding genomic termini) were obtained for all samples.
Isolate O/UKG/1450/2001, which exhibited the highest viral load and total numbers of
reads, generated a coverage depth >22 across 99.72% of the genome.
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Figure 2.3: Application of protocol to field isolates from 2001. Coverage of be-
tween 100010,000x was achieved for 4/6 UKG 2011 isolates (O/UKG/1450/2001 (blue),
O/UKG/1558/2001 (green), O/UKG/1734/2001 (purple) and O/UKG/14597/2001
(red)) with a drop in coverage at the poly(C) tract ( 375 bp position).
O/UKG/4998/2001 (orange) showed lower coverage of between 10-100x. Primer lo-
cations are shown as black arrowheads above the genome illustration.
For the five samples that generated a whole genome sequence, the coverage across the
L fragment was even, peaking in regions of reverse transcription primer binding (Fig.
2.3). All genome sequences have been submitted to GenBank (KM257061-KM257065).
To evaluate reproducibility, one isolate (O/UKG/35/2001) was sequenced 15 separate
times. Analysis was completed on each of these 15 repeats and no changes in the
consensus sequence produced were observed.
Application to cell culture negative FMDV A diagnostic virus sample O/ISR/2
/2013, submitted to the WRLFMD in 2013, was sequenced using the whole genome
sequencing protocol. The virus could not be isolated in cell culture, but FMDV RNA was
detected with diagnostic real-time reverse transcription-quantitative PCR (RT-qPCR)
and quantified as 4.5x106 copies/µl (Table 2.3). The majority of the genome sequence
was generated [(94.10%), with an average coverage depth of 18] with several gaps evident
across the genome length (Fig. 2.4).
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Figure 2.4: Genome coverage profile for FMDV/O/ISR/2/2013 The Israel
2013 isolate of FMDV O was negative when tested in cell culture in IB-RS-2 and BTy
cells. This protocol provided coverage of above 10x for the majority of the genome
although full genome consensus was not acquired. The expected dip in coverage at
the poly(C) was observed. Primer locations are shown as black arrowheads above the
genome illustration.
Pan-FMDV application of WGS protocol After validation with FMDV UKG
field samples the protocol was used to determine whole genome sequences for a panel
of RNA viruses representing each of the seven FMDV serotypes (Fig. 2.5). In order to
optimise the protocol we replaced the type O specific primer 4926R with a pan-FMDV
primer NK-72 designed to bind a region conserved between all seven FMDV serotypes
(Table 2.2. The panel had a viral load >1x108 copies/µl. De-novo assemblies were
completed to provide a consensus against which all reads were aligned. All viruses gave
similar depth of coverage (approx. 1x104) and exhibited comparable library complexity
with the exception of SAT 3 whose depth of coverage was reduced (average coverage:
1x103) (Table 2.3). The 5’ genomic termini was also missing from all panel viruses
ranging from 9 bases of A and Asia1 to 15, 17, 22 and 27 for SAT 2, SAT 1, SAT 3 and
O respectively (accession numbers KM268895-901).
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Figure 2.5: Genome coverage profiles for FMDV serotype panel Sequence data
coverage at each position along the genome is shown for serotype O (black), A (pink),
Asia 1 (orange), C (green), SAT 1 (light blue), SAT 2 (blue), and SAT 3 (yellow). The
majority of the coverage is above 1000x. In all viruses tested, a poly(C) tract within
the FMDV genome at 375 bp was associated in a reduction in coverage. The coverage
depth observed for SAT 3 was lower than other serotypes. Primer locations are shown
as black arrowheads above the genome illustration.
Application to non-FMDV RNA viruses In order to demonstrate the suitability
of this method to attain whole genome sequence from other poly(A) tailed RNA viruses,
we tested the protocol upon three different viruses including encephalomyocarditis virus
1 (EMCV-1) equine rhinitis A virus 1 (ERAV-1) and vesicular exanthema of swine
virus B34 (VESV-B34)(Fig. 2.6). For all three viruses, first-strand cDNA synthesis was
performed using the 3 oligo-dT primer Rev 6 and sequence-specific primers replacing the
pan-FMDV specific NK72 (Table 2.2). The complete genome sequence, apart from the
poly(C) tract was determined for EMCV-1 ATCC VR-129B (KM269482). The complete
genome sequence, apart from 100+ nt at the 5’ end of the genome was determined for
ERAV-1 D1305-03 (KM269483). Similarly, the majority of the calicivirus VESV-B34
genome was determined apart from six nt at the 5’ end of the genome (KM269481).
Chapter 2. PCR-free sample preparation for sequencing 46
Figure 2.6: Genome coverage profiles for three non-FMDV panel of viruses.
Coverage of 10,000 was achieved for the majority of the EMCV-1 genome (olive). Peaks
in coverage can be observed at the location of sequence specific primers used in the RT
reaction ( 4000 bp and 8000 bp). A dip in coverage was evident at the poly(C) tract.
The ERAV-1 genome showed between 10x and 100x coverage with visible peaks in
coverage at the specific primer sites ( 4000 bp and 8000 bp) (black). Approximately
100x coverage of the majority of the VESV-B34 genome was achieved (blue).
2.2.5 Discussion
We have described a novel sample preparation method incorporating minimal amplifica-
tion for the accurate sequencing of RNA viruses to a consensus level, using an Illumina
MiSeq. This protocol is an affordable and reproducible method to generate whole genome
sequences for FMDV and other RNA viruses, which could be adapted to routine high-
throughput diagnostic laboratory workflows. The protocol was validated using FMDV
type O (Fig. 2.3 and shown to be applicable to all other serotypes of FMDV (types A,
C, Asia 1, SAT 1, SAT 2 and SAT 3) (Fig. 2.5) as well as other picornaviruses (EMCV-1
and ERAV-1) and a calicivirus (VESV-B34) (Fig. 2.6).
We have shown that the protocol is able to produce whole genome sequences from
samples with viral loads as low as 1x107 virus RNA copies per µl. Further validation
was performed with five samples submitted during the UK 2001 FMDV outbreak. The
generation of five genomes from these samples, without PCR amplification or virus
culture, demonstrated the potential for this method to investigate larger outbreak sample
sets in a high-throughput, diagnostic setting, such as the UK 2001 FMDV outbreak.
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PCR processes have previously been shown to be error prone [173] and thus eradication
of this step has the opportunity to improve the quality of the data. Our protocol differs
from previous studies in the literature through inclusion of sequence specific primers,
as opposed to random priming at the first strand cDNA stage [207, 208]. This decision
was made with the intent of maximising coverage, across the whole genome, specifically
for FMDV; although it is possible that primer induced bias could be introduced into
sequences through use of sequence specific primers.
We have also demonstrated the effectiveness of adapting this method for WGS of other
RNA viruses (Fig. 2.6). We foresee this protocol being practicable for unknown positive
sense polyadenylated viruses through use of random primers and, where appropriate, an
oligo-dT primer.
The specificity previously provided by PCR has been replaced with reduction of host
DNA and the optional use of specific primers in the reverse transcription reaction. In-
stead of enriching viral RNA we depleted host genomic DNA. We did not target ri-
bosomal RNA in order to keep reagent costs low thus maintaining the suitability of
the protocol for high-throughput sample processing. The method described here was
capable of generating whole genome sequences of FMDV field isolates with a coverage
depth of up to 1x104 (data not shown) that was considered sufficient for the study of
minority variants [192], with only a minimal amount of PCR at the library preparation
stage. This PCR amplification involved 10 cycles of amplification by a hi-fidelity DNA
polymerase, thereby posing minimal risk to biasing the final sequence data [209].
It was evident that in genome sequences generated using this protocol the genomic
termini and poly(C) tract exhibited lower coverage depths. The 5 genomic termini were
always under-represented within the genomes. This was particularly evident in samples
of decreased viral load suggesting that increasing the input RNA of such samples could
improve this coverage. Additionally homopolymeric regions, such as the long poly(C)
tract of FMDV, have been demonstrated here to cause significant decreases in coverage.
With Sanger sequencing, large parts of the genome are often missing or primer derived.
For example, twenty seven to fifty nucleotides of the full genome sequences obtained by
Sanger sequencing described by Valdazo-Gonzalez et al., [210–212] were primer derived
(from the forward and reverse primers to amplify 5’ and 3’ termini of both the S and
the L fragment) and thus the method described here offers a notable improvement on
the resolution of these regions. As previously stated, a minimum read depth of coverage
required to create an accurate consensus for a type O sequence was on average 22 (Fig.
2.2). Even after implementation of this criterion, consensus sequences were generated
with a depth of >22, at more than 80.6% genome positions. This was observed in the
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5 UKG field isolates tested and >99.6% for type O virus tested as part of the panel of
serotypes (Table 1.).
Such advances in WGS will likely impact fields such as virus evolution, diagnosis, and
generation of high/low pathogenicity variants. We have already shown this method
can be advantageous in a diagnostic setting with the successful sequencing of 94.1% of
the genome of a culture negative field isolate. FMDV reads were successfully identified
although the resulting profile exhibits several gaps in the genome sequence suggesting
that the RNA was in fact degraded - an observation potentially explaining the inability
for this virus to grow successfully in cell culture. For this protocol to be fully functional
within a diagnostic environment, it remains to be confirmed whether it is able to correctly
identify all viruses or serotypes within mixed samples.
2.2.6 Conclusion
This paper outlines the development of a high-throughput protocol for the generation of
whole genome sequences of all seven serotypes of FMDV. With minimal changes applied
to priming in the first strand synthesis stage such a strategy can be tailored to other
RNA viruses. The application of NGS to virology will prove invaluable to the fields of
molecular epidemiology and phylogenetic outbreak tracing. This paper describes a fast,
robust and affordable protocol, which is essential to realise this potential.
2.3 Thesis-specific optimisation of the published method
The published method described above [170] was designed to allow high throughput
of samples in a diagnostic environment. Most diagnostic samples are amplified in cell
culture to provide a large amount of high titre virus. Therefore, minimising loss of
sample through processing was not required. Improvements on the molecular method
for sample preparation, included below, focused on improving sample yield and ensuring
that a comparable quantity of each sample was reliably processed.
2.3.1 Increasing sample yield
2.3.1.1 RNA extraction
In the published protocol, the RNeasy kit (Qiagen) was used to extract RNA from cell
lysate. However, numerous studies have found the RNA yield of the TRIzol extraction to
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be superior to that of RNeasy when extracted from a variety of sample types [207, 213–
215]. Therefore, to increase RNA yield TRIzol was used as an alternative to RNeasy. The
time taken to complete a TRIzol extraction is approximately 4x longer than the RNeasy
kit. In an attempt to achieve high yield and efficient use of time a kit that extracts
from samples in TRIzol was judged as the best methodological start point. DirectZol
(Zymo Research, cat. R2072) allows the input of samples in TRIzol and completes the
clean up using a column based chemistry. A comparison was made between TRIzol
extracted RNA and Direct Zol extracted RNA from the same cell lysate. Extractions
were completed as per manufacturers instructions.
TRIzol DirectZol
A260/280 1.93 2.15
A260/230 0.96 1.65
ng/µl 40.7 34.0
Time (mins) 60 15
Table 2.4: TRIzol and DirectZol extraction comparison: RNA yield and
purity One cell lysate sample was split in two and the RNA extracted using TRIzol
and DirectZol. Nanodrop was used to compare the quantity and purity of extracted
RNA.
TRIzol yielded 25% more RNA than DirectZol. However the purity of the DirectZol
sample was greater (Table 2.4). For pure RNA a 260/280 ratio of approximately 2 would
be expected and a 260/230 ratio of 2-2.2. A low 260/280 ratio suggests a containment
such as phenol or residual protein. This is further confirmed by a shifted trough on the
Nano drop trace (Fig. 2.7).
Figure 2.7: TRIzol compared to DirectZol: TRIzol extraction produces
higher yield but lower purity A nanodrop trace of extracted RNA extracted using
A) TRIzol and B) DirectZol. Absorbance (y-axis) compared to wavelength (x-axis) is
shown.
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This can be indicative of phenol contamination [216]. Phenol is capable of degrading
the tagmentation enzyme in the Nextera XT preparation kit (Illumina) and thus phenol
contamination can have a negative affect on sequencing success [217]. From this, Direct-
Zol was deemed the best extraction methodology as it offered acceptable RNA yields of
high purity in a time efficient manner.
2.3.1.2 DNAse Treatment
Following RNA extraction, samples were DNAse treated as stated in the published
method [170]. If the quantity of RNA in the sample was above the recommended input
for the DNA-free DNA removal kit (ThermoFisher, cat. AM1906) samples were diluted
and split into several reactions and DNase treated separately. This allowed for the
transference of all the original sample rather than only the quantity that was present in
one reaction.
2.3.1.3 Ethanol Precipitation
Having split the sample into several DNAse reactions, an ethanol precipitation step was
included to consolidate the output of the DNAse reactions into the smallest volume
possible that provided the correct concentration for the subsequent RT step. RNA from
the DNase reactions was pooled into quantities of up to 400µl, the maximum volume to
complete an ethanol precipitation in at 1.5mL eppendorf tube. If several precipitations
were completed for one sample all were re-suspended in the same 10µl of nuclease free
water (nfH2O).
2.3.1.4 Reverse Transcription
The optimum input for the reverse transcription reaction using the OneStep RT-PCR
kit from Qiagen (cat. 210210) is 1pg-5µg. If the output of the ethanol precipitation
was a higher concentration than required for the RT step it was diluted and several RT
reactions preformed. Again this allowed for all of the original sample to be processed.
The reverse transcription method from Acevedo et al ’s 2014 paper was used [157] to
allow for direct comparison between the CircSeq method and the method optimised
from Logan et al [170].
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2.3.1.5 Second strand synthesis
The second strand synthesis reaction was completed as described in Acevedo et al ’s 2014
paper [157]. As before, multiple reactions were completed where appropriate to allow
for all the sample to be used.
2.3.1.6 Clean-up of double-stranded DNA
In the published method clean up of double-stranded DNA was completed using GFX
clean-up kit (GE Lifesciences, cat. 28-9034-70). However, the loss of material during
this clean-up process was extensive. To ensure high yield and high purity this step was
instead replaced with a phenol-chloroform-isoamyl alcohol (PCI) extraction.
2.3.2 Resolution of this method
Next generation sequencing methodologies and the sample preparation steps utilize error
prone enzymes. Therefore distinguishing low frequency variants from process-derived
errors in sequencing data can be challenging. By taking into account the error rate of
each enzyme used in the sequencing process it is possible to consider above what level
a change can be confidently considered a mutation rather than a processing error. This
is considered the resolution of the method, the limit of detection of low level variants.
Error rates of enzymes were provided by manufacturers on request and are expressed as
frequency of error incorporated, for example the error rate for the reverse transcription
enzyme is 122222 and therefore one error would be expected every 22,222 bases processed.
The error for the second strand sythesis enzyme is 1111111 . The error rate for the PCR
steps involved in the NexteraXT is 12500000 . The error rate for the MiSeq, when using a
cutoff of Q30, is 11000 .
ErrorRate ≈ 1
22222
+
( 1
111111
/2
)
+
(( 1
2500000
/2
)
∗ 12
)
+
1
1000
(2.1)
The error rate for the second strand synthesis is divided by two due to the double
stranded nature of the nucleic acid at this point in the protocol. The Illumina PCR
error rate is divided by 2 (for both strands) but multiplied by 12 due to the 12 rounds
of PCR. The approximate error rate as calculated by Equation 2.1 is 0.001052. That
suggests 1/950 is an introduced error, a threshold of 0.1%. In other words, a mutation
would only be distinguished from errors if it was present in the data at at least 0.1%.
There are numerous concerns with this threshold:
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 This calculation represents an average situation. For a given positions with a
quality score of 30 the probability of an error is 0.001. However, these are random
processes and as such some positions will have more errors than predicted and
some less.
 The threshold must be considered in the context of genome coverage. A threshold
of 0.1 when the coverage is 10,000 would require the variant to be present at least
10 times. However with a coverage of only 1000x the variant would have to be
present only once to be considered relevant.
 Errors are more common at some sites than others. GC content and secondary
structure can affect enzymes and errors are more common at some positions than
others. Furthermore, some mutations are more likely than others. For example
the tendency for one base to mutate to another can be different. In RT or PCR
reactions transitions are favoured over transversions and in Illumina A to C errors
or G to T errors are more common due to the similarity in fluorescence signal
produced by these bases.
Due to the complex nature of this issue many approaches have been established in an
attempt to bioinformatically assess the probability of low level variants being accurately
called [166]. Some sample preparation steps to allow the identification of errors include
barcoding and CircSeq the latter of which was tested in this study and is described in
Appendix A.
In summary, the resolution of the standard method [170] can be estimated at 0.1%.
However any variants at this low level must be considered in the context of coverage and
further work needs to be completed to be more confident of the accuracy of this figure.
Some optimisation steps were not used in this thesis but are outlined in Appendix B.
Chapter 3
Methods
3.1 Media and Buffers
3.1.1 Media
 Maintenance media A: Glasgows modified eagles medium (Sigma Aldrich, cat.
G5154) supplemented with 10% foetal calf serum (Gibco, cat. 16170-78), 5% tryp-
tose phosphate broth, 20mM glutamine (SAFC, cat. 59202C-100mL), penicillin
(100 SI units/mL) and streptomycin (100g/mL)(MP, cat. 1670249).
 Viral growth media (VGM) A: Glasgows modified eagles medium (Sigma
Aldrich, cat. G5154) supplemented with 1% foetal calf serum (Gibco, cat. 16170-
78), 5% tryptose phosphate broth, 20mM glutamine, penicillin (100 SI units/mL)
and streptomycin (100g/mL)(MP, cat. 1670249).
 Maintenance media B: Ham’s F12 nutrient mixture (Sigma Aldrich, cat. N4888-
500mL) supplemented with 10% foetal calf serum (Gibco, cat. 16170-78), 20mM
glutamine (SAFC, cat. 59202C-100mL), penicillin (100 SI units/mL) and strepto-
mycin (100g/mL)(MP, cat. 1670249).
 VGM B: Ham’s F12 nutrient mixture (Sigma Aldrich, cat. N4888-500mL) sup-
plemented with 1% foetal calf serum (Gibco, cat. 16170-78), 20mM glutamine,
penicillin (100 SI units/mL) and streptomycin(100g/mL)(MP, cat. 1670249).
 Eagles overlay: Type 1 endotoxin free water containing 8% (w/v) sodium chlo-
ride (NaCl), 0.5%(w/v) potassium chloride (KCl), 0.25% (w/v) Magnesium sul-
phate (MgSO4), 5.65% (w/v) glucose, 0.125% (v/v) ferric nitrate (1%), 0.157%
(w/v) Sodium dihydrogen orthophosphate (NaH2PO4), 0.365 % (w/v) glutamine,
0.33 % (w/v) calcium chloride (CaCl2), 3.438% (w/v) sodium hydrogen carbonate
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(NaHCo3), 18.75% (v/v) phenol red (1%), 0.053% (w/v) L-arginine, 0.03% (w/v)
L-cystine, 0.026% (w/v) L-histadine, 0.066 % (w/v) L-isoleucine, 0.066 % (w/v)
L-leucine, 0.092% (w/v) L-lysine, 0.042% (w/v) L-phenylalanine, 0.06% (w/v)
L-threonine, 0.01% (w/v) L-tryptophan, 0.045% (w/v) L-tyrosine, 0.059% (w/v)
L-valine, 0.019% (w/v) L-methionine, 0.005% (w/v) L-inositol, 5% (v/v) vitamin
(stock concentrate) and 0.1% (v/v) sodium hydroxide.
3.1.2 Buffers
 Phosphate buffered saline (PBS): Type 1 endotoxin free water containing
0.964% (w/v) Dulbecco’s phosphate buffered saline (DPBS) (Sigma, D5773-50L)
and 0.0132% (w/v) calcium chloride.
 Calcium and magnesium free PBS (PBSa): Type 1 endotoxin free water
containing 0.955% (w/v) PBS’a’ powder (Sigma, 56064C-50L) and 0.04% (v/v)
1M stabilised Hydrochloric Acid.
 Tryptose phosphate broth (TPB): Deionised water containing 2.95% (w/v)
tryptose phosphate broth. Provided by the central services unit (CSU) at the
Pirbright Insitute (TPI)
 4% paraformaldahyde: PBS (as previously described) containing 4% (w/v)
paraformaldahyde powder (Sigma-Aldrich, cat. P6148-1kg). pH adjusted (pH
6.9) and filtered.
 Phosphate buffered saline containing bovine serum albumin (PBS-BSA):PBS
(as previously described) containing 0.5% (w/v) bovine serum albumin (Sigma-
Aldrich, cat. 05479-50g) and 0.05% (w/v) sodium azide (Sigma-Aldrich, cat.
438456-5g)
 Tris/Borate/EDTA (TBE): Deionised water containing 10% (v/v) 10x Ultra-
Pure TBE Buffer (Invitrogen, cat. 15581044)
 0.1% Triton: PBS containing 0.1% (v/v) Triton X-100 (Sigma-Aldrich, cat.
T9284-100mL)
3.2 Cell lines used
 Baby hamster kidney cells (BHK) 21 were cultivated in maintenance media
A. They were received from the CSU at TPI.
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 Bovine foetal aortal cells (BFA) were cultivated in maintenance media B.
Originally purchased from the European collection of Authenticated Cell cultures
(ECACC). Received on the 14/05/12 at passage 14.
 Bovine thyroid cells (BTY) were cultivated in maintenance media A. This is
a primary cell line prepared by CSU at TPI.
3.3 Antibodies and stains
 2C2: Monocolonal antibody 2C2 which recognises FMDV 3A was a kind gift from
E. Brocchi (IZS, Brescia, Italy).
 Alexa fluro-conjugated secondary antibody: Alexa Fluor-conjugated sec-
ondary antibodies were acquired from Invitrogen (cat. A11029).
 TO-PRO®-3:The nuclear and chromosome counterstain TO-PRO®-3 was at-
tained from ThermoFisher Scientific (cat. T3605).
 Crystal violet stain: PBS containing 0.5% (w/v) crystal violet, 10% (v/v)
ethanol (100%), 13.88% (v/v) and formaldahyde (36%).
 Methylblue Stain: PBS containing 3.7 % (v/v) formaldahyde, 0.1% (w/v)
methylblue and 10% (v/v) 100% ethanol.
3.4 Primers and Probes
Primers and probes used within this thesis are outlined within Table 3.1.
3.5 Protocols
3.5.1 Cell Passage
Media was removed from the flask and cells were washed with once with PBSa. Trypsin-
EDTA (0.25%) (ThermoFisher, cat.25300-54) was added (2, 3 or 5 mL for T25, T75 and
T175 flask respectively) and the flask was incubated at 37°C fo 3 minutes. Detached
cells were washed from the flask with 10mL of appropriate maintenance media and the
entire contents of the flask transferred to a universal. Cells were spun 1000rpm for three
minutes and supernatant removed. Cells were re-suspended in 1mL of maintenance
media using a 1000µL pippette. This 1mL of cell suspension was further diluted with
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9mL of maintenance media. An appropriate proportion of this re-suspension was used
to re-seed a new flask(s).
3.5.2 Cloning
Cloning of GeneArt fragments into an FMDV infectious copy plasmid (ICP) was com-
pleted in Chapter 7.
A cloning strategy was designed to systematically knock out regions containing putative
packaging signals (PPS) when identified by bioinformatics analysis. One region contain-
ing one quarter of the PPS was amended (PPS2, 3 and 4). Each PPS was disrupted
both in structure and sequence of the loop. This was completed by editing the nucleotide
sequence without affecting the amino acid sequence in order to create replication viable
virus. The fragment was ordered from GeneArt (ThermoFisher Scientific).
GeneArt strings were cloned into a TOPO vector (ThermoScientific, cat. K2800J10).
The backbone (TOPO) vector was linearised via restriction digest.
3.5.2.1 Restriction enzyme digest
Digests were completed in a 20µL volume reaction as per manufacturers instructions.
Enzymes were supplied by New England Biolabs.
Linearised backbone visualised via gel electrophoresis and UV illumination.
Electrophoresis of DNA was completed as described below. Linearised backbone was
extracted from agarose gel.
3.5.2.2 Gel extraction of DNA
Gel extractions were completed using Illustra GFX DNA and Gel Band Purification kit
(GFX, cat. 28-9034-70) as per manufacturers instructions. In short, gels were visualised
on a UV lightbox (365nm)(BioRad) and required bands were excised with a scalpel.
Agarose bands were placed in a DNAse-free 1.5mL tube. The weight of each bands
was determined. To each 10mg of gel 10µL of capture buffer type three was added.
The sample was heated to 60°C for 15 to 30 minutes until the gel band was completely
dissolved. Samples were mixed by inversion. Gel/capture buffer mix was added to a
GFX MicroSpin column and collection tube and incubated at room temperature for
1 minute. The assembled columns were then spun at 16000xg for 30 seconds. Flow
through was discarded. 500µL of wash buffer was added and the assembled columns
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were spun for a further 30 seconds at 16000xg. The collection tube and flow-through
was discarded. The column was placed in a new collection tube and 10-50µL of nfH2O
was added. The column was incubated at room temperature for one minute before being
spun at 16000xg for 1 minute to recover the purified DNA.
3.5.2.3 Dephosphorylation with shrimp alkaline phosphatase treatment
Dephosphorylation improves ligation efficiency by preventing the vector from ligating
back to itself. 7µL of linearised gel extracted backbone was combined with 0.9µL of
10x reaction buffer and 1µL of shrimp alkaline phosphatase (NEB, cat. M0371S). The
reaction was incubated at 37°C for 30 minutes before being heat inactivated at 65°C for
15 minutes.
Dephosphoryalted vector backbone was ligated to the GeneArt strands.
3.5.2.4 DNA Ligation
Ligation was completed using T4 DNA Ligase (NEB, cat. M0202S) and the provided
10x DNA ligase reaction buffer. A vector:insert ration of 1:1, 1:3 and 1:7 in a total
volume of 10µL were completed. Ligation were completed overnight at 4°C.
Ligated vector and insert were transformed into E.coli One Shot TOP10 chemically
competent cells (ThermoScientifc, cat. K2800J10).
3.5.2.5 Transformation of competent cells
A 50µL aliquot of frozen competent cells (One Shot TOP10 chemically competent cells)
were thawed on ice for 5 minutes. To the thawed cells 1-5µL of ligation reaction was
added. The reaction was tapped gently to mix and incubated on ice for 30 minutes.
Reaction was incubated at 42°C for 30 seconds and then placed back on ice. To the
reaction 250µL of pre-warmed S.O.C medium was added and the vial was placed in a
37°C shaking incubator for 1 hour at 225rpm. The transformed bacteria were plated
on LB/agar plates containing the appropriate antibiotic (e.g. Ampicillin (100µL/ml) or
Kanomycin (50µL/ml)). Plates were inverted and incubated at 37°C overnight.
3.5.2.6 Isolation of plasmid DNA
Small scale (Mini-preps) A single colony was picked from an agar plate and used to
inoculate a 5mL culture of LB medium containing the appropriate antibiotic. Cultures
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were incubated in a 37°C incubator at 300rpm over night. 1mL of this culture was
transferred to a 1.5mL microfuge tube and centrifuged for 14000rpm for 1 minute. The
supernatant was removed and DNA was extracted using the Qiagen Miniprep Kit (cat.
27106) as per manufacturers instructions.
Large scale (Maxi-preps) A single colony was picked from an agar plate and used
to inoculate a 5mL culture of LB medium containing the appropriate antibiotic. Cul-
tures were incubated in a 37°C incubator at 300rpm over night. 200µL of this culture
was diluted in 100mL of LB broth and incubated in a 37°C incubator at 300rpm over
night. DNA was extracted using the Qiagen Maxiprep Kit (12162) as per manufacturers
instructions.
To confirm successful inclusion of the GeneArt insert test digests and agarose gel analysis
was completed.
The backbone plasmid (pT7S3) and gene art fragment (previously cloned in to a TOPO
vector as described above) were digested with Xma1 and Aflii and the products run on
a 1% agarose gel containing ethidium bromide (EtBR). DNA was extracted using the
GFX clean-up kit (GE Healthcare Life Sciences, cat.28-9034-70). The backbone was
dephosphorylated and vector and insert ligated as previously described. Ligations were
transformed into competent cells (TOP10) and colonies produced were minipreped and
text digested. Correct plasmids were grown up and Maxipreped.
Maxipreped cultures were confirmed with sequencing on the applied Biosystems 3730
DNA analyser using the BigDye Terminator v3.1 cycle sequencing kit (applied Biosys-
tems) as described below.
3.5.3 Ethanol Precipitation
On ice, 0.1 volumes 3M sodium acetate (pH5.2) was added to the pooled RNA and
the sample vortex mixed. 2.2 volumes of ice cold 100% ethanol was added and pipette
mixed thoroughly. Samples were then incubated at -20°C for one hour. Samples were
pipette mixed and spun (14,000 xg) for ten minutes at 4°C. Supernatant was remove
and discarded and 500µl of ice cold 70% ethanol added. Samples were spun (14,000 xg)
for five minutes at 4°C. Supernatant was remove and discarded and RNA re-suspended
in 10µl of nfH2O.
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3.5.4 Fragmentation
18µL of RNA and 2µL of fragmentation reagent were combined and vortexed. Sam-
ples were then incubated at 70°C for seven and a half minutes. Samples were then
immediately placed on ice and 2µL of stop solution was added.
3.5.5 Gel electrophoresis
Electrophoresis of DNA was completed using gels of 1% agarose dissolved in TBE con-
taining 0.5µg/mL ethidium bromide. Gels were run at 100v.
3.5.6 Immunofluorescence
Cells were fixed with 4% formaldehyde solution for 40 minutes, PBS washed and per-
meabilised with 0.1% triton for 15 minutes. After a further PBS wash, block buffer
(PBS-BSA) was added for 30 minutes. Primary antibody (2C2) was added for 1hr in
block buffer. Cells were washed 5x with PBS and incubated with Alexa Fluor-conjugated
secondary antibody for 45 minutes. Cells were washed a further 5x with PBS and ToPro-
3 was added for 5 minutes. Stain was removed and cells washed and imaged in sterile
water. Cells were imaged on the SpectraMax MiniMax 300 Imaging Cytometer. To-
tal number of cells was calculated using ToPro-3 fluorescence (excitation 625/20nm),
infected cells were counted using Alexa 488 fluorescence (excitation 460/20nm).
3.5.7 Phenol Chloroform Extraction
An equal volume of PCI was added and the sample vortexed for 2 minutes. Sample was
incubated on ice for 15 minutes before being spun at 13,000rpm for 15 minutes at 4°C.
The aqueous phase was collected and 0.1mL sodium acetate was added per mL. Samples
were vortexed and 2x volume of chilled 100% ethanol added. Samples were mixed well
and incubated at -20°C for thirty minutes. Samples were spun at 13,300rpm for 30
minutes at 4°C and the supernatant was removed. 250µl of 70% ethanol was added and
the sample was spun again at 13,300rpm at 4°C for 2 minutes. The supernatant was
removed and the pellet air dried before being re-suspended in 10µl of nfH2O.
3.5.8 Plaque assays
A dilution series was created from the virus to be titred. To create 10−1 100µL of neat
virus was combined with 900µL VGM and the sample was pipette mixed. 100µL of 10−1
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was combined with 900µL VGM and sample was pipette mixed to create 10−2. This
was continued to 10−9. Samples were maintained on ice.
Cells were prepared at 60% confluencey in a six well plate. Three six well plates were
prepared per sample.
Eagles Overlay 75mL eagles overlay was supplemented with 1.5mL foetal calf serum,
1 mL of penicillin (100 SI units/mL) and streptomycin(100g/mL) and 5mL of tryptose
phosphate broth. Eagles overlay was incubated at 37 degrees until use.
Indibios Agar 25mL of sterile water was combined with 0.6g indubiose A37 Agar
(MP, AGA10025). Agar was was microwaved on full power for two minutes until in-
duboise was completely dissolved. Agar was kept warm at 42 degrees until use.
Procedure Cells were washed with PBS. 100µL of virus dilution was added to rel-
evant wells (Fig. 3.1). Plates were incubated at 37°for 15 minutes. 75mL of eagles
overlay mixture (as described above) was combined with 25mL of agar solution. 4mL of
Eagles/agar mixture was added to each well. Plates were left at room temperature until
agar was set. Plates were incubated at 37°C for 72 hours. 4mL of Crystal Violet stain
(as described above) was added to each well. Plates were left at room temperature for
at least 4 hours to fix. Excess stain and agar plugs were washed off.
Figure 3.1: Plaque assay plate set up
Plaques were counted on the dilution that had between 50-100 plaques. Calculations
were completed as follows:
If the 10−4 wells had 74 and 76 plaques respectively. The average would be calculated as
75 plaques. 100µL of virus was used to innoculate each well so the values are multiplied
by 10 to create the PFU/mL: 75x105 PFU/mL or 7.5 x106 PFU/mL.
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3.5.9 qRT-PCR
One-step qRT-PCR was completed using the SuperScript® III Platinum®One-Step
qRT-PCR Kit (Invitrogen, cat. 11732030). The Callahan 3D assay was preformed [192].
Primers (3DF and 3DR) and probe (3DP) are detailed in Table 3.1. Reactions of 50µL
were set up as follows. On ice, 25µL of 2x reaction mix was combined with 16µL of
nfH2O, 1µL of forward primer (10µM), 1µL reverse primer (10µM) and 1µL fluorescent
probe (10µM). To this, 5µL of template was added and 1U of SuperScript®III. Samples
were pipette mixed before tubes or plates were sealed and loaded onto the qPCR machine
(Mx3005P qPCR System, Agilent Technologies). Samples were heated to 60°C for 30
minutes (cDNA synthesis) before being heated to 95°C for 10 minutes. Samples then
underwent fifty cycles of 95°C for 15 seconds and 60 °C for 60 seconds. Data was
visualised and analysed using MxPro.
Figure 3.2: qRT-PCR standard curve for each serotype A standard curve is
shown for Asia 1(red), type A(Yellow), type O (purple), type C (orange), SAT1 (pink),
SAT 2 (green) and SAT3 (dark blue).
To ensure the assay was comparable for all seven serotypes of FMDV a comparison of
RNA standards was made (Fig. 3.2).
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3.5.10 Quantification of DNA
The concentration of DNA was determined either by Qubit quantification (as previously
described) or optical density readings were taken at 260 and 280nm using a ThermoSci-
entific NanoDrop. Distilled water or elution buffer was used as a reference.
3.5.11 SDS urea page gel
Gel running tank (Biorad, mini-Protean tetra vertical electrophoresis cell), plates and gel
casting station were thoroughly cleaned with RNA zap (Thermo Fisher, cat. AM9780),
rinsed with distilled water, sprayed with 70% ethanol and wiped clean with kimtech
tissue. Glass plates were places in the casting station. 12.5% acrylamide denaturing gel
was created by combining 25g of urea, 10mL of TBE, 15.625mL of acrylamide (40%) and
nfH2O up to 50mL. 6.5mL of 12.5% acrylamide denaturing gel (as above) was combined
with 37.5µL APS and 3.75µL of TEMED in a 15mL tube. Solution was vortexed and
gels poured immediately. Comb was placed and gels were left to set. When set, gels were
loaded into the tank and TBE added until the wire was covered. Wells were flushed with
TBE. Samples were denatured with 2x denaturing dye (Thermo Fisher, cat. R0641) for
5 minutes at 98°C. 1µL of RNA ladder (Novagen, cat. 69003) in 4µL of nfH2O with
5µL of 2x denaturing dye was also denatured. Samples were loaded on the gel and run
at 300v until the dye front ran off the gel. The gel was then removed and shaken in a
solutuon of 20µL of TBE containing 2µL of SYBR gold (Thermo Fisher, S11494).
3.5.12 Sanger Sequencing
Sanger sequencing was completed on a 48 capillary sequencer (ABI3730). Samples were
prepared using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, cat. 4337455). High copy or plasmid DNA was diluted to 500ng in a final volume
of 10µL in a 0.2mL PCR tube and denatured at 96°C for 1 minute. For PCR products,
denaturing was not required and 5-20ng of product for 500-1000bp of product was used.
Components of sequencing reaction were combined on ice. A 10µL reaction was made
containing 1.88µL of 5x Sequencing buffer, 0.25µL of BigDye® Terminator v3.1, 1.5µL
of primer (at 1.6pmol), 5.37µL of nfH2O and 1µL of template (diluted as described
above). Reactions were placed in a thermocycler (Eppendorf) and heated to 96°C for 1
minute. Subsequently 25 cycles of 96°C for 10 seconds, 50°C for 5 seconds and 60°for
4 minutes were completed. Ethanol precipitation was completed on samples and they
were vacuum dried for 15 minutes to ensure no ethanol was present. Pellets were re-
suspended in 20µL of Hi-DiFormamide (Applied Biosystems, cat. 4337455). Samples
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were left to fully re-suspend in the dark for 15 minutes before being loaded onto the
sequencer.
3.5.13 SpectraMax MiniMax 300 Imaging Cytometer
A 50% confluent 96 well plate of cells was counted on the MiniMax cytometer through
transmitted light. This value was used to calculate the viral dilution needed to achieve
the required multiplicity of infection (MOI). Media was removed from the plate and
virus added. A plate sealer was applied and the plate was place in the plate reader at an
incubating temperature of 37°C. Transmitted light images were captured once an hour,
ever hour and the number of objects or area covered counted. Data was visualised using
GraphPad prism.
3.5.14 TCID50
A ten fold dilution of virus lysate was completed to 10−3. A 2 fold dilution of this
was then completed ten times. Virus dilutions were stored on ice. 50µL VGM A was
added to each well of a 96 well plate and incubated at 37°C. A confluent T175 flask of
BHK21 cells was tripsinized and re-suspended in 10mL of maintenance media A. This
cell suspension was counted using a haemocytometer and diluted to 1x106 cells/mL. 50
µL of virus was added to each well (already containing the warmed VGM) as shown in
Fig 3.3. No virus was added to the last column of wells to act as a no virus control. To
each well 50µL of cell suspension was added and plates were incubated at 37°C for 72
hours.
Figure 3.3: TCID50 assay plate set up
Media was removed from the plate and it was submerged in 1% citric acid. The plate
was then submerged in 2% citric acid for 10 minutes. 50µ of methylblue stain was
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added to each well and plate was left to stain overnight. Stain was removed and plates
visually inspected with the number of cells with 100% CPE in each dilution counted and
recorded.
Total number of cells with 100% CPE was counted and this value was divided by the
number of wells per dilution (8). A correction factor of 0.5 was subtracted. This value
was multiplied by the dilution interval (0.3) and added to the highest dilution where all
8 wells showed complete CPE. This was multiplied by 20 to produce TCID50/mL.
3.5.15 Growth of viral stocks
Bovine Thyroid Cells cells were maintained in maintenance media A at 37°C. Prior to
infection with FMDV, the cell monolayer was washed with serum free medium. 2.25ml
of serum free medium was added to the 0.25mL aliquot of virus (in glycerol or cell
suspension). 2.5mL of this solution was added to each flask. The flasks were incubated
at 37°C for 10 minutes to allow the virus to adsorb to the cell monolayer before 20mL of
maintenance media A was added and the flasks were incubated overnight at 37°C. Flasks
were frozen when full CPE was observed. Flask were thawed and contents transferred
to a falcon tube. Sample was spun for 3 minutes at 1000rpm to clarify. Clarified
supernatant was removed and aliquoted and stored at -80°C.
3.5.16 Viral Passage
T25 flasks of BHK or BFA cells were maintained in appropriate maintenance at 37°C.
Prior to infection with FMDV, the cell monolayer was washed with PBS. Clarified super-
natant (from the innoculum or previous passage) was combined with appropriate VGM
(1:1) and 1mL of this was added to the cells. The flasks were incubated at 37°C for 10
minutes to allow the virus to adsorb to the cell monolayer before 4mL of maintenance
media was added and the flasks were incubated overnight at 37°C. Flasks were frozen
when full CPE was observed. Flask were thawed and contents transferred to a falcon
tube. Sample was spun for 3 minutes at 1000rpm to clarify. Clarified supernatant was
removed and aliquoted and stored at -80°C.
3.5.17 Virus purification
Appropriate cells were infected with clarified cell lysate and maintained at 37°C in VGM.
At complete CPE, cultures were freeze-thawed and pelleted by low speed centrifugation.
The supernatant was precipitated by the addition of sufficient ammonium sulphate to
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produce a 50% saturated solution. Once all ammonium sulphate was dissolved and in
suspension, the precipitate was pelleted at 600 rpm at 4°C for 1 hour. After centrifuga-
tion, the pellet was resuspended in PBS (pH 7.4) and Igepal added to a 1% final volume.
Virus was then purified by initial sedimentation through a 30% sucrose cushion (w/v in
PBS), by centrifugation at 28,000 rpm at 12°C for 2.5 hrs. The subsequent pellet was
resuspended, as before, and further purification achieved by sedimentation through a
15-45% sucrose gradient (w/v in PBS) by centrifugation at 28,000 rpm at 12°C for 2.5
hrs. The virus was located by measuring the 260 nm absorbance of gradient fractions.
3.5.18 Virus recovery
Plasmids were transfected into 80% confluent BHK cells using mRNA Trans-IT as per
manufacturers instructions (Mirus, cat. MIR 2225).
3.6 Analysis Methods
3.6.1 Statistical Analysis
Statistical analysis and visualisation of data in a graphical format was completed using
GraphPad Prism6 or R i386 3.2.5.
3.6.2 Bioinformatics analysis pipeline
The bioinformatics pipeline is outlined in Chapter 2[170]. In short, MiSeq reads were
downloaded from Illumina Basespace onto a Linux server. Samples are unzipped using
gunzip:
$ gunzip Read1.fastq.gz
As outlined previously [170] reads were trimmed using Sickle using a quality score of 30:
$ sickle pe -f Read1.fastq -r Read2.fastq -t sanger -o Read1sk.fastq -p Read2sk
.fastq -s GL_sing.fastq -q 30 -l 100 -n
with -t representing the quality score format, -q representing the quality cut off, -l
representing the length the read must be to be accepted and -n deeming no reads with
n in will be accepted.
Trimmed reads were then used in De novo assemblies with Velvet (using Velvet optimiser
to determine Kmer length). An excess of reads input into Velvet optimiser resulted in a
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limited number of contigs. Therefore, only a subsample of reads were used in this step.
Reads were randomly sampled using SubSampleFastq. The program was cloned from
github;
$ git clone https :// github.com/dylanstorey/SubSampleFastq
and used to create a random sample of 20000 of the original reads;
$ RandomSubFq Read1sk.fastq Read2sk.fastq -w 20000
The two random samples from read one and read two were then shuﬄed together using
a perl script provided with Velvet.
$ shuffleSequences_fastq.pl Read1skran.fastq Read2skran.fastq shuffled.fastq
Velvet optimiser was then used to run Velvet. Velvet optimiser is a program that runs
Velvet with a variety of different Kmer lengths to find the optimum length for contig
assembly.
$ VelvetOptimiser.pl -s 11 -e 41 -x 2 -f "-shortPaired -fastq shuffled.fastq"
-d "dir4_shuffled" -o "-cov_cutoff 90 -min_contig_lgth 1000"
In this command -s represents the minimum kmer length to be tested, -e represents the
maximum kmer length to be tested, -x represents the interval of kmer increase, -f is the
velvet command (this shows read type, file type and actual file to be used) and -d is
the output location. The commands after -o are options for velvet such as the coverage
required to accept the contig and the minimum contig length. When trying to construct
the S-fragment of FMDV the latter option was reduced. Contigs produce were entered in
BLAST searches to confirm their origin was FMDV and to determine their orientation.
Contigs that represented host were discarded. The orientated, FMDV contigs were built
into a reference genome using BioEdit. This reference was then used in an alignment of
all sickle trimmed reads. Alignments were completed using Bowtie2:
$ bowtie2 -align -x ref_index -Read1sk.fastq ,Read2sk.fastq -S Alignment.sam
Samtools was used to convert this SAM file to a BAM file:
$ samtools view -bS Alignment.sam > Alignment.bam
and subsequently sort it:
$ samtools sort Alignment.bam Alignment.sorted
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3.6.3 Entropy Calculations
The BAM file created from the alignment pipeline was used to complete entropy calcu-
lations. The Samtools mpileup command was used to make an mpileup file;
$ samtools mpileup -d2000000 -f ref.fas file.sorted.bam > file_pileup.txt
where -d is the max depth and -f represents the reference sequence. This mpilup file was
then counted by a script written by Rocio Enriquez-Gasca at the genome analysis centre
(TGAC). This script counts the number of each base at at each positions on the genome.
A shell script (nt count.sh, Appendix D) runs an R script (eleano.r, AppendixD) that
counts the bases at each positions and outputs them in a chart formatted text file.
$ sh nt_count.sh file_pileup.txt
A python script was written to complete Shannon’s entropy calculations on this text file
(EntropyCalc.py, Appendix D).
$ python EntropyCalc.py inputfile.txt
The output of this file is an entropy score for each position along the genome.
3.6.4 Haplotype Reconstruction
Haplotype reconstruction was completed using QuRE:
$ java . QuRe read_file reference_genome_file
Where read file is an input fasta file of all reads and reference genome file is a comparison
genome reference. Haploptypes were aligned using BioEdit.
3.6.5 Phylogentic trees
Evolutionary analyses were conducted in MEGA6. The evolutionary history was inferred
by using the Maximum Likelihood method based on the Tamura-Nei model. Initial
tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join
and BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum
Composite Likelihood (MCL) approach, and then selecting the topology with superior
log likelihood value.
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3.6.6 dN/dS
Shannon’s entropy is a measure of how much variation present at each nucleotide posi-
tion. However, not all changes in the nucleotide sequence result in amino acid changes in
viral proteins. Some nucleotide changes in the coding region of the genome, particularly
those in the third codon positions, can result in the same amino acid being produced and
are thus referred to as silent or synonymous. Changes that results in a change in amino
acid sequence are referred to as non-synonymous. Considering if nucleotide changes re-
sult in synonymous or non-synonymous changes can be a powerful tool in interpreting
genetic evolution.
Information regarding synonymous and non-synonymous mutations is considered in the
form of the dN/dS ratio.
dN/dN =
dN
dS
(3.1)
Where dN is the estimated number of non-synonymous substitutions per genome posi-
tion and dS is the estimated number of synonymous substitutions per genome position.
This approximation is calculated with equation 3.2 and equation 3.3 respectively.
dN = −3
4
ln
(
1− 4pN
3
)
(3.2)
dS = −3
4
ln
(
1− 4pS
3
)
(3.3)
Where pN and pS are the proportion of non-synonymous and synonymous differences
respectively.
The proportion of differences are calculated with equation 3.4 and equation 3.5.
pN =
∑(
Number of non-synonymous substitutions
)∑(
Number of non-synonymous sites
) (3.4)
pS =
∑(
Number of synonymous substitutions
)∑(
Number of synonymous sites
) (3.5)
The number of synonymous and non-synonymous sites is calculated by considering if
changing each codon of the amino acid would change the amino acid.
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Codon Synonymous Non-synonymous
ATG 0 3
GTG 1 2
AAA 13 2
2
3
CGT 113 1
2
3
TTA 113 1
2
3
Sum 4 11
Table 3.2: An example of the number of synonymous and non-synonymous
sites for amino acids. Synonymous and non-synonymous changes were calculated
for an five exemplar amino acid codons.
For example, consider the start codon ’ATG’. Changing the nucleotide in any of the
three codon positions would result in a non-synonymous change thus for this amino acid
there are three non-synonymous sites and no synonymous sites. In many condons, a
change in the third positions results in a non-synonymous change. Consider for example
Valine. Valine can be coded by GTT, GTC, GTA or GTG. As such, a change in the first
two positions would be non synonymous but a change in the third positions would be
synonymous. For some positions, such as lysine (AAA), 1 of the three alternate options
in the third coding potion would be synonymous (G) and two non-synonymous (T, C).
As such the number of synonymous sites is 13 and non-synonymous sites 2
2
3 . The most
complicated example is potentially arginine which can be coded for by 6 different amino
acids (CGT, CGC, CGA, CGG, AGA, AGG). As both the first and last position can be
more than one nucleotide (the first positions C or A and the last positions any of the
four bases) the number of synonymous sites is 113 and the number of non synonymous
sites is 123 (Table 3.2).
The number of non-synonymous substitutions is calculated by comparing the sequence
of interest with the reference, and considering the number of synonymous or non-
synonymous changes that have been made. This is relatively simplistic with one change:
GCG to GGG is one non-synonymous change or AAA to AAG is one synonymous
change. If there are two changes more consideration needs to be given in the possible
order in which they happened. If CGT changes to CAC this could have been CGT-CGC-
CAC or CGT-CAT-CAC. In the first example the first change is synonymous and the
second is non synonymous. In the second example both changes are non-synonymous
(as in the product is a non-synonymous change from the original.) If both of these
options are equally probable then we consider the synonymous mutation to be 1 and the
non-synonymous mutations to be 1.5 (Table 3.3).
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Codon(ref) Codon Synonymous Non-synonymous
ATG ATG 0 0
GCG GGG 0 1
AAA AAG 1 0
CGT CAC 1 112
TTA TTA 0 0
Sum 2 212
Table 3.3: An example of the number of synonymous and non-synonymous
substitutions. Changes from a reference sequence were used to demonstrate synony-
mous and non-synonymous changes
Considering the discussed examples (Tables 3.2, 3.3) with equations 3.4 and 3.5 pS=
2
4
and pN=
2 1
2
11 . If these values are then used in equation 3.2 and equation 3.3 dN=0.0.27076
and dS=0.82396. The dN/dS ratio is therefore 0.3286.
The dN/dS ratio is used to determine if the protein is undergoing selection. For exam-
ple, if the ratio of non-synonymous mutations to synonymous mutations is significantly
<1 we can suggest that deleterious non-synonymous mutations may have been selected
against. This population would be refereed to as undergoing purifying or negative selec-
tion. Conversely, if the ratio of non-synonymous mutations to synonymous mutations
is significantly >1 the population is considered to be undergoing positive selection or
Darwinian selection; this is to say that selection has allowed some amino acids changes
to happen. Positive and negative selection are not mutually exclusive. During purifying
selection some non-synonymous changes may occur and during positive selection purify-
ing selection will also be occurring but at a lesser rate. However, the dN/dS ratio does
act as a good indicator of the selective pressure the population is under.
dN/dS ratio’s for viral swarms To adapt the use of the dN/dS ratio to NGS data
sets each read that covers a position must be considered rather than just comparison of
individual consensus sequences. So, for each read that covers a sequence the number of
synonymous and non-synonymous changes from the consensus sequence are calculated.
As before, this is then divided by the expected number. The average is then calculated
and can be used in equations 3.2 and 3.3 as previously described. This is an approach
first used by Morelli et al [116] to account for read coverage at each codon.
Software has been designed to consider dN/dS ratios in NGS data. One example of this
is ’diversiTools’ by Richard Orton and Joseph Hughes [218].
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In order to test this tool on viral swarm NGS data FMDV was recovered from the
infectious copy plasmid PT7S3. This sample was sequenced and reads aligned to the
published FMDV O1K genome as previously described [170].
Protein dN/dS(3 d.p.)
Lpro 1.278
VP4 1.067
VP2 0.968
VP3 1.209
VP1 1.116
2A 1.320
2B 1.230
2C 1.110
3A 1.130
3B1 0.870
3B2 1.048
3B3 1.173
3C 0.945
3D 1.167
Entire ORF 1.116
Table 3.4: dN/dS ratio for viral proteins in FMDV O1K The dN/dS ratio for
each protein in the FMDV genome was calculated using deversi tools
diversiTools was then used to consider the dN/dS ratio of the swarm (Table 3.4). This
analysis showed that three of the fourteen viral proteins had a dN/dS ratio less than
one and all others had a dN/dS greater than one. This suggests that the majority of the
genome is undergoing Darwinian selection. When the entire open reading frame is used
in this analysis a dN/dS ratio of 1.116 is calculated. For these values to be considered
relevant they must be significantly greater or less than one. Further repeats would need
to be completed to achieve this.
It is important to note however that this software is still underdevelopment. There is no
universally agreed way to consider dN/dS ratios from NGS data sets. This is due to the
inherent biases. For example, if a non-synonymous mutation was present at a particular
position 100 times out of 100 reads the dN/dS ratio would calculate that that mutation
had arisen 100x individually. However it is not that simple. That mutation could have
appeared once and then been selected via fitness or bottles necks. As such dN/dS ratios
from NGS data can be skewed. Modern dN/dS accounts for phylogeny and so avoid this
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problem but due to the short reads produced by short read high throughput sequencing
technologies this isn’t yet possible for these data.
Therefore dN/dS ratios are a useful tool in comparing consensus sequences and will be
used at this level but they will not be used in considering the swarm.
Chapter 4
Measuring population diversity in
FMDV: a pilot study
4.1 Abstract
A key feature of RNA viruses is the sequence diversity within a viral population. Several
of the objectives of this thesis involved measurement and comparison of this diversity.
Therefore a selection of currently published diversity indices were compared to assess
their suitability for considering the data sets generated in this thesis.
From this comparison, one diversity index, Shannon’s entropy, was then optimised con-
sidering its inherent benefits and limitations. A pilot study was completed to compare
the swarms of seven different viruses.
Differences were found between the seven entropy profiles. These differences were statis-
tically significant. Entropy data for structural and non-structural coding regions corre-
lated well with current published data on conservation in some regions. However, some
proteins appeared to have different levels of selection acting on them at a within the
swarm level in comparison to a consensus level. This work showed Shannon’s entropy
was a good tool for comparing variation within the swarm and identified the manner in
which these profiles can be compared.
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4.2 Introduction
4.2.1 Diversity indices
Diversity indices are mathematical estimates of the diversity present within a population.
They provide a quantitative measure of biological variability.
There are three main groups of diversity indices; species richness, heterogeneity indices
and taxonomic indices. Species richness measures depend upon counting the number of
different options in a population or community. From a genetic stand point, consider
two positions: positions 1 has 997 A, 1 C, 1 T and 1 G, position 2 has 250 A, 250 C,
250 T and 250 G. In consideration of the number of options present at each position
both are comparable with 4. However, if we consider the abundance of each of these
options it can be seen that an A at position 1 is relatively conserved whereas position
two is highly variable. Including a measure of the rarity of each item adds more in-
formation to purely the number of items available. This is what heterogeneity indices
do. These indices measure the individuals present within a community and the evenness
with which they are distributed. If both species number and evenness of these species
distribution are comparable taxonomic indices can be used. These take into account the
taxonomic relation between organisms in a population. This latter class of indices are
more commonly used in measuring diversity in an ecosystem.
4.2.1.1 Heterogeneity indices
Heterogeneity indices combine the number of species present within a population and
their relative abundance. There are two categories of these indices: parametric and non
parametric. Parametric heterogeneity indices are based upon the parameter of a species
abundance model whereas equivalent non-parametric indices make no assumption about
the species abundance/distribution. In order to avoid the requirement for a relevant
species abundance model only non-parametric indices were considered.
Shannon-wiener diversity index The Shannon-wiener diversity index or Shannon’s
entropy is one of the most widely used heterogeneity indices in the literature. It is based
upon information theory. This index makes three assumptions:
1. Individuals are randomly sampled.
2. Samples are taken from an indefinitely large community.
3. All individuals are represented in the sample.
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Shannon-wiener diversity (H’) is calculated using equation 4.1.
H ′ = −
∑
b∈{A,C,G,T}
pblog2(pb) (4.1)
Where pb represents the proportion of each base {A,C,G, T} present.
Brillouin index For samples where assumption one cannot be guaranteed other
indices are available. This can be useful if one species or individual is likely to be
preferentially sampled. In this case heterogeneity measures such as the Brillouin index
are appropriate (Equation 4.2).
HB =
ln(N !)−∑ ln(ni!)
N
(4.2)
Where N is the total number of individuals and ni is the number of individuals in the
ith species.
Simpsons index The Simpsons index (Equation 4.3) is another heterogeneity index
that expresses the probability that two of the same species will be drawn from ran-
dom from a community. This is used for large sampled communities as it assumes an
indefinitely large community.
γ =
∑
i
p2i (4.3)
pi represents the proportion of individuals found in the ith species.
The Hill numbers Hill defined a set of diversity numbers of different orders. These
are used to show the relation between species-richness indices and heterogeneity indices.
For example, the diversity number of an order would be defined as equation 4.4.
Ha = (
∑
i
pai )
(1/(1−a)) (4.4)
pi represents the proportion of species i within the population. The most common
Hill numbers are H0 (Equation 4.5), H1 (the exponential of Shannon-wiener diversity
index)(Equation 4.6) and H2(the reciprocal of Simpsons index)(Equation 4.7).
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H0 = S (4.5)
H1 = expH
′ (4.6)
H2 =
1
γ
(4.7)
As one base is no more likely to be selected than another the Brillouin index was deemed
unnecessary. Shannon-wiener diversity index and Simpsons index were compared.
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Position 1 1000 0 0 0 0 0 1 n/a
Position 2 750 250 0 0 0.5623 0.6246 1.754 1.601
Position 3 500 250 250 0 1.5 0.3744 4.481 2.670
Position 4 250 250 250 250 2 0.2492 7.389 4.0128
Position 5 997 1 1 1 0.03422 0.994 1.035 1.006
Figure 4.1: Heterogenity measures present the data similarly Diversity, as
calculated with different indices, was compared for 5 genome positions with different
proportions of bases. Diversity is shown measured by Shannons’ entropy (H’)(green),
the Simpsons index (γ)(purple) and the hill number of these two measures (H1(blue)and
H2(red) respectively). Shannon-wiener diversity index is show on the left y-axis and
Simpsons index shown on an inverse right y-axis.
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To asses how each of the diversity indices represents different distributions of nucleotides
five potential examples were created (Fig. 4.1). These represented a range of possible de-
grees of variation. Both heterogeneity indices shows the same pattern revealing position
4 as the most variable and position 5 as the least variable (Fig. 4.1).
As all options were comparable, Shannon’s entropy was used in future analysis due to the
simplicity of comprehension (0 is least diverse, 2 is most diverse) and ease of calculation.
4.2.2 Shannon’s entropy
4.2.2.1 Limitations
Coverage One factor affecting the robustness of the Shannons’s entropy analysis is
how the output is affected by areas of the genome with low coverage. Work was com-
pleted to explore the sampling properties of this diversity index and establish the level
of coverage required to be reasonably confident the Shannon’s entropy score produced
is representative of the actual makeup of the virus population. This was first considered
in a mathematical example. Five files containing 1000000nt were created. Each file
contained a different proportion of each nucleotide designed to create an entropy score
of 0.2, 0.5, 1, 1.5 and 2 (Table 4.2).
A C T G H’(1dp)
250000 250000 250000 250000 2
500000 250000 250000 0 1.5
500000 500000 0 0 1
89000 11000 0 0 0.5
97300 2000 700 0 0.2
1000000 0 0 0 0
Table 4.2: A breakdown of the proportion of bases used to create files of
each entropy score.The value for 0.5 is accurate to 1dp. It was not possible to achieve
an entropy score of exactly 0.2 or 0.5 with 4 positions split at whole number values.
It is apparent without mathematical analysis that any position with a Shannon’s entropy
score of 0 would be correctly represented regardless of the coverage as there would only
be one base present at that position in the whole population thus there is only one
possible outcome of sampling. For the other five examples the total files were randomly
sampled to represent different levels of coverage and the Shannon’s entropy calculated
from each of these. This process was iterated 10 times and the average graphed.
Chapter 4. Measuring population diversity in FMDV: a pilot study 79
Coverage (Log)
S
h
an
n
o
n
's
E
n
tr
o
p
y
0.1 1 10 100 1000 10000 100000
0
1
2
Coverage
S
h
an
n
o
n
's
E
n
tr
o
p
y
0 5000 10000
0.0
0.2
0.4
A
B
Figure 4.2: Establishing a suitable coverage cut off for Shannon’s entropy
analysis. A) Files of 100000 nt split into different proportions of bases were created
to represent Shannon’s entropy Scores of 0.2 (blue), 0.5 (orange), 1 (pink), 1.5 (green)
and 2 (turquoise). These files were randomly sampled to represent different levels of
coverage (1x, 5x, 10x, 50x, 100x, 250x, 500x, 1000x, 5000x, 10000x, 25000x, 50000x,
75000x and 100000x) and the Shannon’s entropy calculated from these subsamples.
This process was iterated ten times and the average plotted with a confidence interval
of 95%. B) FMDV O1K was sequenced using the previously described method. An
alignment to the known reference sequence was completed. The subsequent mpileup
file was filtered to produce different levels of coverage (1x, 5x, 10x, 50x, 100x, 500x,
1000x, 1500x, 2000x, 2500x, 3000x, 3500x, 4000x, 4500x, 5000x, 5500x, 6000x, 6500x,
7000x, 7500x, 8000x, 8500x, 9000x, 9500x, 10000x, 10500x and (where sufficient reads
were available) 11000x). Entropy analysis was completed at each of these levels of
coverage. Five high coverage and high entropy (in comparison to other positions in
this example) were plotted (black) alongside the mathematical example of 0.2 entropy
(blue) (Fig. 4.2A)
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For a file with a Shannon’s entropy score of 0 (only one base represented) the score
remains the same regardless of coverage. For all other entropy scores a plateau is reached
from 250x coverage. This was reached more slowly and with more variation previous
to the plateau in the files representing an entropy score of 0.5 and 0.2. This can be
explained by the smaller subsets present; 11000nt and 700nt respectively. These smaller
subsets have a lesser chance of being selected and thus require a larger sample to be
accurately represented. The opposite of this phenomenon can be seen at an entropy
score of 1.0. This file contains two equally large subsets of 50000nt. This is more quickly
correctly represented being almost accurately viewed from 5x coverage and reaching a
plateau by 50x coverage (Fig. 4.2A).
To assess whether the same cut-off was required in a real world example a similar analysis
was completed using a sequenced virus. O1K was sequenced and analysed as previously
described. The resulting sorted bam file was filtered to contain varying levels of cover-
age (Appendix D) and Shannon’s entropy analysis completed on these files. Five high
coverage nucleotides were compared (Fig. 4.2B). As with the lowest entropy score from
the mathematical example these nucleotides exhibit some fluctuation before reaching a
plateau. This is even more evident in these real world example due to the lower entropy
score and the lack of iteration and averaging. In these examples a plateau is reached
from 1000x coverage. This ignores the final data point for nt 7504 and nt 3352. In
these positions there was a sharp increase in entropy at maximum coverage. This is a
reflection of the way the script filters the sorted bam file. Reads in these files are sorted
by read name, SAM flag, position, MAPQ and a series subsequent categories. Because
of this the reads most diverged from the consensus would be listed last and thus present
only in the maximum coverage files in the analysis. This issue would be overcome by
using a bam file that had not been sorted but this proved challenging to design a script
to process due to its format. In reality, these differences (if evenly represented in each
entropy file) would results in only a slightly higher entropy score. This is an artefact
that will only be apparent when using below the maximum coverage, such as in this
example, but will not be reflected in future analysis of total viral populations.
Calculations completed on areas of the genome with lower coverage than 1000x may still
be accurate but regarded with greater caution particularly for areas of the genome with
a low entropy score.
Variation in Shannon’s entropy Based on the analysis described above it was
decided that in this work, Shannon’s entropy score calculated at each position along
the genome would be used as a measure of variation within the swarm. It is important
therefore to show what this measure does and does not show.
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First it is important to consider what Shannon’s entropy analysis would define as most
variable. The highest score possible is 2. This represents an equal proportion of all four
bases being present in the swarm. The lowest score is zero. This is found at a position
where only one base is represented. This fits in well with the concept of conserved and
variable areas of the genome. Those positions that are variable can withstand having
any of the four bases present (Shannon’s entropy = 2) and those that are conserved
always have the same base at that position (Shannon’s entropy = 0). Although the
score gives a good indicator of the variability of the genome position it does not reveal
the underlying proportion of bases present at the position. Positions with a very similar
Shannon’s entropy score can reveal slightly different proportions of bases as shown in
Table 4.3.
Position A C T G H’(3 d.p.)
1 450 450 50 50 1.469
2 500 275 225 0 1.496
3 500 250 250 0 1.500
4 500 350 140 10 1.493
Table 4.3: Differing nucleotide distributions can result in similar entropy
scores Hypothetical distributions of the nucleotide bases A, C, T and G are shown and
the resulting Shannon’s Entropy score (H’) as calculated using equation 4.1.
For each positions shown in Table 4.3 H’≈1.5. This would suggest they were relatively
variable positions. This is reflected in the nucleotide distributions with each of the
positions being represented by three or four bases. However, the two positions with all
four bases represented (Position 1 and Position 3, Table 4.3) show the lowest entropy
scores (1.469, 1.493 respectively). This measure is considering not only the number of
positions present but also the proportion of those represented bases so the positions with
a higher proportion of bases not in the majority group have higher entropy scores. This
highlights the need to be cautious about what the Shannon’s entropy score shows as
although it indicated a positions is variable, it may not show which position is the most
diverse (with all four bases represented).
Overall Shannon’s entropy is a good tool indicating well positions that are variable
in comparison to those that are conserved. However, this method is limited on it’s
resolution and when dissecting minor changes at positions with similar entropy scores
relative frequency of nucleotides may need to be considered.
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4.3 Experimental Design
An experiment was designed to compare and contrast exemplars of FMDV to consider
how the swarm structure varies.
Figure 4.3: Measuring population diversity flowchart of methods used Viral
samples were received from the WRLFMD and a viral stock created via one passage in
BTy cells. Samples were prepared for sequencing as outlined in the published protocol
[170] with some thesis specific amendments (Chapter 2). Library preparation was com-
pleted using the Illumina Nextera XT kit and subsequent sequencing completed on the
Illumina MiSeq. Sequence analysis was completed as detailed in Chapter 3.
A panel of viruses were selected as an example. There were chosen for two reasons:
 Samples had a known passage history.
– Field isolates of FMDV that are heavily passaged in cell culture show cell
culture adaptation and are not necessarily representative of a wild type virus.
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As such viruses were chosen from the World Reference Laboratory that had
been isolated from an infected animal and subsequently passaged only once
in primary cells to establish a large enough sample to sequence.
 Samples had a broad genetic distance.
– To ensure a broad cross section of FMD viruses one exemplar was chosen
from each serotype. This was hoped to ensure a broad genetic range.
The samples in use were received from the WRLFMDV at the Pirbright Institute and
are detailed in Table 4.4.
Serotype Isolate Sample type Material supplied by WRL Passage
history
Type O TUR/11/2013 Epithelium BTY1 ET/Glyc 21/05/2013 1x BTy
Type A TUR/12/2013 Epithelium BTY1 ET/Glyc 21/05/2013 1x BTy
Type C KEN/1/2004 Epi Suspension BTY1 ET/Glyc 05/02/2005 1x BTy
Asia 1 TUR/13/2013 Epithelium BTY1 ET/Glyc 21/05/2013 1x BTy
SAT1 TAN/22/2012 Epithelium 1x BTy
SAT2 TAN/5/2012 Epithelium BTY1 ET/Glyc 30/08/2012 1x BTy
SAT3 ZIM/6/91 Epithelium (Tongue) BTY1 ET/Glyc 26/07/1991 1x BTy
Table 4.4: Samples used for FMDV swarm comparison Details of each isolate
used and the serotype it has been classified as.
Samples were grown for one passage in bovine thyroid (BTy) cells to increase yield.
This is a primary cell line and as such was used to avoid cell culture adaptation. Isolates
then underwent sample preparation as detailed in the published method [170]. The
NexteraXT library preparation kit was used and samples were sequenced on the Illumina
MiSeq. Bioinformatics anlaysis was completed. Methods are outlined in Figure 4.3,
method details are included in Chapters 2 and 3.
4.4 Results and Discussion
4.4.0.1 FMDV swarm variation
The Shannon’s entropy score for each position along the genome was calculated for
positions with a coverage of >1000x as detailed in the previous chapter. The dis-
tribution of entropy scores was then compared as a measure of variation within the
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swarm. It was found that for each exemplar the majority of entropy scores were be-
low 0.5 (Fig. 4.4). For two exemplars, SAT2/TAN/5/2012 and SAT3/ZIM/6/91, only
one or two positions were above this score. Of the others, four revealed some entropy
scores above one (TypeA/TUR/12/2013, Asia1/TUR/13/2013, TypeC/KEN/1/2004,
TypeO/TUR/11/2013,) and one (SAT2/TAN/22/2012) had a large number of positions
between 0.5 and 1 (33 positions) but none above one.
Figure 4.4: The seven exemplars have varying numbers of high entropy
positions Shannon’s entropy score (left y-axis) is shown for each exemplar TypeA/-
TUR/12/2013, Asia1/TUR/13/2013, TypeC/TUR/11/2013, TypeO/TUR/11/2013,
SAT1/TAN/22/2012, SAT2/TAN/5/2012 and SAT3/ZIM/6/91
4.4.1 Assessing if the sample viruses vary significantly in their entropy
profiles.
The entropy scores were statistically compared. An F-test showed the variances for the
samples are significantly different and thus a parametric ANOVA test was not appro-
priate. A non-parametric alternative (The Kruskal-Wallis test) was used. This showed
there were statistically significant differences between the seven exemplars (chi-squared
= 987.5852, df = 6, p=2.2e-16).
Type A Asia1 Type O Type C SAT1 SAT2
Asia1 2.795e-13
Type O 2.2e-16 1.062e-09
Type C 2.2e-16 2.2e-16 1.861e-05
SAT 1 2.2e-16 2.2e-16 2.2e-16 2.2e-16
SAT 2 2.2e-16 0.141 3.796e-06 2.2e-16 2.2e-16
SAT 3 9.562e-06 0.09028 1.416e-12 2.2e-16 2.2e-16 0.0007189
Table 4.5: Pairwise Wilcoxon tests to determine differences between ex-
emplar entropy scores A pairwise comparison of each exemplar with the other was
completed using a Wilcoxon test and the p values are displayed.
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A pairwise Wilcoxon tests was completed to understand which samples were different
from one another. This showed the median entropies are significantly different for all
serotypes except Asia1/TUR/13/2013 vs SAT2/TAN/5/2012 and Asia1/TUR/13/2013
vs SAT3/ZIM/6/91 (Table 4.5). This suggests that the amount of variation within a
swarm does vary isolate to isolate. Although this shows variation isolate to isolate the
differences can not be said it be indicative of the serotype as there is only one exemplar
of each.
4.4.1.1 Can selection be detected within the swarm?
Work was completed to consider if selection could be detected in the swarm. This was
completed by comparing structural and non-structural coding regions and comparing it
to published data on conservation and selection. The majority of genome sites of each
exemplar had >1000x coverage with all bar SAT3/ZIM/6/91 missing only 1.4 to 3.01%
of their genome (Fig. 4.5). These missing regions were at the beginning and end of the
genome which are notoriously under-represent as discussed in Appendix B (Fig. B.3).
The area surrounding the poly(c)region also lack coverage as the sequencing chemistry
struggles to successfully call long cystine tracts.
The sample with the least of it’s genome represented was SAT3/ZIM/6/91. This isolate
was missing coverage >1000x in 10.1% of it’s genome. This is likely due to a lower
proportion of the over all genome reads being attributed to this sample. There are
numerous causes of this. Firstly, incorrect quantification of sample for use in the Nextera
XT kit can affect the tagmentation reaction. Samples with more than one nanogram
of DNA could result in undertagmentation. This results in an excessively large library
that does not cluster efficiently on the flow cell. Conversely, samples with less than one
nanogram of DNA could results in overtagmentation which produces a reduced library
yield and therefore decreased coverage. Although all samples were quantified in the same
manor, using the Qubit (flurometric quantification) there could still be discrepancies
in the quality of the DNA. For example, the tagementation reaction requires DNA
longer than 300bp to work. On the Qubit 5 x 200bp fragments of DNA would quantify
the same as one 1000bp fragment however the 200bp fragments would not work in
the tagmentation reaction. In a repeat experiment this could be checked using the
bioanalyser to consider not only the quantity of DNA being put into the Nextera XT
kit but also the quality.
Alternatively there could be elements of the sample preparation that are inhibiting the
enzymatic reactions in the library preparation procedure. Three main issues have been
identified by Illumina in this area.
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Figure 4.5: Six of seven isolates have a comparable entropy profile Shan-
non’s entropy score (blue, left y-axis) is shown for each positions across the genome
(x-axis) when coverage is greater than 1000x. Coverage (green, right y-axis) is shown
for each positions along the genome on a log scale. This is detailed for each exemplar
A) TypeA/TUR/12/2013 B) Asia1/TUR/13/2013 C) TypeO/TUR/11/2013 D) Type-
C/KEN/1/2004 E) SAT1/TAN/22/2012 F) SAT2/TAN/5/2012 G) SAT3/ZIM/6/91
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 Residual proteins have been found to bind DNA preventing subesequent enzymes
binding.
 Enzymes can be degraded by proteinases or detergent/phenol contaminants left
from sample preparation
 EDTA has been found to sequester enzyme co-factors
As the regions of the genome that were not represented remained at the ends of the
genome and the area surrounding the poly(c)tract, although a slightly larger region,
analysis was continued comparing regions with sufficient coverage.
Of the seven samples, 6 exemplars had a Shannon’s entropy profile of low level fluctua-
tions across the genome with some small clusters of high entropy positions. SAT1/TAN/22/2012
does not appear to fit in with this pattern (Fig. 4.5E). This isolate has a series of high
entropy points across the genome each exhibiting a similar score. This difference is
discussed in more detail in Chapter 5. TypeC/KEN/1/2004 also shows evidence of
a number of high entropy positions across the genome although in a less consistent
manner than SAT1/TAN/22/2012. The three points with high entropy scores in Type-
C/KEN/1/2004 are at nt932 (5’UTR), nt3676 (VP1) and nt3171(3C). They have an
entropy score of 1.0048, 1.18735 and 0.995289 respectively. The highest score is the
nucleotide in VP1. This equates to the first coding positions in amino acid 138 of the
protein. This is situated at the base of the GH loop which has well characterised rel-
evance to immunogenicity and could be evidence that this swarm was under immune
pressure. The positions identified in 3C is in amino acid 48. This is on positions 3’ of
alpha-helix 1. This is the first coding position of a lysine residue and therefore any other
nucleotide will result in change. Asp45, three positions 5’ of this lysine, is involved in
a Cys-His-Asp triad configuration important for protein structure. Therefore, a change
at this point could be functionally relevant although without further structural analysis
it is impossible to know [219, 220].
Although the overall entropy profile from sample to sample are similar (Fig. 4.5) the
number of high entropy positions varies (Fig. 4.4, Table 4.5).
4.4.1.2 Conservation of the genome
Previous studies have been completed of FMDV genome conservation [221]. This work
has indicated that some areas of the genome are more conserved than others. For exam-
ple the region of the genome encoding for the structural proteins is generally considered
to be more variable than the region coding for the non-structural proteins.
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To consider if this previously described genome conservation was reflected by the swarm
the location of high entropy positions was considered. To do this the frequency distri-
bution for each exemplar was calculated. The 75th percentile sat between 0.030 and
0.039 for all seven samples. Therefore an entropy score of 0.04 was classified as ’high’.
A comparison was first made between the structural (VP4, VP2, VP3 and VP1) and
non-structural (2A-3D) coding regions. When a virus is under immune pressure it is
expected that the structural coding region will undergo Darwinian selection to facilitate
immune escape. Consequently, it would be expected that there is more variation in the
structural than non-structural coding region which might be reflected in the entropy
scores.
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Figure 4.6: More variation is evident in the structural coding region in com-
parison to the non-structural The percentage of the coding region for the structural
and non-structural proteins were compared. Positions above the 75th percentile (>0.04)
were considered high. The percentage of positions in each coding region above this cut
off is shown in A. Due to the non-normal distribution statistical significance was anal-
ysed using the Mann-Whitney test, the values were found to be significantly different
(p=0.0006). B) The percentage of high entropy positions in the structural coding region
(black bars) and non-structural coding region (grey bars) is shown for each isolate.
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The percentage of the structural region with high entropy positions was significantly
higher than the percentage of the non-structurals with high entropy positions (Mann-
Whitney, p=0.0006)(Fig. 4.6A). The percentage of high entropy positions in the non-
structual coding region is more consistent between isolates (range=10%) than in the
structural coding region (range=16%). When considered in closer detail, five of the
seven isolates considered differ by only 3% in the proportions of their non-structural
coding region with high entropy scores. This fits in well with the theory that the
structural region is under greater selective pressure than non-structural coding region.
However there are also other explanations. High entropy can arise as a result of relaxed
purifying selection in areas of the protein that are not as important to viral survival or
because of positive selection. Only a dN/dS >1 is unambiguously indicative of positive
selection.
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Figure 4.7: Proteins have a varied proportion of high entropy positions and
variable consistency of this proportion between samples The percentage of
positions in each proteins’ coding region with an entropy score of >0.04 was considered.
The mean and standard deviation is shown for each protein.
When considered on a protein to protein basis the entropy pattern is not so clear cut.
The mean percentage of high entropy (>0.04) varies from 9.9% (3B3) to 43.9% (2A).
However, The range for the data sets varies dramatically. The values for 2B, 2C, 3A,
3B3, 3C,and 3D all have a small range (9.2-11.6%), VP4, VP3, VP2, VP1, 3B1 and 3B2
have a slightly larger range (17.6%-30.4%) and 2A has the largest range (83.3%) (Fig.
4.7).
Published data on conservation Work by Carrillo et al [221] considered the con-
servation of FMDV proteins using consensus sequences of FMDV. Some of the data on
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conservation from this study correlates with the results of these experiments. For ex-
ample 3C and 3D have been found to be highly conserved with 76 and 74 % of their
amino acids shown to be invariable respectively. This was echoed in the entropy scores
with just under twenty percent of nucleotide positions in this coding region having high
entropy scores. Data from Carillo et al ’s paper also correlates with the findings for 3B.
They found overall amino acid conservation to be 50%. Interestingly they found that
3B3 was highly conserved in all variants and reflected by the low number of high entropy
positions found in our analysis.
In some genome positions these two sets of data show different things. For example, in
the non structurals genes, higher percentages of nucleotides had high entropy positions,
the highest of these was found to be VP4. In Carillo’s work however VP4 was found
to be the most conserved protein in the genome with 81% of it’s amino acids being
invariable.
This suggests that although low level variation can be tolerated in the swarm at these
positions the variants rarely become fixed. This could be due to the lack of immune
pressure on VP4. VP4 is the only entirely internal capsid protein. It has a similar
amount of high entropy positions as the other capsid proteins. A Mann-Whitney test
shows VP4 is not significant different from VP2 (p=0.12) and is weakly significantly
different from VP3 and VP1 (p=0.0379, p=0.379 respectively). However VP4 is highly
conserved (81% amino acids invaraibale) compared to the other capsid proteins that are
more variable (VP2=47%, vP3=39% and VP1=24%). This suggest each capsid protein
is equally variable but VP4 lacks the same selection pressure due to it’s internal position.
The other notable outlier in this data is 2A. 2A is an 18 amino acid long protein whose
function is not well understood. It facilitates its own separation from 2B by modifying
cellular translational machinery resulting in ribosomal skipping preventing the original
binding of 2A and 2B. Carillo found amino acids in this protein to be quite highly
conserved with 65% of positions being invariant. In this work from 3% to 87% of
genome positions were found to have high entropy positions hinting at some subconsensus
variation although this level of variation appears not to be translated in the consensus
level changes. Carillo et al suggests this could be due to the small size of the proteins,
only 18AA in length, resulting in changes affecting both the structure and functionality.
This could mean that nearly all mutations that arise are detrimental.
This work has detected a difference between the structural and non-structural coding
regions at the within swarm level. This suggests that there is selection occurring or some
molecular mechanism that allows less variation to be introduced in the non-structural
coding region. However, the differences with Carrilo et al’s consensus data conflicts
with this. Where the data matches the consensus data from Carillo’s paper it suggests
Chapter 4. Measuring population diversity in FMDV: a pilot study 91
that selection is occurring at the virus replication level. Were it differs it suggests
selection is potentially happening at a different level (for example the immune response
and VP4). This raises an interesting question about the functionality of 2A and what
would explain the disparity between selection at the consensus level (and the resulting
genome conservation) and the selection within the swarm.
Cumulative Shannon’s entropy Work was then completed to consider if the sam-
ples vary significantly in the amount of variation across the genome as a whole. Summing
the entropy score of each position provides a cumulative entropy score indicative of the
amount of variation in the swarm across the whole genome. This analysis was completed
on the polyprotein of each sample to ensure the work was comparable. The 7th sample
(SAT3/ZIM/6/91) was not used in this analysis as it was lacking sufficient coverage for
the last 20nt of the polyprotein.
The cumulative entropy for each sample is similar varying from 199.9831 to 232.4176
(range = 32.4345). This suggests that the swarm for each sample is able to contain a
similar amount of variation.
The entropy scores contributing to this value were then considered. Genome positions
were binned into low entropy scores (<0.04), high entropy scores (>0.04<0.25) and
very high entropy scores (>0.25). The number of low entropy positions shows an inverse
patten to that of cumulative entropy (Fig. 4.8 purple triangles, blue circles respectively).
That is to say that samples with high cumulative entropy scores have a lower number of
positions with low entropy scores and samples with low cumulative entropy scores have a
higher number of positions with low entropy scores. When considering the high entropy
positions (red squares) it can be see that the pattern mimics that of cumulative entropy.
The higher the cumulative entropy score the higher the number of high entropy scores
in this range. However, when considering the very high entropy scores (green diamonds)
we see that the pattern is not so simple. In some samples it is inverse of the cumulative
entropy (sample 5) and in some it reflects it (sample 1). In sample 5 it appears that with
an increased number of extremely high entropy positions the number of high entropy
positions decreases and the number of low entropy positions increases. However, in a
sample one with a lower number of very high entropy positions the number of high
entropy positions is higher and the number of low entropy positions is lower.
This pattern hints at the concept that a viral swarm can only withstand a certain amount
of variation. As such the cumulative entropy score of all six examples is relatively
similar. This results in fluctuation among the distribution of positions with different
entropy scores. As the number of extremely high entropy scores increase the number of
high entropy scores decrease and low entropy scores increase. However, if the number of
Chapter 4. Measuring population diversity in FMDV: a pilot study 92
extremely high entropy scores is low, the number of high entropy scores increases and
the number of low entropy scores decrease. A more powerful test of this theory would
be to observe cumulative entropy over time.
This could correlate with the concept of an error threshold. It may be that a swarm
with above this level of variation is unable to survive.
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Figure 4.8: Distribution of entropy scores in comparison with cumulative
entropy The cumulative entropy, as determined by summing the entropy scores for each
nucleotide positions in the poly protein is shown on the right y-axis (purple triangles) for
six samples 1) TypeA/TUR/12/2013 2)Asia1/TUR/13/2013 3)TypeO/KEN/1/2004
4)TypeC/TUR/11/2013 5)SAT1/TAN/22/2012 6)SAT2/TAN/5/2012. The distribu-
tions of nucleotides in each entropy score bin is shown on the segmented left hand y
axis. This axis is divided into 0-100 for the lower 25% and 100-6000 for the upper 75%
to allow visualisation of the lowest group. The number of nucleotide positions in the
three bins is shown; <0.04 (blue circle), >0.04<0.25 (red square) and >0.25 (green
diamond)
Although the cumulative entropy cannot be used as an indicator of if the virus is un-
dergoing any form of selection the distribution of entropy scores could be reflective of
this. As a virus adapts to a new environment, adaptive changes will appear and develop
to the consensus level. These positions will move from low to high to very high entropy
positions and then back down to low as they become fixed. As such, it could be that
genomes with high numbers of extremely high entropy positions and associated high
number of low entropy positions are under adaptive pressure. This is a concept that is
discussed further in Chapter 6.
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4.5 Summary
Shannon’s Entropy is a good measure of diversity within the swarm. Shan-
non’s entropy was found to be a good indicator of variation within the swarm at each
position of the genome. Limitations relating to coverage provided by the NGS data were
considered and the entropy calculation was found to be robust if 1000x coverage was
achieved.
Entropy profiles between exemplars of FMDV are sometimes statistically sig-
nificantly different. Visual comparisons of the entropy profiles produced showed
some difference and these were confirmed statistically. This highlights the level of vari-
ation within the swarm structure of several strains of the same virus.
Selection can be identified at a within swarm level. There is evidence of
selection occurring below the consensus, and selection differs in places from that previ-
ously identified at the consensus level. This has the potential for further defining the
functional roles of FMDV proteins as important for replication, or higher level processes.
The amount of variation within the swarm (as represented by cumulative
entropy) remains comparable. Although there is variation between the swarms
from virus to virus, as detailed above, the cumulative entropy score for each virus re-
mained comparable. This suggests that the swarm can only withstand a certain level of
variation within it.
Chapter 5
FMDV genetic variability is
influenced by the host species
5.1 Abstract
Southern African territories (SAT) serotype viruses have been shown to be more geneti-
cally variable at the consensus level than their European counterparts. The root of this
increased level of variation was investigated.
SAT viruses were received from the WRLFMD and sequenced on the Illumina MiSeq.
De novo assemblies were completed to produce consensus sequences which reads were
subsequently aligned to. This alignment was used to calculate Shannon’s entropy as a
measure of variation at each genome position within the swarm.
This analysis indicated that the increased variability seen in SAT virus samples could be
host derived. When viruses were divided according to the host they had been isolated
from, samples isolated from cattle had less high entropy positions than samples from
buffalo. Both the structural and non-structural coding regions of viruses isolated from
buffalo show plasticity. Therefore, this increased variability does not appear to be solely
due to immune pressure. Bioinformatic dissection of the swarm showed that the buffalo
derived samples sometimes contained a second subconsensus level population. This
could be due to either a secondary infection, co-infection or viral evolution within the
host. Some subconsensus level variant populations were antigenically important and
should therefore be considered in disease control. This work was completed on a small
number of exemplars (n=24) and thus further work needs to be completed to confirm
these preliminary findings.
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5.2 Introduction
5.2.1 Genetic variability of SAT serotypes
The southern African territories (SAT) serotypes 1, 2 and 3 are endemic to sub-Saharan
Africa. In this region they have been found to circulate along with type A, O and C.
Type C has not been isolated since 2004 however and may be extinct in the region and
potentially globally. These seroptypes have all been causative agents of outbreaks to
varying extents. Of the 350 epizootics known in southern Africa since 1931 41 % have
been attributed to SAT2, 25% SAT 1, 7 % SAT 3, 7 % type A, 6% type 0 and 1% type
C . A proportion of outbreaks (13%) were caused by viruses that were untyped [222]. In
more recent years, 2000-2010, SAT2 has been responsible for 41% of outbreaks, SAT1
19% and SAT3 only two outbreaks during this time period [223].
SAT serotypes are genetically diverse. They can differ by up to 40% of their nucleotides
in VP1 [224]. They have approximately 10% more heterogeneity than the European
types when comparing P1 [225]. This high level of variation produces a challenging dis-
ease control environment. High antigentic variability poses problems for single serotype
vaccines as one vaccine will not protect against the large variety of viruses present in
the area.
5.2.2 Wildlife Reservoirs
Wildlife reservoirs are thought to have an affect on FMDV transmission and main-
tenance in southern Africa. It has been found that in this area cattle (Bos taurus),
kudu (Tragelaphus strepsiceros), warthog (Phacochoerus aethiopicus), bush pig (Pota-
mochoerus porcus), wildebeest (Connochaetes taurinus), eland (Taurotragus oryx ), wa-
terbuck (Kobus ellipsiprymnus), sable (Hippotragus niger), buffalo (Syncerus caffer)
and impala (Aepyceros melampus) are susceptible to FMDV infection [226–228]. Of
these, two main species have been suggested as potentially relevant to FMDV spread
and maintenance: impala and African buffalo. Impala and African buffalo have lesser
severity or no clinical signs respectively but high susceptibility to infection. Impala are
thought to be relevant in wildlife to cattle transmission and African buffalo have long
been implicated as a maintenance host.
5.2.2.1 Buffalo
The relevance of African buffalo in FMDV spread in southern Africa remains controver-
sial. Although it has been shown that buffalo can transmit disease to cattle, transmission
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is erratic [229]. Although inconsistent, buffalo to cattle transmission has been shown to
be the source for outbreaks [230]. African buffalo are a natural host of FMDV but they
do not suffer clinical signs [231, 232]. Calves are infected after the lessening of maternal
immunity that originally protects them [232]. Infection of buffalo is widespread. A study
in Uganda found that of the 207 buffalo sampled 85% had antibodies against FMDV
non-structural proteins, of these 96% were positive for antibodies against more than one
serotype [233]. Buffalo have in fact been found with evidence of all three SAT serotypes
in probang samples. This ability to maintain several serotypes, topoypes or strains could
result in an environment that allows for intra and inter serotype recombination.
The sequence variation found between buffalo in the same herd can be great. In work by
Vosloo et al. it was found that FMD viruses from two buffalo in the same herd sampled
on the same day could be very similar (less than 2% nucleotide variation) or genetically
diverse (up to 20% nucleotide variation) when comparing VP1 [224]. This is potentially
due to a significant amount of genetic diversity of FMD viruses can be produced within
a single African buffalo. Furthermore, the rate of change observed over a viral infection
can increase via transmission to another animal [229].
It is generally accepted that buffalo can be persistently infected for 5 years. This stems
from work completed by Condy et al [234]. However, this may not be accurate. Mecha-
nisms of persistence remain inconclusive. Whether the virus persisted within the animal
or within the group was not entirely clear.
Regardless of how infection is preserved in the individual or herd it is clear that FMDV
can be maintained in African buffalo alone for extended periods of time and within this
time the level of sequence variation has the capacity to increases.
5.2.2.2 Impala
Impala are widely distributed across southern Africa. The body of data relating to
their involvement in FMDV epidemiology comes from work in the Kruger National
Park (KNP) due to the high density of impala and the numerous scientific studies. All
three SAT serotypes have been isolated from impala in the last 40 years although the
majority of outbreaks have been SAT2 [235]. Impala show little to no clinical signs
when infected with FMDV [227]. It is likely that impala are infected with FMDV via
contact with African buffalo [236]. As buffalo and impala have little natural cause to
interact it has been suggested that shared grazing and waterholes due to high density
populations and seasonal droughts respectively could be relevant in between species
transmission [235, 236]. Although buffalo continue to be considered the most relevant
animal reservoir there has been some evidence of impala transmitting disease across
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control fencing designed to prevent spread from infected buffalo [237]. Although clearly
relevant in transmission from buffalo to cattle they are not considered as a maintenance
host and therefore not considered in this body of work.
5.3 Experimental Design
Figure 5.1: FMDV genetic variability is influenced by host species flowchart
of methods used Viral samples were received from the WRLFMD and a viral stock
created via one passage in BTy cells. Samples were prepared for sequencing as outlined
in the published protocol [170] with some thesis specific amendments (Chapter 2).
Library preparation was completed using the Illumina Nextera XT kit and subsequent
sequencing completed on the Illumina MiSeq. Sample preparation and sequencing was
completed by Lidia Lasecka and Caroline Wright. Sequence analysis was completed as
detailed in Chapter 3.
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During initial experiments to characterise the viral swarm (Chapter 4, Fig. 4.5), it
became apparent that the SAT1 sample showed a number of high entropy positions
throughout the genome not mirrored by any other sample. Previously published research
in this area has found SATs to be highly variable. To investigate the cause of this
variation and the unusual entropy pattern seen in this isolate it was considered in the
context of a larger sample of SAT viruses sequenced and assembled by Dr. L. Lasecka
and Dr. C.F. Wright. Methods used in this chapter are outlined in Figure 5.1. Details
of these methods can be found in Chapter 2 and 3.
5.4 Results and Discussion
5.4.1 The viral swarms in buffalo show more genetic variation
Exemplars of SAT1 (n=8), SAT2 (n=8) and SAT3 (n=8) were considered in comparison
to non SAT samples described in the published method (type O(n=1), type A(n=1),
type C(n=1) and Asia 1(n=1))(Chapter 2).
As previously described, Shannon’s entropy was calculated at each position along each
genome. This score provides a measure of swarm diversity at each position. As this
analysis can only be considered representative at positions with a coverage of >1000x
(Fig. 4.2), only these scores were considered. Not all of the genomes considered had
>1000x coverage at the same number of positions. Therefore these results are shown as
a percentage of the genome analysed. Positions with a score of >0.25 were considered
to have a high level of variability. In the non-SAT exemplars a relatively consistent
percentage of positions are above this cut off (0.06-0.4%). Some SAT exemplars from
each serotype sit in this low range, but some have a much higher proportion of their
genome with high entropy position (range of 0.19-3.01%, 0.25-1.26% and 0.07-1.88% for
SAT1, 2 and 3 respectively). On average, all three SATs had a higher proportion of
entropy scores >0.25 than the non-SATs although this difference was only significant
for SAT1 and 2 (Mann-Whitney p=0.0081, p=0.0283)(Fig. 5.2A). A proportion of SAT
viruses appear to be similar to non-SATs, the others do not. This suggests the difference
between the SATs and non SATS may be due to something other than the SAT viruses
themselves. This explains why in the original seven serotype panel only the SAT1 showed
a different pattern in comparison to SAT2 and SAT3.
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Figure 5.2: Increased high entropy positions are a product of the buffalo
host. The Shannon’s entropy score for each position along the genome was calculated
for ’Non SAT’ (This data set contained one exemplar each of type O, type A, type
C and Asia 1). This analysis was also completed for 8 exemplars of SAT1, SAT2 and
SAT3. In each graph the values are plotted as percentages (y-axis) of the positions with
sufficient coverage for entropy analysis. Statistical comparisons were completed using a
non-parametric(Mann-Whitney) test due to non-normal distributions. A) Percentage
of positions for Non SATs, SAT1, SAT2 and SAT3 with an entropy score of greater than
0.25. Mean and standard deviation of each group is shown. There was a significant dif-
ference between Non SATs and SAT1 (p=0.0081) and Non SATs and SAT2 (p=0.0283).
There was no significant difference between the SATs and each other or SAT3 and the
non SAT exemplars. B) Percentage of positions for SAT samples isolated from cat-
tle and SAT samples isolated from buffalo with an entropy score of greater than 0.25.
Mean and standard deviation of each group is shown. There was a significant difference
comparing bovine derived and buffalo derived sampes (Man-Whitney, p=0.0038).
In attempt to dissect the within serotype difference in entropy positions >0.25, the
host from which the SAT samples was taken was considered. SAT samples were split
into those isolated from bovine hosts (n=10) and those isolated from African buffalo
(n=14). Samples isolated from cattle show a low proportion of positions above the
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>0.25 cut off (0.07-1.07%). This is higher on average than the non-SAT samples (0.432
compared with 0.190). The buffalo derived samples show a much larger range (0.15-
3.01%). Some values are similar to those found in the cattle derived samples (5/14)
whilst the others have a higher proportion of positions with an entropy score >0.25.
This was a statistically significant difference between samples isolated from buffalo and
those isolated from cattle (Mann-Whitney, p=0.0038) (Fig. 5.2B). This supports the
hypothesis that the differences seen in the number of high entropy positions is due not
to the SAT viruses themselves and suggests it could be a product of the host from which
they are derived.
Having shown there are more high entropy positions within swarm isolated from buffalo
the genetic variability in the swarm was further analysed by calculating the relative
frequency of each nucleotide at each position. This represents a more detailed view of
the data from which the entropy scores described above are calculated. The majority
of the buffalo samples show several nucleotides present at many positions (Fig. 5.3).
The samples isolated from cattle generally show less positions with several nucleotides
represented in the swarm (Fig. 5.4). This indicated that in general the viral swarms
isolated from buffalo are more genetically diverse than those isolated from cattle. It
shows that using the entropy scores as an indicator of within swarm variation works
well.
The cause of this host specific difference was considered. The overall trend shows more
variation within the swarm isolated from buffalo in comparison with those isolated
from cattle. However there are some exceptions. In the samples isolated from buf-
falo SAT2/BOT/Buff/2/1968, SAT3/ZIM-p6-83-Buff-19 and SAT3/BOTBuff/13/1970
(Fig. 5.3 B.2, C.2, C.3) the level of variation is more comparable to the majority of cattle
derived samples (Fig. 5.4). Amongst samples derived from cattle, SAT1/TAN/22/2012
and SAT3/BOT/109/1966 show more variation than the other cattle samples (Fig. 5.4
A.1, C.1). SAT3 sample BOT/109/1966 (Fig. 5.4 C.1) was isolated from a ’carrier
cattle’ (personal communication from Nick Knowles). It could be that the difference
observed between cattle and buffalo is due to the longevity with which they are able to
maintain an infection. If this is true, it would not be surprising to observe the same
pattern in carrier cattle as buffalo and conversely the same pattern between recently in-
fected buffalo and cattle. The variation observed could also be animal specific. Parallel
challenges on their immune systems from other infections or well being of the animal
more generally could be a contributing factor. Without a controlled direct comparison
it is difficult to determine.
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Figure 5.3: Samples isolated from buffalo: Relative frequency of nucleotides at each genome position suggests two viral populations
may be present The relative frequency of each base (A-blue circle, C-red square, G-green triangle, T-purple triangle) at each nucleotide position
was calculated and graphed against genome position.
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Figure 5.4: Samples isolated from cattle: genome wide variability in the swarm appears low.The relative frequency of each base (A-blue
circle, C-red square, G-green triangle, T-purple triangle.) at each nucleotide position was calculated and graphed against genome position.
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5.4.2 The effect of immune pressure on high swarm variability
To consider the evolutionary pressure on the buffalo derived viral swarm the location of
the high entropy positions were considered.
5.4.2.1 Immune pressure acting on the virus particle
The immune systems recognises viral capsid epitopes. Therefore many immune changes
can be found in the capsid coding region. There are numerous known antigenic sites
allowing for immune escape.
5.4.2.2 Cytotoxic T-cells
The capsid monomers are not the only viral elements exposed to the immune system.
Antigens (such as viral proteins or peptides) can be presented on the outside of an
infected cell on MHC molecules. These antigens can then be recognised by the T-cell
receptors (TCRs) on the surface of cytotoxic T-cell. TCRs are specific to particular
antigens, if a specific interaction is made between the TCR and MHC presented antigen
the cell is destroyed. In this way, traditionally internal epitopes could be under immune
selection [238, 239].
The percentage of positions with high entropy scores (>0.25) in the structural coding
region (VP4-VP1) and non-structural coding region (2A-3D) were compared for bovine
derived and buffalo derived samples. For the cattle derived samples the average percent-
age of positions with high entropy scores in the structurals proteins was slightly higher
than the non-structurals proteins (mean=0.34% and 0.19% respectively) although this
difference was not significant (Mann-Whitney, p=0.1666)(Fig. 5.5).
In buffalo derived samples the average percentage of positions with high entropy scores is
actually slightly higher in the non-structurals proteins (mean=1.3%) than the structurals
(mean=1.15%). Again there is no significant difference between these data sets (Mann-
Whitney, p=0.5712).
When comparing cattle and buffalo derived samples there is a statistically significant
difference between the percentage of high entropy positions for both the structural and
non structural coding regions (Mann-Whitney, p=0.004 and p=0.0009 respectively).
This statistically significant difference highlights that there is a difference between cattle
derived and buffalo derived viral swarms.
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Figure 5.5: High entropy positions in buffalo derived swarms are not con-
centrated in the structural region Percentage of positions with high entropy scores
(>0.25) is shown for the coding region of structural proteins (square points) and non
structural proteins (triangular points). This is shown for cattle derived samples (green)
and buffalo derived samples (purple). The mean and standard deviation of each data
set is displayed. There is a statistically significant difference between cattle and buf-
falo in the percentage of both structural coding potions with high entropy scores
(Mann-Whitney, p=0.004) and non-structural coding positions with high entropy scores
(Mann-Whitney, p=0.0009)
These high entropy positions could represent both synonymous and non-synonymous
changes. To understand which areas of the genomes may be undergoing genetic change,
the high entropy positions where the second most prevalent nucleotide at that positions
would result in a non-synonymous change were considered.
The number of non-synonymous changes in the structural protein coding region for
samples isolated from cattle and samples isolated from buffalo was not significantly
different (Mann-Whitney, p=0.3830). The mean of the samples isolated from buffalo
is only marginally higher (0.35% in comparison with 0.25%) (Fig. 5.6). The number
of non-synonymous changes in the non-structural protein coding region for samples
isolated from cattle and samples isolated buffalo is statistically significantly different
(Mann-Whitney, p=0.0018). Interestingly, 72 % of the high entropy positions in the
structural coding region of viruses isolated from cows result in non-synonmous changes.
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In comparison, only 31 % of the high entropy positions in the structural coding region
of viruses isolated from buffalo results in non-synonymous changes. In the nonstructural
coding region high entropy positions resulting in a non-synonymous change for viruses
isolated from cattle was also higher; 45% in comparison to 17% for buffalo. This suggests
there is a greater amount of noise or synonymous changes in the buffalo derived swarm.
This analysis suggests viral swarms isolated from cattle and bovine hosts are both un-
der immunogenic pressure in the capsid region and this pressure results in a similar
proportion of sites under going non-synonymous changes.
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Figure 5.6: Buffalo and cattle derived samples have comparable numbers of
non-synonymous changes in their structural protein coding regions but differ
in the non-structural coding region Percentage of positions with high entropy
scores (>0.25) that result in a non-synymous change when considering the next majority
nucleotide is shown for the coding region of structural proteins (square points) and non
structural proteins (triangular points). This is shown for cattle derived samples (green)
and buffalo derived samples (purple). The mean and standard deviation of each data
set is displayed. There is a statistically significant difference between cattle and buffalo
in the percentage of non-structural coding positions with high entropy scores (Mann-
Whitney, p=0.0018)
The comparable percent of the structural coding region undergoing non-synonymous
change may be reflective of this region’s capacity to undergo change. These sites are
likely associated with immune escape. The level of noise seen in the buffalo derived
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viral swarm coupled with the number of non-synonymous changes in the non-structural
proteins is a marked difference from bovine derived samples.
5.4.3 Increased diversity in buffalo derived viral swarm may be due to
co-infection
The differences described above could hint at a sub-consensus majority variant. If two
virus swarms were present in the same sample the capacity for both non-synonymous and
synonymous differences would increase. The pattern originally identified in SAT1/TAN
/22/2012 was one of a consistent entropy score at several positions across the genome
(Fig. 4.5). From the relative frequency graphs it can be seen that this was due to
an equal split of two nucleotides at several positions across the genome (Fig. 5.4A.1).
This may be due to two majority viruses being present within the swarm. If there
were two majority viruses present, one present at 60% and one at 40% we would expect
to see a consistent split of nucleotides at 60/40% at positions that vary between the
two populations’ consensus sequences. This pattern is repeated to an extent in one
other bovine derived sample SAT2/BOT/109/1966 (Fig. 5.4C.1) and at least six buffalo
derived samples (Fig. 5.3 A.1, A.4, B.1, B.4, B.5, C.4). It is difficult to clearly say from
visual inspection if this pattern is repeated in the most variable buffalo samples as it
would be obscured by the high level of variation present (Fig. 5.3 A.2, A.3, B.3, C.1).
The pattern observed in the samples isolated from buffalo is less evident in the samples
isolated from cattle. Two of the samples have low level variation at a small number of
positions along the genome and SAT1/TAN/22/2012 clearly shows the split in nucleotide
detailed in the buffalo. This split has a lesser percentage of the minority variant (80/20%)
and less positions are showing this pattern (33 nucleotide positions, approximately 0.4
%).
5.4.3.1 Bioinformatic dissection of swarm haplotypes
Analysis was completed to dissect the swarm’s majority variants to confirm if more than
one viral populations was present. If a sufficient number of differences are present in the
genome then software can be used to piece together a prediction of the genomes present
in the population. This requires the genomes to be sufficiently different to have several
differences in one read that can be matched to differences in the next read along. As a
large number of positions were identified, and they were spread across the genome (Fig.
5.4, Fig. 5.3) there seemed to be a high chance of establishing the original haplotypes.
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Several programs have been designed to consider this question to date four of which are
reviewed in Prosperi et al’s paper: ShoRAH [240], QuRE [241], PredictHaplo [242] and
Geneious de novo [243]. Prosperi et al’s work used each of the programs to consider
hepatitis c virus (HCV) and human immunodeficiency virus (HIV). They found that
using contigs of 500bp and 900bp respectively the percentage of variants produced that
were correct, were highest for PredictHaplo (100-75%) and QuRE (89-56%). Both were
better with the shorter contigs (100% and 89%). Although ShoRAH output 200-1247
possible variants only 0.4-0.005% of these were found to be correct. However it did
provide the best recall. The program that had the best recall/accuracy of the four
compared in this paper was QuRE and thus was the one used for this work.
QuRE analysis was completed on SAT1 KNP/196/91. This was a sample that showed
high levels of variation hopefully providing sufficient mutations for the QuRE algorithm
to be successful. It was also a sample where the presence of a subconsensus variant was
not obvious. This analysis reconstructed three variants at a prevalence of 80.2%, 18.3%
and 1.4%. The QuRE program was unable to produce a full genome length sequence;
each sequence ran from 503nt to 7026nt in comparison to the consensus. This resulted
in a genome lacking 1147nt of the non-structural coding region. The 80.2% variant
throughout the region represented was identical to the consensus sequence created de
novo.
Comparison of the minority variants (18.3% and 1.4%) to the consensus revealed 48
and 55 nucleotides different in the structural coding region respectively. 30 of these
differences were present in both. To evaluate if the QuRE reconstruction could be
considered accurate it was compared to the Shannon’s entropy analysis . An approximate
80/18/2 split, as seen in the QuRE variants, would be represented by an entropy score of
approximately 0.8. Therefore the positions different between the QuRE variants should
have an entropy score of between 0.8-1. Therefore, the number of positions with a score
of between 0.8 and 1 should be comparable with the number of positions that differ
between the QuRE variants if the reconstructions are accurate. There are 51 positions
with entropy scores of between 0.8 and 1 which correlates well to the 48-55 differences
between the 18.3% or 1.4% variant and majority. From this we can suggest the QuRE
reconstruction of variants in the structural coding region is accurate. The non-structural
coding region was also considered. Both the 18.3% and 1.4% variants differ from the
majority by 4 nucleotides none of which were represented in both. This equates to only
1 amino acid in the 18.3% variant and none in the 1.4% variant. When compared to the
number of positions identified in the entropy analysis the numbers are not comparable.
In the non-structural coding region represented by the QuRE analysis 26 positions have
a score between 0.8 and 1 compared to the 4 differences identified in the QuRE variants.
This suggests QuREs reconstruction of the variants on assessment of the non-structural
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region may not have been as successful. This could be due to the variants in these
regions being more spaced out. 1.7% of nucleotide positions in the structural coding
region were identified in Shannons entropy analysis compared to just 0.9% of the non-
structural coding region. As this software relies upon mutations being frequent enough
to map reads together, this lower number of variants may have provided insufficient
framework on which the program could build.
5.4.3.2 Maximum likelihood tree of swarm haplotypes
To consider the relatedness of the QuRE variants reconstructed from the KNP/196/91
population a maximum likelihood tree was constructed. The variants were considered
in comparison to all currently published full genome SAT sequences on genbank and
unpublished sequences generated by Lidia Lasecka and Caroline Wright (Chapter A,
Table E.1). The QuRE variants sit in a clade with other SAT1 viruses. They are most
closely related to the virus from which they are derived used in Maree et al ’s original
experiment [231].
This analysis suggested they are quite closely related in the larger scale of all SAT
viruses. However, there are not a large number of full genome SAT sequences available
and therefore the power of this analysis is limited. Due to the lack of time data it
is challenging to identify how each variant evolved. There is a 1.6% difference in the
structural coding region in comparison to the reference. This correlates to the predicted
rate of change in VP1 in a buffalo over a year. Therefore, it is conceivable that the
18.3% variant evolved from the same starting population as the majority population if
the animal was infected for a sufficient length of time. However, if this infection was
less than a year in duration, or if the virus does not replicate at a consistent rate in a
carrier animal the 18.3% population could be a secondary population. This bioinformatic
analysis could be corroborated through molecular techniques such as plaque purification.
5.4.4 Subconsensus level swarm haplotypes can be immunogenically
relevant
Having established that there are several populations present in KNP/196/91, work was
completed to dissect what these differences were and the evolutionary significance behind
them. As the QuRE algorithm was only able to reconstruct the structural coding region
only those changes were considered.
Samples were grown in cell culture and thus these changes were compared to known cell
culture adaptations. Some previous work has been completed on SAT adaptation
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Figure 5.7: Maximum likelihood tree of KNP/196/91 variants The evolu-
tionary history was inferred by using the Maximum Likelihood method based on the
Tamura-Nei model [244]. The tree with the highest log likelihood (-103411.8809) is
shown. Initial tree(s) for the heuristic search were obtained automatically by apply-
ing Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated
using the Maximum Composite Likelihood (MCL) approach, and then selecting the
topology with superior log likelihood value. The tree is drawn to scale, with branch
lengths measured in the number of substitutions per site. The analysis involved 69
nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All
positions containing gaps and missing data were eliminated. There were a total of 5660
positions in the final dataset. Evolutionary analyses were conducted in MEGA6 [245].
The tree is routed with an FMDV Type O (Kaufbeuren) exemplar. QuRE variants
are highlighted in red. SAT1 samples are showing in blue, SAT2 in green and SAT3
in pink. All viruses used in the Maximum liklihood tree (MLT) are listed Chapter A,
Table E.1.
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to cell culture. In a study by Maree et al a virus isolated from an impala was passaged
in a number of cell lines. Cell culture adaptation mutations were observed in VP3/192,
VP3/217, VP1/69, VP1/84 and VP1/110-112 [223]. None of these difference have been
seen between the QuRE variants.
The difference were also compared with known antigenic sites. A paper by Maree et al
predicted antigentically variant sites using structure information, cross protection titres
in virus neutralisation assays and amino acid variants [223]. This study identified surface
exposed structural loops in VP2, VP3 and VP1. A potentially antigenic region in one
of these loops (βH-βI) spanned VP1/177-VP1/179, this includes VP1/178 which has
been identified in this study (Table 5.2). The C-terminus of VP1 was also implicated, a
feature that has been identified in the variants at VP1/205 and VP1/209 (Table 5.2). In
VP1 the βH-βI loop and C-terminus correlate with epitopes previous identified in other
FMDV serotypes: type A, type O and type C. None of the loops identified correlated
with the variants found in VP2 or VP3.
The identification of mutations in positions previously associated with immune escape
is important from a diagnostic and epidemiological stand point. These mutations would
not be identified by current diagnostic procedures but could be relevant in the epidemi-
ology of FMDV and indeed vaccine matching.
Amino acid 18.3% 1.4% Genome Region
10 K → R K → R Lpro
19 T → K T → K
81 D → G
96 I → V
103 T → V
147 D → E
151 A → V
166 E → D
168 T → A
332 Q → R Q → R VP2(57)
454 S → N S → N VP3(10)
716 H → Y VP1(17)
877 E → V VP1(178)
904 R → K VP1(205)
908 R → K VP1(209)
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Table 5.2: Amino acid changes between QuRE variants 18.3% and 1.4% vari-
ants were compared to the 80% majority. Amino acid changes are listed annotated
with the genome region in which they fall. Four changes appear in both variants and
are highlighted in red.
QuRE analysis could not be completed on all samples due to insufficient number of
variants on each read. Sequencing with a longer read length would likely overcome this
difficulty. The sample completed (SAT1/KNP/196/91) suggests that within the higher
level of variation seen in buffalo a secondary populations exists and that subconsensus
populations can have antigenically relevant changes.
5.4.5 SAT3 swarm’s distinct genetic features are not host derived
In much of the analysis described above SAT3 viral swarms appear to differ from SAT1
and SAT2. In comparing the bovine and buffalo derived samples SAT3 appears to
display some interesting genetic features in comparison to SAT1 and SAT2. In two
of the cattle derived samples and two of the buffalo derived samples regions of ex-
treme variability appear to be present. This can be seen at the 5’end of the genome in
SAT3/RHO/7/1974 and SAT3/RV/7/1934 (Fig. 5.4C.2, C.3) and around the 6000nt
mark in SAT3/UGA/Buff/27/1970 and SAT3/ZAM/Nan/11 (Fig. 5.3C.1, C.4). The
latter hot spot of variation is particularly unusual given the usually conserved nature of
the non-structural region. In SAT3/ZAM/Nan/11 it is clear that this area of variation
appears to be a fluctuation between two majority variants at a 60/40 split. One pos-
sible explanation for this could be that it is representative of a recombination hotspot.
SAT3 has previously been found to have the most evidence for recombination within
it’s genome in comparison with SAT2 and SAT1 [139] and recombination sites around
the 6000nt point have previously been suggested [138, 139]. These nucleotide positions
equate to 3B and 3C. Numerous recombination sites have also been suggested in the
5’UTR of the genome which could equate to the hot spot seen in the two cattle derived
samples (Fig. 5.4C.2, C.3).
These difference between SAT3 and SAT1 and SAT2 are of particular interest due to
their differences from an epidemiological stand point. SAT3 causes the lowest number
of outbreaks of the three south African serotypes and these differences in variation
within the swarm could hint at the genetic cause behind this. If SAT3 is the most able
to recombine, this could result in fitness loss. Recombination reduces the ability to
undergo purifying selection due to the exchange of genetic material between genomes.
If a buffalo host produces increase variability, but the SAT3 predisposition to recombine
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results in a decreased ability to undergo purifying selection, it may result in SAT3 being
less fit than the other two SAT seroptypes and thus is out competed by them from an
epidemiological stand point.
5.4.6 Bias introduced by sample collection
The sample used in this study were supplied by the World Reference Laboratory for
FMD (WRLFMD) at the Pirbright Institute. These samples are sent for diagnostic
testing from all over the world and their sample collection method is not always known.
To ensure the pattern viewed is not a sampling bias, samples with a known collection
history were compared.
5.4.6.1 Probang vs Epithelium
African buffalo infected with FMDV show no clinical signs. Sampling from infected
livestock often focuses on sampling epithelial lesions in the mouth or foot.
However, due to the lack of these clinical signs in buffalo, epithelial sampling is unlikely
to be viable. Therefore it is probable an oesophageal sample is taken from these animals
using a probang. As the probang samples the length of the oesophagus it could be sam-
pling several different replication sites, meaning this sampling methodology could show
more variation than a sample extracted from an epithelial lesion. This potential differ-
ence in sample collection from buffalo and cow could be behind the observed difference
detailed in the section above.
Direct comparisons of probang and epithelial samples from African buffalo infected with
SAT viruses were not available for analysis. Therefore, sequence data from a previous
controlled animal experiment performed at the Pirbright Institute was used to ensure
known sample history. This comparison established if probang sampling in cattle pro-
duces the pattern observed in buffalo. Data was provided by Caroline Wright, from
samples previously extracted and sequenced as detailed in Morelli et al ’s paper [116].
The samples used represented a probang sample (PB) taken at four days post contact
(4DPC) and an epithelial sample taken from the front right foot (FRF) taken six days
post contact (6DPC). The coverage, entropy score and relative frequency of nucleotides
at each positions was considered for each of these samples, and the two samples as one.
The samples analysed from the FRF and PB show very similar Shannon’s entropy and
relative nucleotide frequency (Fig. 5.8A,B). The PB sample does not show a different
pattern than the sample retrieved from the FRF lesion. To further investigate
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Figure 5.8: Probang sampling, or sampling two replication sites in one,
does not produce the pattern observed in buffalo. The relative frequency of
each base (A-blue circle, C-red square, G-green triangle, T-purple triangle.) at each
nucleotide position was calculated and graphed against genome position (Left most
graphs). Concurrently (right most graph) Shannon’s entropy at each position (left
axis, red) was compared with genome coverage (right axis, blue). This was completed
for three samples A) Probang sample (PB 4DPC) B) Foot lesion (FRF 6DPC) C)
Probang and foot lesions combined (PB 4DPC + FRF 6DPC)
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the possibility that probang sampling identifies several sites of replication, the data from
the FRF lesion and the oesophagus were combined and the analysis completed again.
This did not result in the pattern observed in buffalo (Fig. 5.8C).
This comparison is limited due the the different host (cattle) and serotype (FMDV
type O). It could be that the amount of variation generated and maintained in type O
infection is less than in comparable SAT infections. The original data also suggest that
bovine host may be less able to sustain or create such high levels of variation so this may
also limit the appearance of a sub consensus variation. This experiment does highlight
that sampling more than one site of replication in one animal (foot lesion and probang)
does not results in the pattern observed in buffalo. These two lesions are days apart
during the infection and are not in close proximity to each other so should represent two
distinct replication sites.
5.5 Summary
SAT’s increased variability is host derived Samples isolated from buffalo have
more high entropy positions than those isolated from cattle (Fig. 5.2). The differences
seen between SATs and non-SAT serotypes (type O, type A, type C and Asia 1) can
be attributed to differences between bovine derived and buffalo derived samples. The
southern African serotypes (SAT1, SAT2 and SAT3) have previously been shown to be
more variable than their European counterparts when comparing P1 [230]. This work
shows that this may not be a virus specific feature as previously assumed but actually
a product of host range.
Variability is not solely due to immune pressure Having established that buffalo
derived swarms have more high entropy positions than their cattle derived counterparts,
the regions of the genome with this plasticity was considered. Viruses under immune
pressure are expected to produce mutations in their capsid coding region to allow for
immune escape. This is not the case for the buffalo viral swarms. A higher percentage of
the non-structural coding region had high entropy positions than the structural coding
region (Fig. 5.5). This suggests that the production of this increased level of variability
is not solely immune pressure as it is genome wide.
Buffalo swarms can obscure a subconsensus level populations Considering
the relative nucleotide frequencies at high entropy positions revealed a consistent nu-
cleotide split at several regions across the genome (Fig. 5.3). The consistency of this
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split suggested a subconsensus majority variant. Bioinformatic haplotype reconstruc-
tion confirmed that one buffalo (SAT1/KNP/196/91) swarm contained a 18.3% variant
that would not have been identified with current diagnostic techniques. This suggests
increased variability in buffalo derived swarm is due to the presence of several viruses.
Subconsensus level variants can be of antigenic importance Having estab-
lished two subconsensus level variants, the antigenic difference between the variants and
consensus level genome were considered. Changes were found at known antigenic sites
(Table 5.2) suggesting the swarm could contain subconsensus immune escape variants.
These variants would not be identified by VP1 consensus level sequencing as currently
used in diagnostic test.
Epidemiological differences seen in SAT3 could be a result of genetic differ-
ences This analysis revealed serotype specific differences between SAT3 and the other
SAT serotypes. When considering relative nucleotide frequencies SAT3 showed regions
of the genome with unique variability patterns (Fig. 5.3, 5.4). One explanation of this
has been proposed as SAT3 having an increased ability for recombination. This could be
the cause of the unique patterns observed. This would also result in decrease efficiency
of purifying selection potentially explaining the different distribution of entropy scores.
If SAT3’s increased level of recombination decreases it’s ability to undergo successful
purifying selection it could be less fit and therefore result in less outbreaks.
In short, this work suggests that the reservoir host African buffalo may be subject to
co-infection, thus resulting in more variation within the swarm across the entire genome.
This reservoir of variation can hide antigenically important variants. Work should be
completed on how buffalo maintain co-infection and if viruses transmitted from these
animals produced a different disease outcome in subsequently infected cattle. Current
diagnostic techniques may also need to change to include subconsensus level sequenc-
ing. This would allow for more accurate epidemiology and disease control strategies.
Furthermore, SAT3 viruses show interesting genetic differences relative to SAT1 and
SAT2 viruses that could be relevant to the reduced spread seen with SAT3. Work could
be completed to establish if these difference are indeed related to the viruses ability to
recombine and why this is a feature specific only to SAT3.
Chapter 6
Swarm dynamics during adaptive
evolution
6.1 Abstract
Picornaviruses, like many positive strand RNA viruses, have error prone polymerases
that lack proof reading capability [246]. This, coupled with short generation times
and recombination, results in a diverse population of viruses that exist as a swarm. The
reservoir of diversity that exists in this swarm allows for a viral infection to evolve quickly
to adapt to new environmental challenges. FMDV’s broad host range shows evidence of
this ability to adapt to different cellular environments with nearly all Artiodactyla and
Camelids susceptible to infection [18].
How variation within a viral swarm affects or allows for this broad host range has not
been considered. To understand how the swarm allows FMDV to evolve in this scenario
an experiment was designed to observe the dynamics of variants present in the swarm
during viral adaptation to a new cell line. The historical model for in vitro study of
FMDV involved using lab strains of virus adapted to baby hamster kidney (BHK) cells.
A virus previously adapted to growth in a BHK cell line was serially passaged through
a bovine foetal aorta (BFA) cell line. Time taken to achieve complete cytopathic effect
(CPE) was observed as an indicator of viral growth rate and the virus was sequenced
after each passage to identify genetic changes and consider swarm dynamics.
Passage through BFA cells produced decreased time to observe CPE and increased rate
of replication. This was associated with four consensus level changes; one change in the
internal ribosome entry site (IRES), one change in VP2, one change in VP3 and one
change in 2C. All of these changes appeared after a drop in titre produced a potential
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genetic bottle neck. A consistent amount of cumulative entropy was apparent through
out the passages but there was variation in the proportion of genomes in high, mid and
low entropy ranges. Two different distribution were apparent in viruses under adaptive
pressure and those not.
6.2 Introduction
In vitro studies to consider FMDV adaptation to new hosts have found two main elements
involved in viral adaptation; virus entry into cells and virus intracellular function. For
cell entry FMDV has been shown to amend its capsid proteins to facilitate cell entry
through different receptors. Within the cell, non-structural protein 3A and the internal
ribosome entry site (IRES) have been shown to have an affect on tropism.
6.2.1 Entry adaptation
The presence or absence of receptors on the cell surface can determine if a particular
FMDV can enter the cell. Therefore, many viral adaptations are found in the capsid
proteins. The receptors used by field isolates of FMDV are RGD-dependent integrins
[52–54, 247, 248]. FMD viruses interact with these integrins using an RGD motif located
in the G-H loop of capsid protein VP1 [55]. Adaptations in cell culture can be a product
of minimal changes in the capsid proteins. Generally a small number of residues will
change increasing the overall positive charge of the virus. This allows for the use of
negatively charged receptor molecules such as heparan sulphate. FMDV adaptation to
use heparan has been studied with the analogue heprin sulphate. A structure of FMDV
and heprin sulphate produced by Fry et al showed that instead of binding areas of the
GH loop the heparin sulphate binding site is actually an indent in the capsid surface
formed by VP1, 2 and 3 [249]. The central point of this depression (VP3 56) and
surrounding positions (VP2 135 and VP1 195) have been shown to be key in adaptation
to negatively charged receptors [50]. Cell culture adaptation has not been found solely
at these residues. Viruses have also been identified with mutations at the fivefold axis
of the capsid. Again these sites introduce positive charges [57]. Changes in this regions
can also allow integrin dependant entry for viruses lacking the RGD motif although
the mechanism for this is not fully elucidated [57]. Not all receptors used by FMDV
are known. Viruses have been identified that use neither heparan sulphate or integrin
receptors and work needs to be completed to identified these novel receptors [56].
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6.2.2 Intracellular adaptation
6.2.2.1 IRES
Work by Sun et al has suggested that the internal ribosomal entry site could affect
cell tropism. An FMDV mutant containing the IRES element from bovine rhinitis B
virus (BRBV) replicated comparably to wildype virus in baby hamster kidney cells but
showed decreased replication efficiency in three porcine cell lines (IBRS2, PK15 and
SK6) [250]. Further dissection revealed that this effect was due to IRES domains 3 or 4.
The IRES element has also been found to be important in poliovirus tropism [251–254].
6.2.2.2 Non-structural protein 3A
Non-structural protein 3A has previously been implicated in host range in rhinoviruses,
enteroviruses and hepatoviruses. FMDV 3A is a partially conserved protein 153aa long.
This is approximately 60aa longer than other 3A proteins in the picornavirus family
such as poliovirus. It contains a highly conserved N-terminus containing hydrophobic
and hydrophilic domains associated with membrane binding and a much less conserved
C-terminus [75]. Deletions and mutations in this C-terminus have been associated with
adaptation to host. For example, egg-adapted vaccine strains have been found to develop
deletions of 19-20aa which produce viruses attenuated in cattle. An outbreak of FMDV
in pigs in Taiwan showed a 10aa deletion in the C-terminus of 3A resulted in attenuation
in cattle but disease in pigs [76, 77]. The effect of mutations on host range suggests this
protein may interact with host factors. Gladue et al completed a yeast two-hybrid study
which identified DCTN3 as a likely interaction factor. This is a subunit of the dynactin
complex which has a role in dynein (a microtuble base motor) function. This suggests
a potential role for intracellular organelle transport in viral replication.
6.3 Experimental Design
An experiment was designed to observe viral adaptation to a new cell line. A sample of
FMDV O1Kaufbeuren (O1K) was recovered from infectious copy plasmid (ICP) pT7S3.
This virus is cell culture adapted to baby hampster kidney (BHK) cells. This virus
was expected to use heparan sulphate to enter the cells. As this sample was recovered
from an ICP an original ’population expansion’ step was included to try and ensure the
swarm was not unrealistically clonal.
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Figure 6.1: Adaptive passage flowchart of methods used FMDV O1K was re-
covered from an ICP and passaged 10x through BHK cells as a population expansion
step (e1-10). e10 was then passaged through BFA cells in an attempt to promote adap-
tation and BHK cells as a control (BFA1-15 and BHK 1-15 respectively). All samples
were prepared for sequencing as outlined in the published protocol [170] with some
thesis specific amendments (Chapter 2). Library preparation was completed using the
Illumina Nextera XT kit and subsequent sequencing completed on the Illumina MiSeq.
Sequence analysis was completed as detailed in Chapter 3. DeNovo assembly was com-
pleted on e1 to provide a reference sequence. All subsequent sample’s sequencing data
was aligned to this reference. BFA samples were titrated using IF. BFA1 and 15 were
compared directly on the MiniMax Cytometer.
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To achieve this the recovered sample, referred to as ’inoculum’, was blind passaged
through BHK cells 10 times. These ten passages were called expansions 1 to expansion
10 (e1-e10). e10 was then passaged through bovine foetal aorta cells (BFA) fifteen times
to observed if the virus would adapt. Concurrently it was passaged through BHK cells
fifteen times as a control. These samples were referred to as BFA1-BFA15 and BHK1-
BHK15 respectively. The viruses were titred and an equal MOI infection of BFA1 and
BFA15 in BFAs was completed on the SpectraMax MiniMax 300 Imaging Cytometer
to consider time to achieve cytopathic effect. Each sample was also sequenced on the
Illumina Miseq to identify any genetic changes that could be responsible for phenotypic
changes observed and to consider the dynamics of a viral swarm undergoing adaptation.
Methods used in this chapter are outlined in Figure 6.1. Further detail on methods is
included in Chapters 2 and 3.
6.4 Results and Discussion
6.4.1 Adaptive passage produces a phenotype change
6.4.1.1 Optimisation of Immunofluorescence titration
To allow for equivalent amounts of virus to be compared the cell lysate from each passage
needed to be titred in BFAs. To consider the time point at which a titration should be
completed, BFA adaptive passage one (BFA1) and fifteen (BFA15) were compared at
three different time points (4hpi, 5hpi and 6hpi) in BFA and BHK cells. The number of
cells were counted by ToPro3 staining.
In BFA cells unpaired t-tests showed a significant difference between the control and wells
infected with BFA15 at 4hpi infection (p=0.347) but no significant difference between the
control and BFA1 (p=0.2167). There was no significant difference between the control
and BFA1 or BFA15 at five hours post infection in BFAs (p=0.9517 and p=0.1811
respectively). There was a significant difference between the control and BFA1 and
the control and BFA15 at six hours post infection in BFAs (p=0.0003 and p=0.0002
respectively.). In BHK cells there was a significant difference between the control and
monolayers infected with BFA15 at 4hpi (p=0.0165) but not between the control and
BFA1 (p=0.2167). At 5 and 6hpi infection in BHK there was a statistically significant
difference in the number of cells between the control and BFA1 (p=0.002, p=<0.0001)
and the control and BFA15 (p=<0.0001, p=<0.0001) From this it can be see that the
number of cells in infected wells is significantly different than the uninfected control by
6hpi infection for both BFA and BHK cells. This suggests that by this point the virus
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has started to kill the cells. This time point was therefore discounted for titration. This
is also the case for five hours post infection in BHK cells. However, at 5hpi in BFA cells
there is no statistically significant difference in the number of cells in infected wells when
compared to the control (Fig.6.2). This indicates that both viruses (BFA1 and BFA15)
cause delayed cell death in BFA cells compared to BHK cells.
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Figure 6.2: CPE in virus infected cell monolayers Cell monolayers of BFA (blue)
and BHK (red) cells infected with cell lysate from BFA1 and BFA15. Monolayers
were fixed at 4 (horizontal stripe), 5 (solid fill) and 6 (no fill) hours post infection
and stained with ToPro3. Cells were the counted using the SpectraMax MiniMax 300
Imaging Cytometer. Number of cells was normalised in comparison to an uninfected cell
monolayer. The un-infected cell monolayer was considered 100% and the cell number
for each infected monolayer is shown as a percentage of that.
This variation from timepoint to timepoint creates a challenge in determining the op-
timum time to calculate titre as calculations at different time points would produce a
different titre. The time point of 6hpi was deemed too late due to extensive cell death
and at 4hpi it was decided it was likely that the full extent of infection would not be
identified therefore 5hpi was chosen as the time at which to titre the viruses.
6.4.1.2 BFA15’s replication cycle appears faster than BFA1
Although the experiment described above was designed as an optimisation step it is
also interesting to note that for BFA15 in BFA and BHK cells there are less cells in
comparison to the control suggesting some cell death before 4hpi. Furthermore, in
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BFA1 in BFA cells there is no decrease in cell number until 6hpi. In comparison BFA15
in BFAs show cell death by 4hpi that continues to decrease at 5 and 6hpi. This would
suggest that BFA15 is causing CPE in BFA cells faster than BFA1 and has therefore
successfully adapted. To consider the number of infected cells causing this monolayer
degradation (to insure CPE was not solely due to higher virus titre) immunofluorescence
against FMDV non-structural protein 3A was performed.
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Figure 6.3: Number of infected cells Cell monolayers were infected with adaptive
passage one (BFA1) and adaptive passage fifteen (BFA15) and fixed at 4, 5 and 6hpi.
The number of infected cells was calculated using IF against non-structural protein 3A.
The infected cell counts for passage 1 in BFAs (blue circle) and BHKs (green triangle)
and adaptive passage fifteen in BFAs (red square) and BHKs (purple triangle) are
shown with standard deviation.
This showed that the peak number of cells infected in BHKs was at 4 hours post infection.
There was only one replicate for BFA1 at this time point in BHKs (due to a pipetting
error). For all other samples three replicates were available. For the BFA1 sample in
BHKs 505 cells were infected. For BFA15 in BHKs at 4hpi an average of 462 cells
were infected. This number decreases by five hours post infection (382 and 315 cells on
average respectively) and again by six hours post infection (140 and 33 respectively).
For BFA cells more cells were identified as infected at five hour post infection than 4 or
6hpi. At this time point an average of 382 cells were infected for BFA1 and 315 cells for
BFA15. BFA1 and BFA15 in BHK cells produced a similar number of cells identified
as infected at four and five hours post infection. This is not the case for viruses in
BFAs. Although comparable at five hours post infection, at four hours post infection
less cells are identified as infected in passage one than in passage fifteen (67.3 on average
compared to 185 respectively)(Fig. 6.3). It is possible that less cells were identified in
BFA1 at four hours post infection not because less cells were infected but because the
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cells had not completed a sufficient amount of replication and translation to be identified
by IF at this time point. More cells were identified in BFA15 at 4hpi, a similar number
at 5hpi (both at their maximum replicative rate) and less at 6hpi (as cells start to die).
This could suggest that BFA15’s replication cycle is ahead of BFA1.
This work was completed on three separate plates as samples needed to be fixed at
different timepoints. The plates were seeded with the same cells at the same density
and infected with the same virus stock in order to make the results as comparable as
possible. The difference observed were therefore assumed not to be due to difference in
set up.
6.4.1.3 Viruses in BFA15 have higher replication efficiency than those in
BFA1
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Figure 6.4: Average fluorescence of infected cells as an indicator of repli-
cation The average fluorescence of infected cells (as determined by IF) was calculated
for adaptive passage one (red) and adaptive passage fifteen (blue) at four hours (circle)
and five hours (triangle) post infection. There was a statistically significant difference
between average fluorescence of adaptive passage one at 4 and five hours post infection
(unpaired t-test, p=0.0475). There was also a statistically significant difference between
adaptive passage fifteen at 4 and 5 hours post infection (unpaired t-test, p=0.0171).
There was a significant difference between adaptive passage one and fifteen at both 4
and 5 hours (unpaired t-test, p=0.0181 and p=0.0081 respectively)
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To observe if the replication/translation efficiency differed the average fluorescence of
each infected item was compared at four and five hours post infection. The average
fluorescence was lower in BFA1 than BFA15 at both four and five hours although it has
increased by five hours post infection. The level of fluorescence for BFA1 at 5hpi is similar
to the level of fluorescence BFA15 at 4hpi (Fig. 6.4). These results suggest BFA15 is
replicating more efficiently than BFA1. However, IF is indicative of translation efficiency
not replication efficiency. Further work could be done to complete qPCR comparisons
of these samples as a more direct indicator of replication.
6.4.1.4 There is a drop in titre at BFA5
Having identified 5 hour post infection as an appropriate time to complete IF to de-
termine titre, a cell monolayer was infected with 100 µL of diluted lysate (10−1) in
triplicate. This was left for 1 hour before the supernatant was removed and replaced
with VGM. Five hours after the original infection the cell monolayers were fixed. Im-
munofluorescence against FMDV 3A was performed. The number of infected cells were
calculated from this.
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Figure 6.5: Titre of lysate from adaptive passage series The number of in-
fectious units per mL was calculated by infecting a cell monolayer of BFA cells with
10−1 of each cell lysate. The cells were fixed at 5hpi and IF labelled for non-structural
protein 3A. The number of infected cells was counted and adjusted to represent the
number of infectious particles per mL.
There is a dramatic drop in titre at BFAF5 (drop of 1 log from the previous passage;
3.7 x 104 to 1.5 x 103). This is recovered partially in BFA6 (4.6x103) and fully by BFA7
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(3.58 x 104) (Fig. 6.5). The cause of this is unknown. Due to the process of blind
passage, titre transferred to the next passage is not controlled for (Fig. 6.5).
6.4.1.5 BFA15 is slightly more efficient at destroying the cell monolayer
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Figure 6.6: BFA1 and BFA15 cell death over time The change in the number
of cells in a cell monolayer is shown for a control uninfected BFA wells (blue, circle),
BFA cells infected with adaptive passage one (BFA1)(red, square) and BFA cells in-
fected with adaptive passage fifteen (BFA15)(green triangle). Each value is plotted
with standard deviation
To compare the time BFA1 and BFA15 take to cause CPE an experiment was designed
on the SpectraMax MiniMax 300 Imaging Cytometer to measure time to observed CPE
in an equal MOI infection. This titre data was used to produce an equal MOI infection
of BFA1 and BFA15 in BFAs. The number of cells infected were compared using IF at
five hours to ensure the samples were correctly calculated as comparable. There was no
significant difference between the number of cells infected (unpaired t-test, p=0.2222).
Just under 10% of the cells in each monolayer were infected. Both infections produced
full CPE within 24 hours. When observing the decrease in the number of cells over
time it can be seen that both infections mimic the control (with the number of cells
increasing) until 6 hours post infection. At this point passage one appears to plateau
and passage 15 decreases and plateaus. By ten hours post infection both experiments
are showing a decrease in the number of cells infected although the difference between
passage 15 and the control is greater than passage one and the control. By 15 hours
post infection both experiments are directly comparable. This represents complete CPE
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in each experiment although the number of cells continued to decrease slowly as cells
detach and are no longer counted by the machine (Fig. 6.6).
BFA15 appears to be destroying the monolayer slightly more efficiently than BFA1 in
an equal MOI infection although the difference is not extensive. This data does not
correlate with what has previously been seen which showed a more notable change in
phenotype. This may be because the MOI was too high resulting in complete CPE in
under 24 hours. Due to the speed of cell death it may be that the difference between
the viruses were not apparent. Previous work has found that to produce an infection in
BFA cells a higher quantity of virus needs to be added (more than, for example, BHK
cells)(data not shown). This may be due to the cells innate immunity having an effect
on infection, a concept that needs to be further investigated.
6.4.2 Virus adapted to BFA cells shows consensus level changes.
During the 15 passages completed in BFA cells there were seven consensus level changes.
Of these, three genome positions showed nucleotide fluctuation in the control passage
also and four were uniquely identified in the BFA passage with no variation apparent at
these positions in the control passage (Table 6.1).
Genome
position
Coding
region
Nucleotide
change
Amino acid
1056 5’UTR G to A n/a
2651 VP3 G to C Serine to Threonine
3916 VP1 A to C Lysine to Glutamine
5180 2C T to C Isoleucine to Asparagine and Threonine
5203 2C G to A Alanine to Threonine
5681 3A C to T Alanine to Valine
6411 3D C to T Valine to Valine
Table 6.1: Consensus level changes in BFA adaptation passage. Positions in
red showed nucleotide fluctuation of more than 5% during the control passage series.
(That is to say, during the control passage the majority nucleotide at that position went
below 95 percent)
6.4.2.1 Three consensus level changes in the adaptive passage also showed
plasticity in the control
Of the three changes identified both in the control passage and the BFA adaptation, one
was synonymous (nt 6411) and two were non-synonymous (nt5203 and nt5681)(Table
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6.1). Synonymous changes are often ignored as they have no affect on the amino acid
code. However, it should be noted that in some cases synonymous changes can have a
relevant affect on RNA secondary structure. The synonymous change in this instance
is consensus level by e3 (Fig. 6.7 C). This transition of C to T in the adaptive passage
reaches almost 100% in comparison to the control where the two variants are maintained
a 60/40 split for the majority of the passage slowly reaching an 80/20 split.
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Figure 6.7: Three sequence changes that became fixed in the BFA adaptive
passage that showed flexibility in the control passage. The relative frequency
of the fluctuating nucleotides (y axis) is plotted for each passage (x axis) for the BFA
adaptive passage (red) and the BHK control passage (blue) at positions with a coverage
>10x. This includes the expansion of the original BHK passage (p0-10). Fluctuating
nucleotides in the BFA passage and the corresponding genome position in the BHK is
plotted for positions A) 5203 B) 5681 C) 6411. The changing bases are distinguished by
the marker shape: Adenine (circle), Cytosine (square), Thymine (triangle) or Guanine
(diamond).
This split population suggests both variants are viable but the original change suggests
a thymine at this positions is preferable. This synonymous change at position 6411 is in
the coding region for 3D. The non-synonymous changes at genome positions 5203 and
5671 are in 2C and 3A and equated to an alanine to threonine or valine substitution
respectively. Both alanine and the substituted amino acids are neutral although it should
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be noted that threonine has a polar side chain (in comparison to the original non-polar
alanine and other change, valine).
With variability in both the control passage and the adaptive passage it is possible these
positions in the genome might be less conserved. This correlates with the findings of
Wang et al [255] in poliovirus. They identified a region tolerant to variation down stream
of Motif C between amino acids 252 and 263. This region in poliovirus correlates with
the position of the non-synonymous change found in 2C that showed flexibility in both
the control and adaptive passage in this study (nt5203, Table 6.1). This could explain
the slightly more erratic distribution of nucleotides in the BFA passage (Fig. 6.7), a
pattern that is only seen in these three changes (Fig. 6.8).
6.4.2.2 Four consensus level changes showed no plasticity in the control
Of the four consensus level changes at genome positions with little to no variation in the
control one position was non-coding (nt1056) and the other three were non-synonymous
(nt2651, nt3916 and nt5180)(Table 6.1).
Each of the four changes observed, that were unique to the adaptive passage series,
appeared at BFA5. This conincided with a large drop in titre. For nt1056, 2651 and
3916 the variant slowly increases from BFA5 and becomes fixed in the populations by
BFA14. The proportion of the variant continues to rise from this point and it is possible
with further passages it would reach 100% (Fig. 6.8A, B, C). The pattern for nt 5180
differs slightly. The variant appears in the population at BFA5. By BFA8 the majority
variant is present at approximately 30% with a second variant population also present
at 20%. This plateaus until BFAF12 where the minor variants begins to decrease as
does the original majority and the majority variant increases and is fixed (Fig. 6.8D).
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Figure 6.8: Four sequence changes became fixed in the BFA adaptive pas-
sage that showed little to no variability in the control. The relative frequency
of the fluctuating nucleotides (y axis) is plotted for each passage (x axis) for the BFA
adaptive passage (red) and the BHK control passage (blue) at positions with a coverage
>10x. This includes the expansion of the original BHK passage (p0-10). Fluctuating
nucleotides in the BFA passage and the corresponding genome position in the BHK is
plotted for positions A) 1056 B) 2651 C) 3916 D) 5180. The changing bases are distin-
guished by the marker shape: Adenine (circle), Cytosine (square), Thymine (triangle)
or Guanine (diamond).
6.4.2.3 Change in FMDV IRES could be associated with eIF4G binding
The non-coding change (G to A) was at genome positions 1056 which is situated within
the 5’UTR. This nucleotide maps to the internal ribosome entry site (IRES) of FMDV.
It lies within stem loop 4 at the 3’ end of the adenine rich nucleotide bulge associated
with eIF4G binding [88, 256](Fig. 6.9). This is a feature that is completely conserved
and essential in another picornavirus, EMCV [257]. eIF4G plays a key role in internal
initiation as well as CAP dependant cellular translation. The N-terminal region associ-
ated with the latter is cleaved by FMDV Lpro and 3C to result in a truncated protein
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that no longer functions in its role for cellular translation. eIF4G contains a core se-
quence of approximately three hundred amino acids between aa745/772 and aa941/949
that specifically bind the IRES [258]. When comparing the amino acid sequence for this
region in bovines and hamsters it can be seen there are some differences (Fig. 6.9B)
which could explain the associated change in the IRES sequence when passaging a ham-
ster cell line adapted virus into a bovine cell line. Equally the amino acid change results
one more adenine at the end of a poly a chain of 5, potentially adding further stability
to the interaction.
Figure 6.9: FMDV IRES loop 4 and associated species specific binding
sequence of eIF4G A) The secondary structure of the FMDV IRES is shown (adapted
from Saleh et al [88]) with the sequence of loop 4. Position 744 in loop 4-3 is the residue
changed in this experiment. B) The binding site for eIF4G’s interaction with the IRES
is shown for human, cattle and hamster and differences between them highlighted.
6.4.2.4 Two changes are in the viral capsid
The three changes in the coding region of the genome were in the capsid proteins VP3
(nt2651) and VP1 (nt3916) as well as one change in the non-structural protein 2C
(nt5180). The amino acid change in VP3 was from the neutral serine to the also neutral
threonine whilst the change in VP1 was from the positively charged lysine to neutral
glutamine. The change in VP1 is surface exposed whereas the change in VP3 is mostly
obscured, sitting close to the fivefold axis (Fig. 6.10). Cell culture adaptation often
results in the addition of positive charges. As this is adaptation from cell culture to
bovine cells it could be the opposite (although this is unlikely as the ability to bind
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heparan does not prevent binding of integrin). Previously changes on the five fold axis
have been identified as involved in adaptation to new receptors [57] although not in these
positions (VP3 74 and VP1 629).
Figure 6.10: Consensus level capsid changes mapped on a pentamer Changes
in the structural capsid proteins map to one surface exposed position in VP1 and one
positon on the fivefold axis in VP3. Non-structural changes were mapped on to an
FMDV O pentamer using pymol. The change in VP1 is indicated in red and the
change in VP3 is indicated in blue.
6.4.2.5 Changes in the ORF could affect autophagosome formation
The mutation in the non-structural protein 2C is at nucleotide positions 5180. This non-
synonymous substitution results in a change from isoleucine to a mix of threonine and
asparagine although it is the threonine mutation that becomes fixed in the consensus
sequence. Isoleucine is non-polar whilst both threonine and asparagine are polar. This
change is in a multifunctional domain of 2C (Fig. 6.11).
This region has been found to be involved in ATPase activity (yellow). 2C has been
defined as a hexameric AAA+ protein that is involved in ATP hydrolysis [72]. It requires
all three of the labelled domains to be functional (walker A, walker B and 3) and is
relatively specific for ATP in comparison to GTP, CTP, UTP which show a 10 fold
lower level of hydrolysis. The mutations sit in an area associated with ATPase but not
one of the essential binding domains. This suggests that potentially one amino acid
change would not result in sufficient amendment to protein structure to have a notable
effect. The region in which the variant mutation was identified has also been associated
with Beclin 1 binding activity (Fig. 6.11(orange))[73]. Work by Gladue et al found that
mutations in the Beclin binding regions identified resulted in non-viable virus and they
suggested that this interaction is therefore essential for replication. They do acknowledge
however that they cannot rule out the possibility that their alanine scanning mutagenesis
affect the structure of the protein and thus disrupted one of its many other functions.
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Figure 6.11: A schematic of the known functional elements each region of
2C codes for FMDV 2C includes a predicted amphipathic helix at the N-terminus
(grey), ATPase binding activity (yellow) and beclin binding activity (orange). It is a
hexameric AAA+ protein with a co-ordinated ATP hydrolysis mechanism requiring the
Walker A, B and site three domains (red). It has also been found to interact with the
cellular component vimentin (maroon). Various 2C mutants have been characterised in
poliovirus including Hydantoin resistant mutants (light blue stars), uncoating defective
mutants (purple) and 2C packaging mutants (brown circle). An interaction has also
been found in CAV three between 2C and VP3 (green). The 2C mutation found only in
the BFA adaptation and not in the control of this experiment is marked on the diagram
with the blue arrow.
6.4.2.6 There is evidence of these mutations in WT viruses
To confirm the possibility of these mutations occurring in WT samples, an alignment of
all currently published full genome sequences was completed and the presence of these
mutations investigated.
Mutation: 5’UTR VP3 2 VP1 2C
Bovine host 14 1 5
Ovine host 1 1
Buffalo 1 1
BHK-21 passage 2
Other 1 (porcine) 1(murine)
Unknown 4 11 12
Table 6.2: Presence of mutations in published sequences. An alignment of all
currently published FMDV genomes was completed and the presence of each mutant
in published sequences identified. The host from which the sample was taken was
considered
From this it was found that the mutations in the IRES and the mutations in 2C were
present in 20 sequences (4%) of the currently published sequences. For the IRES muta-
tion 70% of the changes were derived from bovine hosts supporting the hypothesis that
this is an adaptation to bovine cells (Table 6.2). These regions are relatively conserved
and therefore it is easy to determine the presence of a variant. The same analysis is
more complicated in the variable capsid proteins. The mutation in VP3 resulted in a C
at the position nt2651, this is true of 24% of the published sequences. However, in our
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WT virus the base after this positions (nt2652) is a C, so the mutation results in GC
to CC. The CC motif is only present in 2.5% of the genomes; other genomes with C at
position 2652 had a variety of bases subsequent to them although the majority had CG
(17%). For the mutations in VP1 only two published sequences showed this mutation
(0.3%) although there was a great amount of variation in the vicinity.
6.4.3 Swarms dynamics during adaptive passage
Having considered the consensus level changes, and associated phenotype, the dynamics
of the swarm in achieving this adaptation were investigated. Although each passage was
sequenced not all passages had sufficient coverage to be used in this analysis. This is
expanded on in Appendix C.
6.4.3.1 Cumulative entropy was comparable between expansion, adaptation
and control passages
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Figure 6.12: Cummulative entropy of the population expansion, BFA adap-
tation and associated control Shannon’s entropy was calculated at each position of
the genome and summed to produce a cumulative entropy score.
Shannon’s entropy was calculated at each position along each genome as a measure of
variation within the swarm. These values were added together to give a cumulative
entropy score. Cumulative entropy was calculated using the region of the L-fragment
represented at >1000x coverage in all compared genomes (nt646-8118). The L-fragment
represents the entirety of the ORF and is usually well represented as it does not include
the beginning of the genome or poly-c fragment, both of which are challenging
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Figure 6.13: The majority of genome positions have low entropy positions
Entropy scores were sorted into bins of 0.001. The number of positions (y-axis) is shown
against the bin centre (x-axis)(log) for each passage of A) the population expansion
(Inoculum - blue circle, E1 - red square, E2 - green triangle, E5 - purple triangle, E6
- orange diamond, E8 - black circle, E9 - brown square) B) the BHK control (H1 -
blue circle, H2 - red square, H3 - green triangle, H4 - purple triangle, H5 - orange
diamond, H6 - black circle,H7 - brown square, H8 - navy triangle, H9 - purple triangle,
H10 - maroon square, H11 - dark green asterisk, H15 - beige star) and C) the adaptive
passage (F4 - blue circle, F8 - red square, F10 - green triangle, F12 - purple triangle,
F13 - orange diamond, F14 - black circle).
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Figure 6.14: The majority of genome positions have low entropy positions
Entropy scores were sorted into bins of 0.001. The number of positions (y-axis) is
shown against the bin centre (x-axis) for each passage of A) the population expansion
(Inoculum - blue circle, E1 - red square, E2 - green triangle, E5 - purple triangle, E6
- orange diamond, E8 - black circle, E9 - brown square) B) the BHK control (H1 -
blue circle, H2 - red square, H3 - green triangle, H4 - purple triangle, H5 - orange
diamond, H6 - black circle,H7 - brown square, H8 - navy triangle, H9 - purple triangle,
H10 - maroon square, H11 - dark green asterisk, H15 - beige star) and C) the adaptive
passage (F4 - blue circle, F8 - red square, F10 - green triangle, F12 - purple triangle,
F13 - orange diamond, F14 - black circle). This graph is the same as Fig. 6.13 without
the log scale.
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to sequence. Cumulative entropy for the BHK population expansion appears to fluc-
tuate with an average of 240.14 and a range of 153.23. The following control passage
in BHK cells had a similar average of 264.61 and an almost identical range of 155.95.
The adaptive passage in BFAs have a similar but slightly lower average (232.47) and a
much smaller range of 39.58. There was no statistically significant difference between
the expansion and the BHK control passage or the expansion and the BFA adaptation
passage (Mann-Whitney p=0.3328, p=0.9293 respectively). There is a statistically sig-
nificant difference between the BHK control passage and the BFA adaptation passage
(Mann-Whitney, p=0.0469) (Fig. 6.12). It should be noted however that less of the BFA
passage series had sufficient coverage for analysis (5/15) than the BHK control (12/15)
and the population expansion (8/10). This could be the reason for the comparably small
range in values.
6.4.3.2 The majority of genome positions in each passage have a low entropy
score but this majority is smaller in the adaptive passage
Although the cumulative entropy of each passage was comparable, the distribution of
the entropy scores resulting in this value may not be. For example, if four positions
had an entropy score of 0.25 their cumulative entropy would be 1. If three positions
had entropy scores of zero and one an entropy score of 1 this region would also have an
cumulative entropy of 1.
Distribution of entropy scores was therefore considered in a histogram. It can been
seen from this analysis that the distributions of entropy scores does differ slightly. Each
set of passages had a peak bin of low entropy values. That is to say, that for each
passage in the expansion, the control and the BFA adaptation the majority of genome
positions had low entropy scores. On average, the number of positions in the majority
bin for the expansion was 287.37 (range 139) for the control 250.58 (range 151) and for
the adaptation 250.42 (range 43). Although there was some variation in the expansion
and control in this figure the variation between the adaptive passages was low (range
43). When considering the high entropy scores, the tail of the histogram, the population
expansion and BHK control have no positions with a score over 1.04 or 0.97 respectively.
In comparison, every passage of the BFA adaptation has positions with a score >1 ((Fig.
6.14).
Passages with a higher number of positions within their majority bin have a lower entropy
score as the majority. This can be seen most clearly in e5 (Fig. 6.13 A) purple triangles)
and BHK9 (Fig. 6.13 B) purple triangles. These peaks are tall and thin. There is a
statistically significant correlation between the majority bin and the values within this
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bin (p=0.0018)(i.e. passages with a lower majority score have more genome positions
in the bin). This gives rise the the idea of two different distributions of entropy scores:
low majority with a smaller distribution and a higher majority with a more broader
distribution.
This pattern appears to be cyclical in the BHK control. BHK1 shows a higher majority
bin with less values in it, BHK2 shows a lower entropy bin with more values in it, BHK3
shows a higher majority bin score with less in it and BHK4 shows a lower majority bin
with more positions in it (Fig. 6.15). It could not be observed if this pattern continued
due to a drop in titre potentially resulting in a genetic bottle neck. This is evident in
e5 having a much lower entropy majority bin with more positions in it (Fig. 6.13A,
purple triangle). This is expected as the smaller the population the lower the capacity
for variation.
Entropy Score
N
u
m
b
er
o
f
p
o
si
ti
o
n
s
in
b
in
0.00 0.05 0.10 0.15
0
100
200
300
400
Entropy Score
N
u
m
b
er
o
f
p
o
si
ti
o
n
s
in
b
in
0.00 0.05 0.10 0.15
0
100
200
300
400
Entropy Score
N
u
m
b
er
o
f
p
o
si
ti
o
n
s
in
b
in
0.00 0.05 0.10 0.15
0
100
200
300
400
Entropy Score
N
u
m
b
er
o
f
p
o
si
ti
o
n
s
in
b
in
0.00 0.05 0.10 0.15
0
100
200
300
400
Entropy Score
N
u
m
b
er
o
f
p
o
si
ti
o
n
s
in
b
in
0.00 0.05 0.10 0.15
0
100
200
300
400
A) B)
B
H
K
1
B
H
K
2
B
H
K
3
B
H
K
4
Figure 6.15: Two distributions of entropy scores are apparent Entropy scores
were sorted into bins of 0.001. The number of positions (y-axis) is shown against the
bin centre (x-axis) for BHK1, BHK2, BHK3 and BHK4 A) separately and B) overlayed
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6.4.3.3 Decreases in the majority midrange scores are reflected by an in-
crease in low and/or high entropy positions
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Figure 6.16: Percentage of the genome with a Shannon’s entropy score of
0.01-0.1 The percentage of the genome with an entropy score of between 0.01-0.1 is
shown for (A) the BHK control (B) and the adaptive passage (C)
As shown above, the majority of genome positions for each of the passage series have
low entropy scores. To consider the distribution of entropy scores outside this majority
scores were sorted into three larger bins: 0-0.01 (low entropy scores), 0.01-0.1 (mid
range entropy scores) and 0.1-0.15 (high entropy scores). These values are considered
as a percentage to make it comparable regardless of the region of the genome with
>1000x coverage. For both the population expansion and the BHK control passage
series approximately 95% of genome positions fall between 0.01-0.1.
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Figure 6.17: Fluctuations between entropy score histrogram bins Shannon’s entropy scores were binned into three bins low entropy (0-
0.01(blue circle)), mid-range entropy scores (0.01-1 (red squares)) and high entropy scores (1-1.5(green triangles)). This is shown for the populations
expansions (A) the BHK control (B) and the adaptive passage (C).
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This consistent proportion only dips for one passage before recovering. This 95% is
annotated on Fig. 6.16 with a red line with the one passage dips shown with a dashed
red line. In comparison, the adaptation series is generally below this proportions and
the dips last longer than one passage (Fig. 6.16).
When the percentage of values in the majority bin (0.01-0.1) drops (as displayed in Fig.
6.16) a concurrent increase is seen in the low range entropy scores (0-0.01, blue circle)
and vice versa (Fig. 6.17). In some situations this is coupled with the appearance of a
proportion of high entropy scores (1-1.5, green triangles) for example expansion passage
five and six and BFA adaptation passage 12-15 (Fig. 6.17).
Obviously, as these are percentage values, if one drops something else must increase.
What is interesting is that if high entropy values appear there is also an increase in low
entropy values. As high entropy changes appear in the population the number of mid
range entropy scores drop and the number of low entropy scores increase leaving the
cumulative entropy relatively consistent as previously shown.
As these high entropy positions become fixed in the population they would go from
having a high entropy score to mid range and potentially to low. This can potentially
be seen at the latter end of the BFA adaptation. Dips where no associated increase in
high entropy position are shown (i.e. BHK5 or BHK9) could be evidence of a bottle
neck with no adaptive pressure. If there is a bottle neck of some form, a percentage of
the swarm is removed. This would cause the overall level of variation to decrease (less
midrange values, more low level values). One of these outlying values equates to a drop
in titre of inoculating virus (from the previous passage). Inconsistency of blind passage
sampling could explain this. The other drop does not relate to lower titre from the
input virus. However, cell number, quality or time of CPE could all affect the quality of
virus produced by this experimental procedure. It does seem however that these changes
are rapidly recovered with the next passage showing the expected 95/5% split between
midrange and low entropy positions.
The observation of the cycling pattern between very low tight distribution and the higher
broader distribution lead to the suggestion that when under no adaptive pressure the
swarm cycles between a swarm with minimal variation and swarm with slightly more
variation. This makes logical sense as as more variation is introduced some of it is
likely to be non viable and be eradicated leading to less variation. However in periods
of adaptive pressure, when some highly variable positions appear as adaptive changes
come to fixation, the low level variation is somehow restricted with high entropy posi-
tions resulting in less midrange positions and more low level positions. These proposed
population dynamics are outlined in Fig. 6.18.
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Figure 6.18: Proposed swarm dynamics A) The mean average entropy of the BHK
control passage from BHK1-BHK15 is shown on the left hand side. The right hand side
of the panel shows the number of high entropy positions each passage. B) Shows mean
entropy score for the BFA adaptive passage on the left hand side of the panel. The
associated number of high entropy positions is shown in the right hand panel. A cartoon
of this pattern is seen in the lower panel. C) Under no adaptive pressure the swarm
cycles between a swarm with minimal variation and swarm with slightly more variation.
D) In periods of adaptive pressure there are some highly variable positions as adaptive
changes come to fixation but less low level variation
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This could be because less genomes will have the capacity to survive in the new envi-
ronment or evidence of the swarm having the capacity to withstand a limited amount of
variation. If the latter explanation proves to be correct this could be some preliminary
evidence towards the FMDV swarm being a quasi-species as discussed in the Chapter 8
(Fig. 6.18).
6.5 Summary
Adapted virus shows a different phenotype The adapted virus had improved
replication efficiency and appears to cause CPE more efficiently.
Virus adapted to BFAs shows consensus level changes. There were four
consensus level changes identified on each in the IRES, VP2, VP3 and 2C. These all
appeared following a decrease in viral titre suggesting a bottle neck produced in the
blind passage process.
Swarm dynamics This work suggests when a viral swarm is under no continued
adaptive pressure the swarm cycles between a state of minimal variation and slightly
more variation. These two states are a product of each other (more variation means
an increased number of non-viable genomes resulting in less variation). These periods
of more variation may allow the virus to adapt when under selective pressure as the
increased variation may included a mutation to respond to/overcome the pressure. When
under this pressure or adapting to it, high entropy positions appear as mutations and
become fixed in the majority of genomes. This is coupled with a lower mean entropy
score, either because less genomes can survive under the selective pressure (smaller
swarm = less variation) or because the swarm can withstand only a limited amount of
variation - a concept that would hint at FMDV acting as a quasi-species.
Chapter 7
Putative packaging signals
7.1 Abstract
Next generation sequencing is now an affordable technique that allows the creation and
interrogation of large data sets revealing details about how a virus exists and evolves.
These large data sets can be used not only for observing viral dynamics and consensus
level sequencing but to consider fundamental biological questions from a new perspec-
tive. The following work shows how interrogation of a viral swarm can be used in a
more fundamental virological study to investigate a feature that may have previously
been camouflaged by the highly variable nature of the virus swarm: RNA packaging in
Picornaviridae .
FMDV samples before and after virus purification were sequenced on the Illumina Miseq.
These samples represented the ’total’ population and ’encapsidated’ population of the
viral swarm respectively. Comparison of Shannon’s entropy score at each position of the
genome for each population allowed regions of the encapsidated population’s genome
that were more conserved to be identified. Secondary structure analysis of these regions
showed conserved stem loop structures. Repeats of this analysis with the same virus
showed that the features are, to an extent, functionally redundant with approximately
50% repeated in both experiments. These potentially functionally redundant secondary
structures were confirmed in a second virus from the Picornaviridae family; poliovirus.
Subsequent molecular work disrupted a subset of these conserved features in FMDV
and resulted in a phenotype that achieved full CPE more slowly and produced a log
less virus. The mutant virus was shown to replicate and translate comparably to the
wildtype virus and the phenotype was therefore attributed to genome packaging.
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7.2 Introduction
Although much is known about Picornaviridae capsids, and to an extent how the capsid
physically assembles, detailed explanation of how the RNA folds and interacts with
the capsid proteins is still to be elucidated. The folding of viral genomic material and
subsequent packaging into outer capsid proteins offers a target for effective antiviral
strategy as has been shown for DNA viruses hepatitis B and herpes simplex virus [259,
260] and RNA viruses HIV and influenza [261, 262]. If a sufficiently conserved element of
the picornavirus encapsidation process can be identified an antiviral could be designed.
7.2.1 Encapsidation processes
Diverse mechanisms are used for genome packaging by different virus families. In double
stranded DNA viruses, DNA is often packaged into a pre-formed viral capsid through
an entrance vertex with the assistance of powerful ATP driven motors [263]. In RNA
viruses however virions are inclined to assemble spontaneously around the genome. For
this process to be successful the genome must be small enough to fit within the capsid
and co-ordination is required for the capsid and RNA to assemble together. Therefore,
this strategy for packaging is chiefly dependant on two elements: genome compactness
and RNA-protein interactions. The simplest RNA viruses selectively package a single
copy of their genome into a capsid derived from a single protein subunit minimising
the protein required to produce virions and thus maximising potential output from one
infected cell.
7.2.1.1 Genome compactness
Naked viral RNA can be 25% larger than the virion [264]. Furthermore, a compacted
structure can be necessary to bind capsid proteins [265]. RNA folding and collapse
is therefore a key part of the RNA encapsidation process. The compact, high density
form of viral RNA is created by branching and folding. This can be due to binding or
proximity of the RNA and capsid protein resulting in a rapid collapse of the viral RNA
which would previously have had a hydrodynamic radius far larger than the inside of
the capsid.
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7.2.1.2 RNA-protein interactions
Viral packaging processes usually involve interactions between the viral genomic material
and structural proteins (capsid elements) or non-structural proteins. These interactions
can either aid in packaging efficiency or be an essential step in the packaging process.
RNA-protein interactions have been well studied in several viruses and are primarily
electrostatic. Electrostatic interaction depends on a non-covalent bond between a posi-
tive area on the proteins surface and the negatively charged RNA. Several RNA-protein
interactions have been described [266]. For example, in one group, the groove in an
RNA-helix binds peptides or proteins. Alternatively single stranded RNA can interact
in a sequence specific manner with pockets created in a protein’s β-sheet surface. This
latter interaction can be enhanced by the RNA structure [267].
Most RNA-capsid interactions are assumed to be nonspecific but more recently, studies
have been completed that show certain electrostatic interactions are sequence specific.
This has been shown for example in Cowpea mosaic virus (CPMV)[268, 269]. A slightly
more complex situation exists in satellite tobacco necrosis virus (STNV). In STNV a
combination of sequence specific interactions and electrostatic forces result in successful
packaging [270]. STNV capsid monomers have sufficient electrostatic force to prevent
them from forming a full capsid due to repulsion. The addition and interaction of the
RNA overcomes this [271].
In RNA bacteriophages such as MS2 from the Leviviridae family the encapsidation
process has been quite fully defined. In this scenario binding of an RNA stem loop to
the capsid protein can cause a conformational change in the capsid protein, facilitating
dimerization. These dimers bind one another to form the assembled capsid [272]. RNA
can also interact with neighbouring dimers, helping to bring together the capsid [273].
Stem loop structures with capsid-protein interactions such as the ones described in MS2
have been found in many viruses although they do not necessarily result in conforma-
tional changes in structural proteins. They are often termed packaging signals [271]. In
some cases, such as for hepatitis B, one stem loop is sufficient for encapsidation [274].
Recent work completed by Dykeman and colleagues has suggested an assembly mecha-
nism for some viruses which includes multiple degenerate packaging signals throughout
the genome that results in a conserved assembly pathway [275].
7.2.2 Picornaviridae encapsidation
In viruses belonging to the picornavirus family the encapsidation process is not well
understood. Advances in viral structure analysis have allowed for the visualisation of
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RNA-protein interaction points. Electronmicroscopy facilitated the structure of the pi-
cornavirus Ljungan virus to be resolved at 3.78 in 2015 revealing potential electrostatic
interactions between the inside of the capsid shell and the RNA itself [276]. A similar
finding was reported from the structure of human parachovirus 1 suggesting a hexanu-
cleotide association close to the 5-fold axis [277]. This suggests that RNA-structural
protein interactions may be important in picornavirus encapsidation.
These interactions could be specific. An RNA stem loop packaging signal has been
identified at the 5’ end of Aichi virus (Genus: kobuvirus, Family:picornaviridae) [278,
279] which has given rise to investigation of RNA packaging signals as a method for
encapsidation in other picornaviruses.
Work with the picornaviruses coxsackie virus and poliovirus has suggested a role for
viral non-structural protein 2C in RNA encapsidation. It has been suggested that 2C
provides specificity to the RNA during the encapsidation process (for enteroviruses) and
scanning mutagenesis has more specifically shown the C-terminus of 2C to be required
for RNA encapsidation [255, 280, 281]. Studies have found co-localisation between capsid
proteins VP1 and VP3 and 2C further highlighting its involvement in the encapsidation
pathway [280, 282].
Other pieces of information are available about packaged picornavirus RNA. It has been
shown that poliovirus only encapsidates newly synthesised positive strand RNA [98, 99]
that are linked to the genome linked protein (VPg) [283]. This protein acts as a primer
during RNA synthesis and is covalently linked to the 5’ end of the genome. This has led
to the suggestion that viral replication could be linked to encapsidation, thus allowing
for specific encapsidation of newly synthesised RNA molecules.
Numerous potential elements of the picornavirus packaging pathway have been identified
but the variation between viruses of the same family makes for a highly confusing and
contested area of research. Work to understand which of these mechanisms is in use for
each of the picornaviruses needs to be completed.
7.2.3 Experimental approaches
Previous studies to consider packaging signals have been completed in a range of viruses.
Methods used have included, but are not limited to, deletion analysis, trans-encapsidation
studies and SELEX. Each of these methodologies has limitations. In deletion analysis
regions of the genome are systematically deleted and packaging of subsequent mutants
considered. Similarly, different regions of viral genomes have been cloned into other
viruses or non-viral RNA to observe if this confers the ability to package. In retrovirus
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Moloney murine leukemica virus, experiments have successfully cloned packaging sig-
nals into non-viral mRNA allowing their subsequent encapsidation [284]. Issues with
this area of research relate to the difficulty in separating packaging from other genomic
functions. Many small RNA viruses have short genomes and it has been predicted that
each region of the genome is likely to be multifunctional with its sequence and/or struc-
ture being important in several viral processes. Therefore amending a viruses even with
synonymous mutations could result in changes in as yet unknown processes. Realisti-
cally, this may be unavoidable as in viruses where processes are inherently coupled it
would be impossible to alter one aspect without effecting another.
SELEX is the systematic evolution of ligands by exponential enrichment [285]. This
process involves the exposure of a protein or ligand to a random library of nucleotide
sequences. Those that successfully bind are subsequently amplified and the process
is repeated with this new selected library. This process is repeated numerous times
to identify the sequences most likely to be bound by the protein of choice. In work
considering packaging signals these selected sequences are then aligned to the genome
with a mapping algorithm to identify their most appropriate positions and identified
regions are statistically and structurally analysed to consider their potential function
in packaging [275]. This methodology is preferable over traditional deletion studies
because it does not depend on genomic regions being solely responsible for one function.
This process requires the bombardment of small fragments of genomic material at capsid
pentamers. The capsid pentamers are created by denaturing fully formed empty capsids.
Formation of capsids involves the auto-catalytic cleavage of VP0 so any fully formed
capsid would have already undergone this cleavage. Consequently, the pentamer subunits
produced by capsid denaturation are slightly different from natural pentamer subunits.
Secondly the fragment length means that each fragment could align to several regions
in a genome, requiring statistical analysis to find positions of best fit.
7.3 Experimental Design
This study uses a novel approach to consider the question of FMDV RNA packaging.
Virus populations before and after encapsidation have been sequenced and compared to
assess restrictions put on the encapsidated population only (Fig. 7.2). This offers an
improvement on previous methodologies as it does not require any amendments to the
genome or protein that could obscure or alter identification.
In short, exemplar viruses were grown up in large culture and a proportion of this culture
was purified to produce virions.
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Figure 7.1: Putative packaging signals: flowchart of methods used Samples
of FMDV and poliovirus were purified by Lidia Lasecka and Caroline Wrights or Toby
Tuthill and Hannah Wenham respectively. Samples pre and post purification were
sequences and entropy scores at each position of the genome compared. Areas more
conserved in the packaged population were identified and used to inform the design of
a packaging mutant. Geneart fragments with the mutation were cloned into an ICP
and comparisons made between the WT and mutant.
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The original population (total) and the resulting purified virions (encapsidated) were
used in RNA extractions and the genomic material sequenced on the Illumina MiSeq
as previously described [170]. At positions with coverage of greater than 1000x the
Shannon’s entropy score was calculated and the score for the encapsidated population
subtracted from the score for the total population.
Figure 7.2: Packaging requirements: experimental design Two populations of
RNA were sequenced to consider requirements for sucessful packaging: A) The ’total’
population. This contained packaged full length positive sense RNA (red, in capsid),
unpackaged full length positive sense RNA (red, no capsid), unpackaged full length
negative sense RNA (blue, no capsid) and non full length of both negative and positive
sense RNA (blue and red respectively.) B) The ’encapsidated’ population. This pop-
ulation included only successfully formed virions, assumed to contained positive sense
full length RNA strands.
Positions with positive values were deemed to show less variation in the encapsidated
population than the total population and thus likely to be required or at least prefer-
able for successful packaging. This process was completed with FMDV and poliovirus
to asses if any packaging elements could be identified that were conserved within the
picornaviridae family. A mutant virus was then created lacking 3/12 identified regions
identified in FMDV. This mutant was then compared to the wildtype. An outline of the
methods used in this chapter can be seen in Figure 7.1. Further detail can be found in
Chapter 2 and 3.
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7.4 Results and Discussion
7.4.1 Bioinformatic analysis
7.4.1.1 The majority of genome positions are more variable in the encapsi-
dated swarm.
A pilot experiment was conducted with O1Kaufbeuren (O1K) to confirm the proposed
protocol would have the resolution to identify differences between the total and en-
capsidated population. The difference in Shannon’s entropy scored between the total
population and the packaged population was calculated and visualised to identify regions
more conserved in the encapsidated population (positive values). 70% (5630 genome po-
sitions) had negative scores, 29.1% (2329 genome positions) had positive values, 0.1%
(9 genome positions) showed no difference between the two populations and 2.5% (202
genome positions) had insufficient coverage in at least one population preventing accu-
rate comparison of the entropy scores (Fig. 7.3).
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Figure 7.3: Difference in Shannon’s entropy scores. The Shannon’s entropy
score from the encapsidated populations was subtracted from the score from the total
populations and values were plotted against genome positions (Equation. 4.1.)
The majority of positions reported a negative score, that is to say the entropy score
from the total population was smaller than that in the encapsidated population. This
was an unexpected finding. Considering the encapsidated population is a subset of the
total population it was expected that the amount of variation in this population would
be mostly lower due to the smaller population size. One possible explanation for this
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can be seen in recent work by Schulte et al. This work suggests that the traditional
’stamping out’ method of viral progeny production may not be accurate. They propose
that virions produced from each cell are approximately five generations removed from
the virus that entered [286]. A similar point is made by Thebaud et al [143]. This
provides the opportunity to accumulate variation. If the later replicated genomes are
the genomes that are preferentially packaged then the encapsidated population will in
fact be made up of the genomes in the population most diverged from the original
infecting population. Further work needs to be completed to identify if this explains the
pattern seen.
7.4.1.2 Conserved genome positions in the encapsidated swarm cluster.
Figure 7.4: Genome positions more conserved in the packaged swarm clus-
ter. The Shannon’s entropy score from the packaged populations was subtracted from
the score from the total populations and positive values were plotted (representing
less variation in the packaged population) against genome positions. Clusters of posi-
tive values representing conserved regions were marked and termed putative packaging
signals (PPS).
The difference in entropy score, calculated at each nucleotide position, between the
packaged and total population which resulted in a positive value was used to identify
12 regions (termed putative packaging signals (PPS) 1-12) more conserved in the en-
capsidated swarm in comparison to the total population (Fig. 7.4). These regions were
spread throughout the genome. Previously it has been assumed that any packaging
signal present in the genome would not be situated in P1 as numerous picornaviridae
sub-genomic replicons have been created with a reporter gene in place of P1 and some
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of these have been shown to encapsidate in transencapsidation studies. This may not be
entirely accurate however. Hamiltonian pathway theory suggests that packaging signals
may be present throughout the genome and their efficiency may be degenerative. If this
is the case, replicons with no P1 may be able to package but with lesser efficiency [275].
Figure 7.5: The secondary structure of each PPS formed a stem loop with
a consistent shape and motif. Synonymous nucleotide changes could be
engineered that changed the structure. A) Each identified conserved region, or
PPS, was run through Mfold to consider its secondary structure (PPS2 shown as an
example). B) A consistent pattern was found in 10/12 stem loops. This featured an
adenine and cytosine rich loop with a smaller adenine bulge or protrusion in close
proximity. C) Non-synonymous changes could be made to disrupt both loop region
(highlighted in orange) and the structure (PPS2 shown as an example).
7.4.1.3 Conserved clusters form repetitive secondary structures termed pu-
tative packaging signals (PPS).
To consider if the less variable regions identified (PPS 1-12) had a repetitive secondary
structure the PPS were analysed using Mfold. This revealed a conserved stem loop
structure around all the PPS positions with the exception of PPS3 and PPS9. These
structures consisted of an adenine and cytosine rich loop complemented by a proximal
adenine rich bulge (Fig. 7.5). Although this structure was not obvious in PPS 3 or 9
there were adenine rich regions and thus it could be possible that these structure do
exists although they were not immediately obvious.
To asses whether this structure was conserved from isolate to isolate findings were con-
firmed using locaRNA [287–289]. This software performs a structural alignment to show
structures that are conserved, regardless of their nucleotide sequence. This showed con-
servation of the structures in 30 other type O consensus sequences downloaded from
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genbank (Appendix A,Table E.2). This suggests that the structures found could be
biologically relevant as there is evidence of them on a serotype wide scale.
7.4.1.4 Approximately half the identified PPS are repeated from passage
to passage.
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Figure 7.6: FMDV: a subsection of PPS regions are identified in multiple
strains and some appear to be viral swarm specific. A frequency distribution of
the number of positive values per 20 nucleotide window was completed for experiment
one (A) and experiment two (B). Windows with a score above the 75 percentile (10
and 9 respectively) were visualised (C). Experiment one (red) on the left axis and
experiment two (blue) on the right axis had 711 nucleotides in common (green) spread
throughout the genome.
Having established a protocol, repeat experiments were performed with a new virus
preparation of the same virus (FMDV O1K experiment 2) and two different virus prepa-
rations of type 1 poliovirus (Mahoney) (poliovirus experiment 1 and 2). This resulted
in four data sets: two FMDV O1K and two poliovirus M1. In the previous experiment
regions of conservation were identified visually. This allows for some human introduced
bias. An improved analysis techniques was developed to improve repeatability. A slid-
ing window analysis was performed across the genome (with a 20 nucleotide window)
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to count the number of positive values within a window. The frequency distribution of
these values was considered and windows with a score above the 75 percentile highlighted
(Fig. 7.6).
For FMDV O1K there were 711 nucleotides identified in both analysis (Fig. 7.6C). 35
regions were identified in experiment one and 53 in experiment two potentially suggesting
improved resolution in the latter experiment. This could be due to slightly higher
coverage in experiment two, although this difference is minimal. 51% of the regions
identified in experiment one share some overlap with regions highlighted in experiment
two, which equates to 45% of the identified regions in experiment two.
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Figure 7.7: Comparable levels of coverage were not achieved between po-
liovirus repeat experiments. The coverage across the genome is shown for total
samples (solid line) and encapsidated samples (dashed line) for experiment 1 in black
and experiment 2 in grey. Coverage cut off is marked at 1000x. Analysis on experiment
one was completed on regions above 100x (also marked).
For poliovirus M1 coverage of one of the viral preparations was low (Fig. 7.7). This is
likely due to the first sample being in the freezer for a long time and potentially suffering
some degradation. The second sample, a passage grown from the first sample, achieved
much higher coverage. The coverage cut off for the poliovirus data sets was therefore
set lower at 100x. The distribution of positive scores per window for the poliovirus
experiment one was slightly different from that of the second poliovirus experiment and
the FMDV experiments. The different distribution of values can be explained by the
differences in coverage achieved for each of the repeats (Fig. 7.7).
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Figure 7.8: Poliovirus: a subsection of PPS regions are identified in multiple
strains and some appear to be viral swarm specific. Sliding window analysis was
completed counting the number of positive values in 20nt windows across the genome.
The frequency distribution is shown in a histogram for experiment 1 (A) and experiment
two (B) with a bin width of 1. The mean of experiment one is 1.510 with a standard
deviation of 1.545. The mean of experiment two is 3.999 with a standard deviation of
2.969. C) Experiment one (red) on the left axis and experiment two (blue) on the right
axis had 4549 nucleotides in common (green) spread throughout the genome.
Lower levels of coverage in experiment one would have resulted in some low level variants
not being represented and thus more positions returning a Shannon’s entropy score of 0
(Fig. 7.8). Although the distributions are markedly different the descriptive statistics
of the frequency distribution could be used to identify windows with values above the
75% percentile. Using these value as a cut off clusters were identified in experiment 1
(windows with >2 positive values) and experiment 2 (windows with >6 positive values).
Regions were merged together if they were within 50bp of one another on the genome
revealing 24 regions of interest in experiment one and 26 regions of interest in experiment
2 (Table 7.1). As with FMDV approximately half showed overlap in the other experiment
(0.5-0.53).
This data suggests that approximately half of the putative packaging signals are consis-
tent and half vary from isolate to isolate. There could be a number of reasons for this.
Given the extensive secondary structure in the FMDV genome, and to a lesser extend in
the poliovirus genome, it may be that there are numerous packaging signals that could
be utilised throughout the genome but that they are, to an extent, functionally redun-
dant. Therefore a selection of packaging signals will be evident in each passage but they
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will not necessarily always be the same selection of packaging signals. Potentially, sec-
ondary structures of the genome that have a dual purpose are more common packaging
signals. This would lead to a system where genomes with structure required for entry
or replication would be preferentially packaged. This fits with the observation that the
secondary structure in the IRES has been identified in all experiments. A secondary
structure element required for replication was also identified in FMDV experiment one
in the form of stem loop one (SL1) but the coverage was insufficient at this location in
the second experiment to confirm this observation. Similarly, in poliovirus experiment
two, stem loop Y was identified. This is also a secondary structure element required for
replication.
Some secondary structures have been found to be functionally redundant in other pi-
cornavirus process. For example, two functionally redundant RNA structures (α and β)
have previously been described by Song et al in poliovirus 3Dpol [290]. These structure
have been identified in this analysis also: α sits 6995nt-7042nt highlighted in poliovirus
experiment one (7009nt-7087nt) and β sits 7192nt-7267nt highlighted in poliovirus ex-
periment two (7114nt-7209nt). As the viruses used are different passages of the same
strain it is conceivable that the majority in the swarm of experiment one use α while the
majority in experiment two use β. This couples with the concept that exactly the same
combination of packaging signals is not required in every genome, potentially highlight-
ing the slightly flexible nature of this process. Each virus may have a similar number of
packaging signals in similar regions but there may be several options in each region.
If α and β represent functionally redundant features that can sometimes act as packaging
signals, there are other more consistent structural elements that may always act as pack-
aging signals. Four known secondary structure elements in poliovirus were identified by
the analysis in this current study: the IRES [291, 292], 2C Cre [293], RNase L competi-
tive inhibitor [294, 295] and Stem loop Y [296]. Each of these features were identified in
both experiments except Stem loop Y which lacked sufficient coverage for consideration
in experiment one. The fact that previously recognised secondary structures may also
have an additional function in packaging is not surprising as small RNA genomes have
previously been shown to have multifunctional secondary structure elements [270]. The
largest difference in entropy between total and encapsidated population was found in
poliovirus experiment two and coincides with stem loop Y. This stem loop is at the 3’end
of the open reading frame and has previously been implicated in replication. This being
the most constrained stem loop in a swarm would be beneficial from an evolutionary
standpoint as the full length genomes would be preferentially packaged thus producing
viable virus. Further work would need to be completed to asses if this was a theory
reflected by the data.
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Experiment 1 Genome region Experiment 2 Genome region
*204-219 IRES *14-277 Clover leaf/IRES
416-465 IRES 329-372 IRES
534-568 IRES 513-528 IRES
*742-855 VP4 *699-759 VP4
*811-1322 VP4/VP2
*1303-1625 VP2 *1404-1467 VP2
1712-1741 VP2 1617-1680 VP2
1743-1757 VP2
1865-1905 VP3 *2067-2080 VP3
*1980-2080 VP3
2270-2320 VP3
*2498-2567 VP3/VP1
*2663-2867 VP1 *2540-2691 VP1
*2999-3123 VP1 *2884-2886 VP1
3222-3248 VP1 *3030-3041 VP1
*3374-3723 VP1/2A *3383-3475 VP1/2A
3620-3669 2A 3582-3587 2A
3785- 4065 2A/2B
4400-4414 2C 4286-4379 2C
*4483-4532 2C *4441-4505 2C
4658-4720 2C
4561-4575 3A
5117-5126 3A/3B
5566-5590 3C 5346-5406 3C
5653-5866 3C
5925-6081 3C/3D 5467-5591 3C/3D
*6771-6907 3D *5933-5938 3D
7009-7087 3D *6810-6909 3D
7261-7268 3D 7114-7209 3D
*7267-7284 3D
7343-7420 Stem loop Y
Table 7.1: Location of PPS within the poliovirus genome. Regions of the
genome identified in the sliding window analysis for experiment 1 and experiment 2 and
the regions of the genome in which they lie. Regions identified in both experiments are
marked with an asterisk (*). Regions of the genome where coverage was not sufficient
in the comparison genome for analysis to be completed are marked in red.
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Previous studies have shown that poliovirus lacking the 3’UTR produced up to a log less
virus although whether this was due to a packing deficiency was not considered [297].
It should be noted that not all secondary structures previously reported in poliovirus
have been found in the current analysis. For example a structure found in 3D by Burill
et al [298] has not been identified, however this is consistent with their results as they
showed knocking out this structure did not affect the viruses ability to package and
shows the specificity of the technique described here.
7.4.2 Molecular confirmation of bioinformatic observations.
7.4.2.1 Packaging mutant achieves CPE more slowly than wild type virus.
Using regions identified in FMDV experiment one, synonymous changes were designed
to amend the secondary structure and coding loop of a mutant region spanning PPS2-
PPS4. These loops were mutated with 5-13 nucleotide changes per region. Mutated
regions were ordered from GeneArt and cloned in to the pT7S3 infectious copy plasmid.
Mutant virus was recovered and confirmed using Sanger sequencing.
Figure 7.9: In equal MOI infections cell death was more apparent in wild-
type than mutant at comparable time points. BHK-21 cells infected with wild-
type or mutant virus at comparable MOIs at differing time points imaged on Juli smart
fluorescent cell analyser (Digital Bio). A)MOI1 wildtype virus 30hpi. B) MOI1 mutant
virus 30hpi. C) MOI0.01 wildtype virus 45hpi. D) MOI0.01 mutant virus 45hpi.
Equal MOI infections were completed and infected cell monolayers were imaged to com-
pare mutant and wildtype rate of CPE. At thirty hours post infection with an MOI
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of 1, cells infected with the wildtype virus were all rounded and mostly detached. In
comparison, at the same MOI and time point the cells infected with the mutant showed
some cell death with some rounded and detached cells but it also showed some healthy
cells either not yet infected or in an early stage of infection. This effect is even more
apparent at a lower MOI over a longer period. When infected with an MOI of 0.01
the wildtype had completely eradicated the monolayer by 45 hours post infection. In
comparison the mutant virus at the same time point still had a number of viable cells.
This suggests that the time taken for the mutant viruses to produce complete CPE is
greater than that of the wildtype (Fig. 7.2).
7.4.2.2 Replication and translation efficiency of packaging mutant is com-
parable to wildtype virus.
To confirm the MOI used was comparable the number of infected cells were calculated
at four hours post infection. The Minimax plate reader was used to count the number
of cells as determined using ToPro3 nuclear stain. Infected cells were identified with
immunofluorescence (IF) to viral non-structural protein 3A. The proportion of cells
infected was not statistically significantly different (two-sample T-test, p-value=0.830)
between the wildtype and mutant (Fig. 7.10A).
Figure 7.10: Infection and replication efficiency between mutant and wild-
type is comparable. Immunofluorescence images were taken and quantified on the
MiniMax. This data represents 8 replicates and is graphed with standard deviation A)
ToPro3 staining and subsequent fluorescent object count at 620nm identified the total
number of cells (black bar) and 2C2 labelling and fluorescent object count at 425nm
determined the number of infected cells (grey) at 4hpi. 18.98% of cells in wild type
were infected. 20.51% of cells in mutant were infected. B)The average fluorescence of
each infected cells was calculated for wildtype (red) and mutant (green) at 4hpi.
The immunofluorescence data was further used to consider replication efficiency. The
average fluorescence for infected cells in mutant and wildtype were compared. This
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was used as a measure of replication as the more replication completed, the higher the
number of non-structural proteins produced and thus the more labelling visible. The av-
erage fluorescence of wildtype infected cells and mutant infected cells is not significantly
different (Mann-Whitney, p=0.1930) (Fig. 7.10B). This suggests that the translation
efficiency of the two viruses is comparable.
Translation is not a completely accurate measure of replication as the ratio of replicat-
ing genomes to translating genomes is not fully understood. To address this potential
discrepancy quantitative PCR (qPCR) was completed on samples taken every hour for
eight hours for mutant and virus samples infected at equal MOIs. This analysis suggests
comparable amounts of RNA are produced by the wildtype and mutant virus in an equal
MOI infection (Fig 7.11).
The only point at which this was not consistent was at 2 hours post infection. At two
hours post infection there was a dip in the amount of RNA present in the wildtype
sample. This could be a product of cellular degradation. Not all RNA that reaches the
cell goes on to be successfully translated or replicated, some may be degraded by cellular
proteins or remain in the cell but in a non-functional capacity. Why there is a difference
between mutant and wildtype at this point is unclear but as the remaining time points
are comparable it suggests replication is not affected by the introduced mutations.
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Figure 7.11: Comparable amounts of RNA are produced by an equal MOI
infection of wildtype and mutant viruses RTqPCR was preformed on Direct-
zol extracted RNA samples from an equal MOI time course comparison of wildtype
and mutant viruses. Three time courses of wildtype and mutant were completed and
RTqPCR was completed on each sample in triplicate. Cycle threshold Ct) averages of
the triplicate values are shown for wildtype (red) and mutant (green) plotted against
hours post infection.
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Figure 7.12: The mutant virus depletes the monolayer more slowly than the
wildtype virus. Change in area covered by cell monolayer for uninfected cells (blue),
wildtype infected cells (red) and mutant virus infected cells (green) is shown every two
hours over a 36 hour period. These values were calculated by the MiniMax plate reader
on the transmitted light channel. This data is representative of 8 replicates for the cell
only control and mutant and 7 replicates for wildtype and is graphed with standard
deviation.
Having confirmed that the infection rate and replication efficiency of the mutant and
wildtype viruses were comparable (Fig. 7.11,7.10) an assay was designed on the Spec-
traMax MiniMax 300 Imaging Cytometer to compare the spread of virus through a cell
monolayer. Equal MOI infections were performed in a 96-well plate and monolayers
were imaged every two hours over a 36 hour time period.
Both sets of infected monolayers show the same growth as cell only control wells for the
first four hours. From this point, the first round of replication is expected to be near
complete and the equal number of cells originally infected by both is reflected by the
plateauing of both the wildtype and mutant. From 9hpi a decrease in the area of the
well covered by cells is apparent in the wildtype sample. An equivalent decrease is not
evident in the mutant until 11hpi. Further to this delay the gradient of the wildtype
curve appears steeper than that of the mutant (Fig. 7.12). These observations were
confirmed statistically (Fig. 7.13) showing that the two curves were different and that
the wildtype kills more cells than the mutant and earlier.
Chapter 7. Putative Packaging signals 163
Figure 7.13: The wildtype virus kills more cells, more quickly. Model fitted
by Dr. Simon Gubbins. A logistic (S-shaped) curve was fitted to the cell death data
assuming the parameters were the same for both wildtype and mutant, the same pro-
cess was completed assuming the parameters were different. The fit of the two curves
were considered, and the curve with different parameters had a significantly better fit
than the curve with common parameters. It can therefore be concluded that the pa-
rameters differ. From this model it can be seen that the wildtype (black) kills more
cells (k2(wt)<k2(mut)) than the mutant (green) and earlier (d(wt)<d(mut)).
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Figure 7.14: The mutant virus produces a log less viable virus than the wild-
type. Triplicate plaque assays were completed on samples from equal MOI infection
of mutant and wildtype virus at 5hpi and titre graphed on a log scale.
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The delay in the mutant could be attributed to the decrease in packaged viable virus
being produced. A plaque assay at five hours post infection showed a statistically
significant log reduction in titre produced by the mutant in comparison to the wild-
type: 5.3 x 105 PFU/mL and 3.3 x106 PFU/mL respectively (two-sample T-test, p-
value=0.039)(Fig.7.14).
Although the sequence changes used to create the packaging mutant virus were syn-
onymous it is important to consider if any of the genomic changes could have had an
effect on known packaging requirements. There are a number of possible requirements
on the genome to allow it to package. It has previously been shown that poliovirus only
packages genomes linked to VPg. This could also be true for FMD. VPg is covalently
linked to the 5’end of the FMDV genome [60]. The 5’ end of the genome is unchanged by
the mutations introduced. Reduction of VPg genes has a dose dependant effect on the
quantity of viral RNA synthesised and virions produced [299]. There are three copies of
VPg encoded within the FMDV genome, a unique feature of this virus among animal
picornaviruses [300]. The mutations introduced do not sit in the region of the genome
encoding the three copies of VPg. This suggests the mutations introduced are unlikely
to have affected the linkage or production of VPg specifically. Furthermore, Falk et
al [299] show the VPg reduction affects RNA synthesis and therefore virion formation
although it is not required for translation [301]. This work has found that the titre is
reduced but RNA synthesis remains the same (Fig. 7.14,7.11) suggesting the effect is
not due to the genomes interaction and production of VPg.
It has also been shown that poliovirus only encapsidates newly synthesised RNA genomes,
if this is also true in FMDV, mutations could have affected the number of newly syn-
thesised RNA produced. Both wildtype and mutant genomes produced comparative
amounts of RNA so it is unlikely this can explain the effect seen.
An important factor in virus encapsidation is genome compactness as previously dis-
cussed. Tubiana et al completed an experiment that modelled the effect of synonymous
mutations throughout the genome on maximum ladder distance (MLD), a measure of
genome compactness [302, 303]. They found that as mutations were introduced compact-
ness was reduced in a gradual manner. This suggests that changes across the genome
have a similar effect rather than certain regions being of maximum importance in terms
of compactness. They also found that mutating 5% of genome positions or more was
sufficient to eradicate the compactness observed in the wildtype virus. The number of
nucleotides changed in the packaging mutant was 34. This accounts for only 0.4% of the
genome and thus Tubiana et al ’s model suggests should not result in a decrease in com-
pactness. The targeted nature of the mutations made in my work (between nucleotide
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positions 1700-3700) should not have had an increased effect as no evidence for genome
hot spots dramatically affecting the compactness of RNA have been identified [303].
Non-structural protein 2C has previously been implicated in RNA encapsidation in some
members of the picornavirus family although not directly demonstrated in FMDV. The
mutations introduced are not in the coding region of 2C. However they are in the region
encoding capsid proteins that 2C may interact with. As the changes are minimal and
non-synonymous it is unlikely they have any effect on potential interactions between 2C
and structural proteins.
As the mutations introduced are unlikely to have inadvertently affected known packaging
requirements it is reasonable to suggest the previously unidentified predicted secondary
structures identified in this study could be acting as packaging signals. In repeat ex-
periments of the same strain in both FMDV and polio the results are not exactly the
same with approximately half of the signals being evident in both repeats. I propose
a model where a series of degenerate packaging signals exist along the genome. A se-
lection of these are used by a given virus population, and the majority is reflected by
conservation in the swarm. There are some that are used with greater prevalence that
may have the strongest affinity for the capsid and represent the 50% overlap found in
repeat experiment. These structures potentially have dual purpose, being required for
processes such as replication, creating a system that allows for preferential packaging of
replication competent genomes.
The idea that viral processes are not entirely distinct is not new. Due to the small
genome length it is conceivable that RNA structures have dual purposes. For example
the internal ribosomal entry site (IRES) of poliovirus has previously been found to
have a role in encapsidation [304]. Experiments replacing the poliovirus IRES with
the IRES from encephalomyocarditis virus (EMCV) [253], hepatitus C [305], human
papilloma virus 14 (HPV14) [253] and coxsackievirus B3 [306] have all been completed
previously. In each of these experiments the chimeric viruses showed slowed growth and
a small plaque phenotype. This phenomenon has been further dissected by Johansen and
Marrow [304] who created a poliovirus replicon with firefly luciferase in place of P1 and
EMCV IRES in place of PV IRES. When packaged with vaccina virus expressing P1 the
control PV replicon packaged at 37°C with a higher yield when passaged at 33°C. The
EMCV-IRES replicon was unable to package efficiently at 37°C and, although possible
to passage at 33°C, the yield was lower than the wildtype at either temperature variable.
Both replicons were temperature stable and showed comparable amounts of luciferase
fluorescence confirming comparable replication. The authors highlighted that the IRES
was unlikely to be a singular packaging signal, as the EMCV-IRES replicon was unable
to transencapsidate into EMCV capsids, but that the IRES might function as part of
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the larger encapsidation process. This corroborates with the packaging signal identified
in this region in both poliovirus experiments.
This theory that secondary structures are multifunctional is further validated by the
identification of α and β in poliovirus 3D. These elements are functionally redundant
but at least one is required for successful replication. In each poliovirus experiment one
of these features was identified suggesting that these features are functionally redundant
in replication and packaging.
In FMDV the IRES has also been identified in both experiments as a potential part of
the packaging story. A further known structure, stem loop 1 (SL1), was also highlighted.
SL1 is within the 3’ non-coding region of FMDV between the coding region and poly-A
tail. This region has previously been shown to be required for replication [307] and has
also been identified by our analysis. As with previous studies mutating the stem loops
in this region (PPS11) resulted in a replication incompetent virus (data not shown). It
is therefore impossible to dissect the necessity of these structure for packaging without
also affecting replication, but it is possible, as with the IRES in poliovirus, that these
RNA structures are relevant for both processes.
This difficulty in separating other cellular functions from packaging coupled with the
variable nature of the packaging signal repertoire explains why this viral process has
been so difficult to elucidate. Previous experiments looking for single packaging signals
have been misleading and led to the assumption, for example, that P1 has no elements
relevant to packaging. The packing signals mutated in this work are all in a region that
has been removed by cloning (P1). The effect is subtle, as have been shown by other
experiments [304], because only a subset of the PPS are affected. This has potentially
led to it being unnoticed in experiments where packaging is not the focus of the study.
7.5 Summary
These experiments have identified regions of the genome that are less conserved in the
total population than in the encapsidated virions formed from it. These regions are
predicted to form stem loop structures. This has been identified in FMDV and po-
liovirus. It is hypothesised that these regions are involved in the packaging of viral
RNA. To asses this theory, non-synonymous mutations were introduced to create a mu-
tant FMDV where some of these structures had been eradicated. It has been shown that
the transfection and replication of both mutant and wildtype viruses is comparable (Fig.
7.10,7.11) but the titre and spread through the culture are lower and slower respectively
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in the mutant (Fig.7.14,7.12) consistent with the conjecture that it is the encapsidation
and not transcription or translation that was impeded by these mutations.
Chapter 8
Conclusions
8.1 Introduction
The study of RNA virus evolution typically considers the consensus-level viral genomes
present in an infection. Understanding how the virus evolves and survives in new environ-
ments has focused on reverse genetics. The cloning of genetic features from virus genome
to virus genome and observation of resulting phenotype has greatly expanded our under-
standing of how genomic change can affect virus survival. However, it is widely accepted
that RNA viruses exist as a swarm of genetically related variants. This is a product of
their generally error prone RNA-dependant RNA polymerases that lack proof reading
capabilities, coupled with relatively short generation times and large populations. Much
as the effects on fitness caused by changes in one part of the genome may depend on the
precise nucleotide sequence (or genotype) in other parts of the genome, the evolution
of a virus may be affected by the genetic variants present within the swarm - a form of
epistasis. Work to fully consider genetic evolution of RNA viruses can no longer focus
solely on the majority genome in the swarm, but must consider the swarm itself and the
variants within it. This study has investigated the evolution of foot-and-mouth disease
virus (FMDV) from this perspective.
8.2 FMDV swarm dynamics appear to be limited
Work was completed to consider how the dynamics of the swarm can impact fitness and
phenotype. Previous experiments focusing on poliovirus have shown that mutations that
increase polymerase fidelity, decrease viral virulence and fitness [308]. Equally, mutagens
that decrease fidelity, such as ribavirin, result in error catastrophe [137]. This suggests
that the mutant spectrum of an RNA virus like poliovirus is limited. This agrees with
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the findings of this thesis that each isolate sequenced has relatively consistent cumulative
entropy score (defined as the sum of the entropy score of each position of a genome).
In this work, the range in this value was less than 100. Considering the approximate
length of an FMDV genome is 8500nt, and entropy scores at each positions can range
from 0 to 2, cumulative entropy can theoretically range from 0 (where every position
is completely conserved) to 17000 (where each positions has an equal distribution of all
four nucleotides). This suggests that although there is the capacity for variation in this
measure, each virus swarm is able to withstand a comparable amount of variation within
it.
Distributions of entropy scores contributing to this cumulative entropy score was inves-
tigated in Chapter 6. An experiment to observe how the swarm evolves under adaptive
pressure of a new cell line in vitro was completed to understand how this swarm struc-
ture exists as a consequence of viral evolution. Analysis of the swarm structure showed
that as consensus level changes appeared, a population under adaptive pressure and a
comparative control population had a similar amount of variation within them. When
considering this at a finer resolution it became apparent that although the overall level
of variation was comparable (as represented by cumulative entropy) the distribution of
entropy scores varied. One interpretation of these findings is that as variants increase
and become fixed in the population, variation elsewhere in the genome is restricted.
This means that although there are more high level entropy positions there are less
mid-range entropy positions (with midrange positions now showing low entropy). This
makes logical sense; due to the adaptive pressure, less of the genomes produced may
be able to survive efficiently, restricting the overall size and variation of the swarm.
Conversely, under neutral conditions without selection pressures, there are numerous
genomes able to survive; consequently there are less high entropy positions associated
with consensus level changes, but more midrange positions that contribute to a larger
swarm. In addition, the swarm structure without adaptive pressure appears to cycle
between two distributions of entropy scores; a tight distribution with a low mean and a
broader distribution with a higher mean. Again this makes logical sense; as the virus
replicates it produces numerous genomes some of which will be viable some will not.
This large swarm of variation will undergo purifying selection and those that survive
will produce a smaller less variable swarm of viruses.
Further work could be completed to understand the restrictions on the populations
more fully. It would be interesting to observe if a more diverse swarm (with a larger
mutant spectrum) evolved more efficiently than a less diverse swarm: i.e. does the size
of the mutant spectrum directly affect a virus’ evolvability? This could be achieved
with experiments similar to the poliovirus polymerase experiment previously described
[137, 308]. It is important to determine if the restriction on the amount of variation the
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swarm can withstand is purely mechanical, as described above, or if the swarm has a
limit of variation as a whole which would hint at it acting as a quasi-species which is
discussed in more detail below.
8.3 The FMDV swarm may not be a quasi-species
The swarm within which FMDV exists is often termed a quasi-species [309]. However,
whether the FMDV viral swarm actually acts as a quasi-species has yet to be determined.
A ’molecular quasi-species’ was first defined by Eigen, McCaskill and Schuster [150] who
proposed a model of evolution that is strikingly different from Darwinian survival of the
fittest. Their evolutionary theory highlights that it is not necessarily the individual
that is evolving but the swarm of genetically related variants. Therefore, the term of
’fitness’ is no longer relevant to an individual virus within a swarm but the mutation
spectrum as a whole. Eigen et al suggest that the entire quasi-species is the target of
selection. Swarm structure can be affected by a complex number of factors including
environment and external parameters as well as competing neighbouring mutants in the
swarm. Furthermore Eigen et al ’s hypothesis that due to their large population sizes but
small genome sizes viral swarms may include all possible options in the neutral space
surrounding the master sequence. This suggests that because the sequences space is
fully explored, the population does not undergo genetic drift into low fitness regions but
instead evolves along high fitness ’ridges’ associated with increased fitness. Jenkins et al
explore this concept through modelling [310]. Their model argues against the concept
of FMD viral swarms being refered to as a quasi-species. They suggest that the neutral
space FMDV has the capacity to cover exceeds the populations size of a viral swarm
suggesting it cannot form the quasi-species distribution Eigen et al describe. They
propose instead a model they referred to as the ’random walk’ model which fit more
closely with traditional population genetics where each genome evolves independently.
The quasi-species being the target of selection rather than solely the genomes within
it is difficult to separate. A study by Domingo et al was completed using the RNA
phage Qβ and used T1 fingerprinting to show that comparing multiple passages showed
as similar distribution of mutants, and these mutants were diverged from the majority
by only one or two nucleotide changes. They suggested that these populations had a
constant equilibrium, a factor that would be consistent with it behaving as a quasi-
species [311]. A similar experiment in vesicular stomatitis virus (VSV) showed that
after 523 low MOI infections the T1 oligonucleotide map for each passage remained
identical [312]. This ’equilibrium’ is perhaps hinted at by the consistent cumulative
entropy score identified in this thesis. The consistent pattern seen in VSV in a low MOI
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infection was very different from similar experiments at a high MOI. High MOI infections
prompted rapid consensus level changes in and vastly more genetically different viruses
within the population. This suggest perhaps that the equilibrium in the swarm found
in these experiments is only apparent when no obvious adaptive pressure is present and
would potentially be less evident in an in vivo infection. Equally, the high MOI infection
increases swarm size introduced, and thus the potential for variation within it, and could
explain the difference between the low and high MOI results. The experiments in this
thesis have found however that the cumulative entropy score is consistent both with and
without adaptive pressure.
8.4 Selection acts on the swarm at a sub-consensus level
Although the work in this thesis cannot demonstrate that selection acts on the swarm as
a whole, there is evidence of selection acting on several different levels. In Chapter 4 work
was completed to characterise the FMD viral swarm. It was found that selection could
be identified at a within swarm level. Interestingly this level of selection differed at some
genome positions from selection at the consensus level. This identifies the concept of
FMDV proteins having functional roles that are important for replication (and observed
at the consensus level) and for higher level processes which are only apparent at the
within swarm level. Further work needs to be completed to use sub-consensus level
data to understand the selection acting on the swarm more clearly. One protein, 2A, is
thought to be highly conserved at the consensus level (as shown by Carillo et al [221])
but is highly variable within the swarm based on the data in this thesis. Understanding
what level of selection is acting on this protein to produce this affect could help in
understanding fundamental viral processes.
8.5 Sub-consensus level analysis can help reveal how di-
versity is created
Identification of these sub-consensus level features via deep-sequencing is a developing
area of research. Methods are being designed to allow for accurate deep sequencing of
RNA-swarms. These methods include, but are not limited to, the method outlined in this
thesis [170], CirSeq (designed by Acevedo et al [157]) and barcoding methodologies [163,
164]. These techniques have allowed for the accurate creation of a mutation landscape
for a poliovirus swarm [157] and the identification of low level drug resistant variants
[154, 160, 161]. The identification of these low level drug resistant variants highlights
that understanding the mutations present in a viral swarm can allow you to understand
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what genomes may evolve from it. For example, in Chapter 5, sub-consensus level
immune escape variants were identified in diverse SAT populations. Previously, the SAT
serotypes have been considered genetically and antigenically more variable than their
European counterparts (type A, type O and type C) [224, 225]. However, this thesis
offers evidence that this variability may not necessarily be only a virus specific feature
but a product of the host from which the isolate was derived. This finding changes
the way in which SAT variability should be viewed. Furthermore, this work suggests
the maintenance host, African buffalo, can sustain multiple infections simultaneously of
closely related viral genomes. This agrees with a serological study of African buffalo in
Zambia, completed by Sikombe et al, which found 68.6% of African buffalo that tested
positive for FMDV harboured mixed infections [313]. However, serological data is not
directly comparable due to this longevity of the immune response and cross-reactivity.
This could provide an environment for between serotype recombination. Further work
needs to be completed to understand why buffalo are able to maintain multiple infections
and how this contributes to FMDV epidemiology in this region. Understanding how
these infections are established is important to determine if it is a product of co-infection
or evolution of a secondary population from the originally infecting population. Work
to understand how this increased variability is passed from buffalo to cattle should be
completed to determine if a mixed population is originally contracted but cannot be
maintained in the bovine host and whether this more variable swarm affects disease
progression in the bovine host.
8.6 Sub-consensus level analysis can inform fundamental
virology studies
These types of deep sequencing experiments have the capacity to define the limits a
virus must evolve within. This has been done more generally with error catastrophe ex-
periments, but can be used more specifically to investigate functional requirements for
viral processes. For example, in this thesis, interrogating NGS data of the viral swarm
has been used to determine whether successfully encapsidated genomes are under any
form of genomic restriction. Picornavirus packaging constraints are a contested area
of research. Findings in different viruses within the family suggest different packaging
processes. In this thesis a novel approach was considered to understand packaging con-
straints without amending the genetic code through deletion analysis or cloning. This
allowed for the unbiased identification of relevant features without the risk of affect-
ing other viral processes. Sequencing of the successfully encapsidated viral population
in comparison to the total population from which it was derived revealed clusters of
constrained nucleotides. Comparison of these regions found they contained conserved
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stem loops with conservation of structures through multiple isolates. These structures
appeared to be, to an extent, functionally redundant with approximately 50% present in
replicates of the analysis. Sometimes the identified stem loops had already been found
to be necessary for replication suggesting a system where replication competent genomes
are preferentially packaged. Molecular removal of a subset of these structure through
the introduction of synonymous changes produced a mutant virus which was replication
competent but produced less viable virus and spread through the culture more slowly
than the wildtype comparison. This was potentially due to a packaging defect. Fur-
ther work can be completed to understand if an increasing number of the structures
being removed results in a more obvious phenotype. Identification of the coding loop
of the structure and how conserved this needs to be to function also needs to be com-
pleted. Work to clone these features into non-viral RNA to prompt packaging would
be a relatively conclusive demonstration of the concept. Although the bioinformatic
analysis was also completed in poliovirus, concurrent molecular experiments have not
been completed, it would be interesting to establish if a similar effect would be evident
in a poliovirus mutant. Finally it would also be interesting to establish if the proposed
packaging signals are a general feature of more picornaviruses and to understand if this
works as part of a larger packaging process involving other previously identified features
such as protein chaperones. Work in the picornavirus Aichi virus has shown one stem
loop at the beginning of the genome beneficial to packaging. However, the authors of this
work have suggested this may not be the sole determinant [278, 279]. This would agree
with what has been found in this thesis for FMDV. This novel technique allowed for the
identification of regions not necessarily conserved in sequence (and thus not represented
in the consensus) but conserved in structure.
8.7 Concluding remarks
In total this work highlights the importance of considering the viral swarm not just
the consensus genome within it. From a diagnostic perspective the swarm can disguise
immune escape mutants. Subconsensus level sequencing would allow for the identifica-
tion of these mutants and subconsensus level strains to better inform vaccine strategy.
Using swarm data in epidemiological studies may eventually allow for predictive models
explaining virus evolution, as understanding the variation present within the swarm al-
lows you to understand what can evolve from it. From a more fundamental perspective,
analysis of the swarm allows the investigation of selective pressure acting on the virus
at a subconesensus level. This has the capacity to help resolve fundamental virus traits
and understand protein functions that may not yet be known.
Appendix A
CirSeq Comparison
An experiment was designed to compare CirSeq to the method used in this thesis (Table
A.1).
CirSeq Published Protocol
TRIzol Extraction
DNase Treatment
Ethanol Precipitation
Fragmentation
Elution
Ligation
Ethanol Precipitation
Rolling Circle RT RT
Second Strand Synthesis
P:C:I Extraction
Table A.1: CirSeq comparison experimental design An experiment was de-
signed to compare elements of the CirSeq protocol with our published protocol [170].
The CirSeq protocol differs by including fragmentation of the genome, selection of the
correctly sized fragments and their elution. Ligation of the fragments into circularised
sections a clean up and subsequent rolling circle reverse transcription reaction.
The output from the two compared protocols (Table A.1) were sequenced on the Illumina
MiSeq using the Nextera XT library preparation kit. The samples represented different
percentages of the overall reads (CirSeq=4.11%, Published Protocol=5.54%). As 24
samples were multiplexed on this run each sample would expect to have ≈4.16% of
the reads attributed to it. These two figures were within this range and relatively
comparable.
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Quality of the reads was considered using FastQC which provides a graphical output of
the average quality score at each position along the read (Babraham Bioinformatics).
Figure A.1: Quality score across the read The average quality score at each
position along the read for Read One (left hand side) and Read Two (right hand side)
for CirSeq and the published protocol. The y axis represents quality score. Each base
is represented by a BoxWhisker Plot showing the median value (red line), the inter-
quartile range (yellow box) and the mean quality (blue line). Reads with a median
Illumina quality score of 30 or above are consider to be of good quality, shaded in
green. The x axis is separated into shaded bar representing 1 base for the first 10 bar
and 5 bases for the subsequent bars.
The quality of read one is better than that of read two. At least 150 positions of
read one have a ’good’ mean and median quality score (Q>30) in both protocols. In
comparison neither protocol have positions with ’good scores’ in read two. The second
run usually shows lower quality scores than the first but poor quality on this run was
notable. After communication with Illumina it became apparent that the chemistry
in the sequencing kit we were sent was not functional and as such the rotation of the
fragments between reads was unsuccessful. Due to this, data from the second read was
not used in subsequent analysis. The lower quality the latter end of read one of the
CirSeq protocol could be attributed to shorter cDNA fragments due to a less efficient
RT reaction caused by the circular nature of the template. Due to the fragmentation
and subsequent rolling circle RT, long reads are dependant on the success of the RT
reaction.
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Figure A.2: Fragment length produced by CirSeq Protocol The CirSeq analysis
software has an output that details the counts of reads with repeats from 25 - 99
bases long. This distribution can aid in diagnosis of issues with sequencing library
preparation. The counts of reads (y-axis) is show in comparsion to read length (x-
axis). This represents not actual length of the read but the length of the tandem
repeat.
Maximum coverage was 375x and 10,226x for CirSeq and the published protocol respec-
tively. This coverage for the CirSeq protocol was too low for the published software to
make accurate observations regarding mutation frequency and transition/transversion
ratios. In the work completed by Acevedo et al the samples run with the CirSeq proto-
col were not multiplexed [157]. In this work each sample is multiplexed in a total of 24
samples. As in CirSeq each read represents tandem repeats, the coverage that can be
achieved is automatically 3x less than it could be. It could be that to achieve sufficient
coverage for subsequent analysis samples need to be run non-multiplexed. The reads
created in the protocol could also have been too short for the analysis. In order for the
CirSeq analysis to be used each read must represent three repeats of the same region
otherwise the read is discarded. As the quality scores suggest that some of the reads
could be shorter than 250bp they would not contain three complete repeats and thus
be discarded. Samples selected should have been between 80-90nt. The protocol did
output some reads of the correct length however (Fig. A.2) and this was not entirely
unsuccessful.
Appendix B
Un-used protocol optimisation
steps
B.0.0.1 Removing host material
FMDV is a polyadenylated virus. The poly(A)tail at the 3’ end of the genome is the
site of one of the FMDV specific reverse transcription primers (Rev6) described in the
published methodology paper by Logan et al [170]. Ribosomal RNA (rRNA) also has
a poly(A)tail which acts to protect the RNA from degradation and is involved in it’s
functionality. Due to these common motifs there is some back ground level of rRNA
in the sequencing data produced from the published protocol. To address this issue
and improve the percentage of reads aligning to the FMDV genome an rRNA depleting
kit was tested. RiboMinus (ThermoScientific) selectively depletes ribosomal RNA. Ri-
boMinus involves a probe that specifically targets rRNA. This probe is linked to biotin
allowing for rRNA to be removed using steptavadin bound magnetic beads. This kit
has, as yet, only been validated against mouse and human ribosomal RNA. Therefore
it was tested for it’s specificity of bovine rRNA. RiboMinus depletion was completed as
per manufacturers instructions and depletion of ribosomal RNA confirmed by analysing
the sample before and after via gel electrophoresis on the Agilent bioanalyser.
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Figure B.1: RiboMinus efficiently depletes bovine rRNA Bioanalyser traces of
Extracted RNA is shown A) before and B) after RiboMinus depletion. The trace shows
in graphical form the fluorescence units (FU) produced at each bp over time (s). This
is duplicated in a gel format. Experiment completed by Eleanor M. Cottam.
The first peak is a marker input during sample preparation. The small peaks present
just after the marker in sample A represent 5S and 5.8S subunits, tRNA and small
RNA fragments. The next two large peaks represent the 18S and 18S ribosomal peaks.
These are clearly visible in the bioanalyser trace before treatment (Fig. B.1 A) but are
depleted after RiboMinus treatment (Fig. B.1 B). This suggests riboMinus treatment
efficiently reduces the ribosomal RNA present in the sample.
Having confirmed the kits ability to deplete bovine rRNA, RiboMinus was used in a
direct sequencing comparison. In this comparison a 17 fold increase was seen in the
number of reads aligning to the FMDV genome. Ribominus treatment also resulted in
more even coverage and more of the genome being represented (only 21nt unrepresented
compared to 148 in the non-treated sample). The increased amount of the genome
covered and more even coverage is likely a product of the higher number of FMDV reads
present.
Although this product provided marked improvement in number of reads aligned to the
genome the cost was deemed impractical on the PhD budget. RiboMinus treatment
costs approximately £95 per sample.
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B.0.0.2 Improving end coverage
As detailed in the published method, coverage at the ends of the genome is lower or
non-existent. This is particularly apparent at the 5’ end of the genome. In an attempt
to overcome this bias work was completed to circularise the genome.
To aid in the ligation of the genome an oligo ’bridge’ was designed. This oligo was
complimentary to the FMDV genome ends holding them closer together to increase
the chance of ligation. This bridge was biotinylated to allow for specific selection of
bound RNA using streptavidin beads. Primers were also designed to allow for PCR
confirmation of the ligation of the genome ends. These oliogs are detailed in Table B.1.
Oligo Name Sequence (5’→3’)
Oligo Bridge ATATGCGATCGCCCTTRCGCCCCYTTTCAATTTTTTTTTTT
TTTTTTT
Circ Primer 1.4 CGCGGTCCCGTGAGTCCAG
Circ Primer 2.1 TCCAGGCTACAGATCACTTTACCTGC
O-1C272F TBGCRGGNCTYGCCCAGTACTAC
EUR-2B52R GACATGTCCTCCTGCATCTGGTTGAT
Table B.1: Oligos created for genome circularisation Oligos were designed to
bridge the ends of the genomes together to allow for efficient ligation (Oligo bridge).
PCR primers were then designed to confirm this ligation had been successful (Circ
Primer 1 and 2). Primers for VP1 were also used as a control (O-1C272 forward and
EUR-2B52 reverse)
After TRIzol extraction and DNase treatment an annealing and ligation step was added
to the protocol. An annealing solution was created by combining 100µL of 5M Sodium
Chloride (NaCl), 1µL of 0.5M EDTA, 50µL of 1M Tris HCL and 4849µL of nfH2O. An
annealing reaction was assembled by combing 20µL of annealing solution (as described
above) with 10µL of RNA and 5µL of Bridge Oligo (10µM). This reaction was heated
to 72 degrees for three minutes to allow for the bridge to anneal to the RNA and then
incubated on ice for three minutes to stop the reaction. To the annealing reaction 5µL
of ligation buffer, 1 unit of RNase Ligase (NEB), 8µL of nfH2O and 1 unit of RNase
OUT(ThermoScientific) was added and the reaction was heated to 37°for 15 minutes
and boiled for two minutes to terminate.
Two separate RT-PCR reaction was completed using the Qiagen One-step RT-PCR kit
to check for the presence of FMDV genomes (VP1 primers O-1C272 forward and EUR-
2B52 reverse, Table B.1) and check for successful circulariastion of the genome (Circ
Primers, Table B.1).
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The reaction mix included 8µL of nfH2O, 5µL of 5x buffer, 1µL of dNTPs, 2.5µL of the
forward and reverse primer required, 1 unit of enzyme and 2.5µL of RNA. Samples had
an initial RT step of 50°for 30 minutes followed by a PCR activation step of 95°for 15
minutes. 45 cycles of denaturation (95°- 15 seconds), annealing (55°- 15 seconds) and
extension (72°- 60 seconds) before a final extension step at 72°for 5 minutes.
PCR products were subjected to electrophoresis through a 1 % agarose gel containing
ethidium bromide and visualised by trans illumination with UV light. The presence of a
PCR product of 1000bp in the reaction containing VP1 primers indicated the presence
of FMDV genome in the starting sample (Fig. B.2). The presence of product of 400bp
in the reaction containing bridge primers indicated the sucessful circularisation of the
genome. There was evidence of some non specific priming in the latter reaction as shown
in the fainter bands representing different lengths of product.
Figure B.2: PCR of genome circularisation Agarose gel electrophoresis products
generated. Lane 1 contains HyperLadder 1, Lane two contains PCR product represent-
ing VP1 (O-K 272F and OK 272R) and lane three contains PCR product representing
the bridge between the beginning and end of the genome(Circ Primer 1.4 and Circ
Primer 2.1)
Circularised samples were used in RT and second strand synthesis reactions described
above. PCI clean-up and subsequent Nextera XT prep was completed. Coverage of the
genome termini was compared between a sample with and without genome circularisa-
tion.
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Figure B.3: Circularised genomes offer better end coverage Sample prepa-
ration including genome circularisation steps (red) and lacking genome circularisation
steps (blue) was sequenced and aligned to a reference genome as detailed in the pub-
lished protocol [170]. Coverage (y-axis) was established from the alignment using bed
tools and graphed in comparison to genome position (x-axis) for the 20nt at each end of
the genome. In the circularised genome all positions achieved some coverage (11-454x)
in the non circularised sample no coverage was achieved for this region.
Without circularisation essentially no coverage of the first and last 20nt of the genome
was achieved. With circularisation all of these region were represented with coverage
ranging from 11x-454x (Fig. B.3). Therefore coverage achieved for the genome termini
was improved with genome circularisation. However, there is still a noticeable dip.
This suggests only a small proportion of genomes were successfully circularised. This is
corroborated by the increased VP1 product in comparison to the bridge product (Fig.
B.2).
Although this methodology clearly improves end coverage it introduces a notable bias.
This selection of genomes bound to the bridge oligo results in the selection of only full
length genomes. This would not be fully representative of the viral genomes present in
the swarm as the large number of truncated genomes would not be included. Even with-
out streptavaidin selection of bridge bound particles the extra annealing step decreases
the copies of RNA present dramatically (1.99x1011 copies lost). The high temperature
termination step is likely to be resulting in degradation of genomes.
As the work in this thesis is considering the viral swarm rather than the genome termini
genome circularisation was not used in general sample preparation. However, it should
be noted as a useful asset when trying to achieve full genome sequences.
Appendix C
Adaptive passage low coverage
investigation
C.0.0.1 Some samples had low overall coverage
Forty one samples were sequenced on the Illumina Miseq (11x population expansion, 15x
BFA adaptation and 15x BHK control). In an attempt to achieve high coverage only
24 samples were multiplexed on each run instead of the maximum 96. This resulted in
the samples being sequenced on two separate runs. Run one included inoculum, e1-10
and H1-8. Run two included H9-15 and F1-15. Both runs had acceptable quality scores
with 80.50% of the reads in run one having an average quality score of 30 or above and
85.18 % of the reads in run two. The percentage of clusters on the flow cell that passed
filter (%PF) was also good; 92.56% and 95.52% respectively. This is a measure of signal
purity from each cluster and shows that clusters are not close enough together to produce
problems with fluorescent signal overlap. The second run having higher values for each
of these measures is likely due to it being under clustered. During the normalisation
step of sample preparation for read two the shaker being used failed. This is reflected
in the output. The incorrect normalisation procedure resulted in underclustering of the
flow cell. Cluster density is an important parameter that can greatly affects run quality.
Although under clustering does not affect the quality of the reads or the proportion of
clusters passing filter, it does result in a lower data output. Run one produced 7.87GB
or data compared to only 4.46GB of data for run two. As there were less clusters
representing each sample, less reads were produced and therefore these samples had
lower coverage.
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Figure C.1: Samples with less reads attributed to them contain a lower
percentage of FMDV reads. The total number of reads attributed to each sequenced
sample for virus passaged in BHK cells (dark blue, circle) and virus passaged in BFA
(dark red, square). The number of reads that aligned to the FMDV genome is also
shown for virus passaged in BHK cells (light blue, circle) and BFA cells (light red,
square.) Passages marked with an ’x’ were on run 2.
The majority of samples sequenced on the first run have approximately 1000000 reads
attributed to them (average 1318024). The only two samples on this run that have less
than this are e3 and e4 which have 52965 and 14516 reads respectively. The second read
are in the same range as these two low samples with an average total number of reads
as 473292.5. The number of reads that align to the FMDV genome is slightly less than
than the total reads. This is to be expected as some reads associated with the bovine
host are likely. This difference between the total reads and FMDV reads seems to be
exaggerated the lower the number of total reads (Fig. C.1).
C.0.0.2 Low coverage equates to a lower percentage of reads being FMDV
Correlation analysis was completed to see if a decrease in the number of total reads
resulted in a decrease in the proportion of the reads that aligned ot the FMDV genome.
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Figure C.2: Decreased total number of reads correlates with the proportion
of reads that are FMDV A)Total reads against the percent of total reads that
align to the FMDV genome is shown. The data is not normally distributed and thus
a non-parametric test was completed to consider correlation. A two tailed Spearman
correlation was completed with a 95% confidence interval. This showed there was
significant correlation between the total number of reads and the percentage of these
reads that aligned to the FMDV genome (p<0.0001). B) No significant correlation
was found between viral titre and the number of reads aligning to the FMDV genome
(Spearman’s correlation, p=0.9437)
Comparing the percentage of reads identified as FMDV and the total number of reads
showed a monotonic relationship. Correlation analysis showed a significant correlation
between these two parameters (Spearmans, p=<0.0001)(Fig. C.2A).
This phenomenon is difficult to explain. One cause could be some level of inefficiency in
the virus specific primers. This would decrease both the overall efficiency of the reverse
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transcription (RT) reaction and the proportion of sample that were FMDV. What makes
this unlikely is that each set of samples was processed as a batch of 5 i.e. F1-5, F6-
10 and F11-15. In every instance where possible (i.e. the RT reaction) master mixes
were made and thus it would be expected that any preparation induced issue would be
evident in all five samples processed together which is not the case here. Each sample
was Qubit quantified and diluted to 0.2ng/µL before library preparation so the amount
of double stranded DNA at this point should be comparable. Qubit quantification relies
upon fluorescent dies that are specific to the target of interest. These dyes are designed
to emit only if bound to this molecule. This therefore does not differentiate between full
length dsDNA and fragments or partially degraded DNA. Therefore it is possible that
although the quantity of dsDNA was comparable the length of the DNA was not. Again
this would have to have been caused by sample preparation steps but remains confusing
as not all samples in each batch showed the same low percentage of FMDV reads. Gel
electrophoresis of the sample at each stage of the process to asses nucleic acid length
would help to asses if an issue arises during sample preparation but could result in lower
overall yield due to loss of sample to each gel.
This could also have been caused by low titre of input virus. However when considering
virus titre there appears to be no correlation between titre and percentage of reads
aligning to FMDV (Spearmans, p=0.2439) (Fig. C.2B).
Due to these issues with normalisation and the proportion of reads aligning to the FMDV
genome not all samples had a sufficient quantity of their genome represented by >1000x
coverage for further analysis.
Appendix D
Scripts Used
Listing D.1 and D.2 were written by Rocio Enriques-Gasca at TGAC. The shell script nt
count.sh runs an Rscript eleano.r which counts the number of each nucleotide represented
in the sequencing data at each position along the genome and outputs this information
in tabular format.
#!/bin/sh
i=$1
#source R -2.15.0
awk ’{print $1"\t"$2"\t"$3"\t"$4"\t"$5}’ $i | sed ’s/+.\w
\+/+/g’ | sed ’s/-.\w\+/-/g’ | sed ’s/\^.//g’ | sed ’s/\
$//g’ > filtered_${i}
Rscript eleano.r filtered_${i}
rm filtered_${i}
Listing D.1: nt count.sh -Written by Rocio Enriquez-Gasca
args <-commandArgs(TRUE)
pos <-read.table(args[1], sep="\t", header=FALSE)
cero <-rnorm ((nrow(pos)*9), 0, 0)
val <-matrix(cero , nrow(pos), 9)
#a=1, c=2,g=3,t=4
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states <-c("A", "C", "G", "T", "\\+", "\\-")
for(i in 1:( nrow(pos))){
bases <-strsplit(as.character(pos$V5[i]), split="")
val[i, 1]<-pos$V1[i]
val[i, 2]<-pos$V2[i]
val[i, 3]<-pos$V3[i]
if(pos$V3[i]=="A"){
val[i, 4]<-length(grep("\\.", bases [[1]]))+
length(grep(",", bases [[1]]))
val[i, 5]<-(length(grep("c", bases [[1]]))+
length(grep("C", bases [[1]])))
val[i, 6]<-(length(grep("g", bases [[1]]))+
length(grep("G", bases [[1]])))
val[i, 7]<-(length(grep("t", bases [[1]]))+
length(grep("T", bases [[1]])))
val[i, 8]<-(length(grep("\\-", bases [[1]]))
)
val[i, 9]<-(length(grep("\\+", bases [[1]]))
)
}else if(pos$V3[i]=="C"){
val[i, 4]<-(length(grep("a", bases [[1]]))+
length(grep("A", bases [[1]])))
val[i, 5]<-length(grep("\\.", bases [[1]]))+
length(grep(",", bases [[1]]))
val[i, 6]<-(length(grep("g", bases [[1]]))+
length(grep("G", bases [[1]])))
val[i, 7]<-(length(grep("t", bases [[1]]))+
length(grep("T", bases [[1]])))
val[i, 8]<-(length(grep("\\-", bases [[1]]))
)
val[i, 9]<-(length(grep("\\+", bases [[1]]))
)
}else if(pos$V3[i]=="G"){
val[i, 4]<-(length(grep("a", bases [[1]]))+
length(grep("A", bases [[1]])))
val[i, 5]<-(length(grep("c", bases [[1]]))+
length(grep("C", bases [[1]])))
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val[i, 6]<-length(grep("\\.", bases [[1]]))+
length(grep(",", bases [[1]]))
val[i, 7]<-(length(grep("t", bases [[1]]))+
length(grep("T", bases [[1]])))
val[i, 8]<-(length(grep("\\-", bases [[1]]))
)
val[i, 9]<-(length(grep("\\+", bases [[1]]))
)
}else if(pos$V3[i]=="T"){
val[i, 4]<-(length(grep("a", bases [[1]]))+
length(grep("A", bases [[1]])))
val[i, 5]<-(length(grep("c", bases [[1]]))+
length(grep("C", bases [[1]])))
val[i, 6]<-(length(grep("g", bases [[1]]))+
length(grep("G", bases [[1]])))
val[i, 7]<-length(grep("\\.", bases [[1]]))+
length(grep(",", bases [[1]]))
val[i, 8]<-(length(grep("\\-", bases [[1]]))
)
val[i, 9]<-(length(grep("\\+", bases [[1]]))
)
}
}
write.table(val , "bases.txt", quote=FALSE , sep="\t", row.
names=FALSE , col.names=c("Seq Name", "Position", "Base
in the reference", "A", "C", "G", "T", "Insertions", "
Deletions"))
Listing D.2: eleano.r - Written by Rocio Enriquez-Gasca
EntropyCalc.py (listing D.3) is a python script that uses R to calculate Shannon’s en-
tropy as out put from the nt count script included above.
#!/usr/bin/python
##GracieLogan ##
’’’usage - python EntropyCa.py inputfile.txt ’’’
import sys
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from rpy import r
bases =(sys.argv [1]) #import file
f=open(’Entropy.txt’,’w’) #make new file called Entropy
f.write(’EntropyScore ’)
f.write(’\n’)
f.close ()
with open (bases) as fi: #calling the open file f
for line in fi: #for each line in f
try:
#turn each item into a float (as split by split)
numbers_float = map(float ,line.
split ())
#creating a sum by adding total of ACG and T together
sum = (( numbers_float [3])+(
numbers_float [4])+( numbers_float [5])+( numbers_float
[6]))
try:
Ae1 = str (((( numbers_float
[3])/sum)*(r.log2(( numbers_float [3])/sum))))
#A entropy (turned into a string)
if Ae1 == ’nan’:
#if A entropy is not a number
Ae1 = 0
#report it as zero
else:
Ae1 = Ae1
except ZeroDivisionError:
Ae1=0
try:
Ce1 = str (((( numbers_float
[4])/sum)*(r.log2(( numbers_float [4])/sum))))
if Ce1 == ’nan’:
Ce1 = 0 #report it
as zero
else:
Ce1 = Ce1
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except ZeroDivisionError:
Ce1=0
try:
Ge1 = str (((( numbers_float
[5])/sum)*(r.log2(( numbers_float [5])/sum))))
if Ge1 == ’nan’:
Ge1 = 0
else:
Ge1 = Ge1
except ZeroDivisionError:
Ge1=0
try:
Te1 = str (((( numbers_float
[6])/sum)*(r.log2(( numbers_float [6])/sum))))
if Te1 == ’nan’:
Te1 = 0
else:
Te1 = Te1
except ZeroDivisionError:
Te1=0
#changing string back into a float
Ae = float(Ae1)
Ce = float(Ce1)
Ge = float(Ge1)
Te = float(Te1)
#adding it together
EntropyScore = -(Ae+Ce+Ge+Te)
f1=open(’Entropy.txt’,’a’)
f1.write(str(EntropyScore))
f1.write(’\n’)
f1.close ()
except ValueError:
pass
Listing D.3: EntropyCalc.py
NS mpileup cutoff.1.0.2.py is a python script written by Nick Sanderson that implements
a coverage cut-off on an mpileup file.
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#!/usr/bin/env python
import sys
# usage pipe to -> | python NS_mpileup_cuttoff.py limit |
# where limit equals your coverage cut -off
target = sys.stdin # data from pipe |
limit = int(sys.argv [1])
def ignoreIndel(seq , qual): # function to get limit of
each
n = 0 # total number of reads
s = 0 # total number in string
seq2 = [] # list to add sequences strig to
while n < limit: # while total n reads is below limit
if seq[s] in OK_list: # increase n if bona -fide
read in OK_list
s = s + 1
n = n + 1
elif seq[s] in insertion: ## this adds teh exact
amount dependent on the insertion
s = s + 2
s = s + int(seq[s-1])
# elif seq[s] in deletion: ## this adds the exact
amount dependent on the deletion
# s = s - 1
# n = n + 1
# s = s + int(seq[s-1])
else:
s = s + 1 # go to next in string
for r in range(s): # iterate through total string
range which contains n reads
seq2.append(seq[r]) # add to list
seq3 = "".join(seq2) # join list to create string
return seq3 # return string from function
insertion = set()
#deletion = set()
insertion.add("+")
Appendix D. Scripts Used 192
insertion.add("-")
#deletion.add ("*")
OK_list = set() # create OK_list set , list of allowed
sequence
OK_list.add(".")
OK_list.add(",")
OK_list.add("a")
OK_list.add("A")
OK_list.add("c")
OK_list.add("C")
OK_list.add("t")
OK_list.add("T")
OK_list.add("g")
OK_list.add("G")
OK_list.add("*")
#OK_list.add("$") # these don’t actually count as reads ,
just signal the end of a read , F and K represent quality
too
#OK_list.add ("^")
for line in target: # for each line from the pipe
l = line.split("\t") # split line on the tab to make
list l
if int(l[3]) > limit: # if greater than limit than do
sequence = str(l[4])
quality = str(l[5])
qual4 = quality [0: limit]
seq4 = ignoreIndel(sequence , quality) # run
function with sequence string to generate cut off seq4
print str(l[0]) + "\t" + str(l[1]) + "\t" + str(l
[2]) + "\t" + str(limit) + "\t" + seq4 + "\t" + qual4
else: # or do this
print line.replace("\n","")
Listing D.4: NS mpileup cutoff.1.0.2.py - Written by Nick Sanderson
Appendix E
Comparison Genomes
Samples used in MLT Fig.5.7.
Genbank Number Isolate
HM067706.1 SAT1/Buff/17/QE
HM067705.1 SAT2/Buff/10/QE
HM067704.1 SAT2/Buff/6/QE
AF540910.1 SAT2/ZIM/7/83
KM268901.1 SAT3/ZIM/6/91
KM268900.1 SAT2/TAN/5/2012
KM268899.1 SAT1/TAN/22/2012
KJ820999.1 SAT3/UGA/1/13
KC440884.1 SAT2/EGY/3/2012
JX014256.1 SAT2/PAT/1/2012
JX014255.1 SAT2/EGY/9/2012
KU821592.1 SAT2/ZAM18/2009
JF749864.1 SAT2/ZIM/22/2003
JF749862.1 SAT2/UGA/002/2002
JF749861.1 SAT2/KEN/002/2002
JF749860.1 SAT1/KEN/004/2002
FJ461346.1 SAT2/MFNP
KU821590.1 SAT1/NAM01/2010
KR108950.1 SAT3/KNP/10/90
KR108949.1 SAT2/KNP/19/89
KR108948.1 SAT1/KNP/196/91/1
AY593853.1 SAT3/4bech/iso23
AY593852.1 SAT3/3kenya/iso22
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AY593851.1 SAT3/3bech/iso29
AY593850.1 SAT3/2sa/iso27
AY593849.1 SAT2/3kenya/21
AY593848.1 SAT2/iso25
AY593847.1 SAT2/1rhod/iso26
AY593846.1 SAT1/rhod/iso33
AY593845.1 SAT1/bot/iso47
AY593844.1 SAT1/7isrl/iso12
AY593843.1 SAT1/6swa/iso16
AY593842.1 SAT1/5sa/iso13
AY593841.1 SAT1/4srhod/iso24
AY593840.1 SAT1/3swa/iso14
AY593839.1 SAT1/20/iso11
AY593838.1 SAT1/1bech/iso30
AJ251473.1 SAT2/KEN/3/57
Unpublished O1K
Unpublished SAT3/BOT/109/66
Unpublished SAT3/BOT/BUFF/13/70
Unpublished SAT3/RHO/7/74
Unpublished SAT3/RV/7/34
Unpublished SAT3/UGA/BUFF/27/70
Unpublished SAT3/ZIM/2/84
Unpublished SAT3/ZIM/P6/83/BUFF/19
Unpublished SAT1/UGA/47/71
Unpublished SAT2/ZIM/8/89
Unpublished SAT2/ZAM/BUFF/18/74
Unpublished SAT2/UGA/BUFF/24/70
Unpublished SAT2/UGA/BUF/12/70
Unpublished SAT2/SRHO/1/65
Unpublished SAT1/NR/1/64
Unpublished SAT2/ETH/1/90
Unpublished SAT2/BOT/BUFF/170/74
Unpublished SAT2/BOT/BUFF/107/72
Unpublished SAT2/BOT/BUFF/17/69
Unpublished SAT2/BOT/BUFF/7/72
Unpublished SAT2/BOT/BUFF/2/69
Unpublished SAT2/BOT/BUFF/2/68
Unpublished SAT1/UGA/BUF/10/70
Unpublished SAT1/SWA/2/89
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Unpublished SAT1/MOZ/5/81
Unpublished SAT1/K303/83
Unpublished SAT1/BOT/BUFF/62/74
QuRe80.21477356739344
QuRe18.349784802998503
QuRe1.4354416296080705
Table E.1: Genomes used to create MLT
Samples used in LocaRNA analysis (Chapter 7).
Genbank Number Isolate
AY593826.1 type O2brescia, iso17, 1947
AY593825.1 type O1valle, iso64, 1953
AY593812.1 type O10phil, iso76, 1958
AY593830.1 type O7polland, iso49, 1959
AY593813.1 type O1indonesia, iso52, 1962
AY593837.1 type Ouraguay, iso51, 1963
AY593820.1 type Ocanefa, iso59, 1964
AY593814.1 type O1argentina, iso5, 1965
AY593834.1 type Orey-iran, iso53, 1966
AY593815.1 type O1bfs, iso18, 1967
AY593823.1 type O1manisa, iso87, 1969
AY593827.1 type O3venezuela, iso15, 1971
AY593817.1 type O1brugge, iso79, 1973
AY593835.1 type Otaiwan, iso106/112, 1997
AY593833.1 type Openghu, iso108, 1999
AJ539139.1 type O, strain SKR/2000
AJ633821.1 type O/FRA/1/2001
EF614457.1 type O/SKR/14/02
HQ632770.1 type O MAY/1/2004
HQ632771.1 type O MAY/8/2005
FJ175666.1 type Oisrael 07-6387
GU384682.1 type O/PAK/44/2008
JN998085.1 type O/BY/CHA/2010
Table E.2: Genomes used for LocARNA Analysis
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Additional Coverage Graphs
F.1 Coverage Zam/Nan/11
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Figure F.1: Coverage of Zam/Nan/11 (Log scale) The coverage of each position
a long the genome is shown
Zam/Nan/11 showed an unusual distribution of nucleotides in Chapter 5, Fig. 5.3 at
6000-7000nt. This does not equate to a dramatic fluctuation in coverage Fig. F.1. There
is some variation in the coverage (Fig. F.2) but this is evident from 2000-7000nt. The
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unusual distribution of nucleotides does not span this entire area suggesting the two are
not related.
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Figure F.2: Coverage of Zam/Nan/11 The coverage of each position a long the
genome is shown
F.2 Coverage KNP/196/91
SAT KNP/196/91 was used in a haplotype reconstruction in Chapter 5. Typically QuRe
is less successful in low coverage genome regions. The point at which the reconstruction
fails (after the structural region) does not coincide with drop in coverage.
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Figure F.3: Coverage of KNP/196/91 (Log scale The coverage of each position
a long the genome is shown
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